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ABSTRACT

Macroalgae are an abundant and diverse group of organisms. Their
polysaccharides are successfully utilised in industry due to their rheological
properties, but the diverse and unique functional metabolites in macroalgae
are still poorly exploited. This holds a lot of promise for health and
nutritional applications. However, the variability across taxa and shifting
metabolites in response to environmental conditions has resulted in an
inconsistent or complex story of nutritional and health opportunities from
macroalgae. In addition, the methods used to analyse metabolites from
sources other than macroalgae may not be directly transferable, due to
peculiarities of the algal organic tissue matrix. Therefore standardising the
methods for characterisation of important macroalgal metabolite profiles
and the cultivation effects on metabolites of target taxa are two of the aims
of this work. Consistent and validated metabolic and compositional
metabolite profiles will be required to deliver traceable, quality-controlled
biomass with optimal chemistries for applications in health and nutrition.
South Eastern Australia is a diversity hot spot for algal flora and species
endemism, yet it is poorly understood which species should be targeted for
cultivation towards food and health markets. Here for the first time, typical
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Abstract

macroalgae of the Eastern temperate coastal zone of New South Wales
(NSW), Australia were explored including the taxa Hormosira banksii,
Phyllospora comosa, Myriogloea sciurus, Ecklonia radiata, Solieria
robusta and the green macroalgae Ulva.1 Particular attention was directed
towards their fatty acid (FA) profiles, anti-inflammatory, anti-oxidant and
cell toxicity or functionality. In doing so, robust methods were tested and
developed to establish optimal protocols for effective metabolite extraction
and characterisation.
All taxa showed variable FA profiles with Ulva sp. representing the most
desirable (n-6/n-3 ratio of 0.4) and the only species to contain the FA
C22:6n-3 in this research. All non-polar extracts strongly inhibited the
production of the inflammatory-mediator nitric oxide (NO). Furthermore, it
was demonstrated for the first time that Ulva extracts were non-toxic on a
primary cell line whilst selectively exhibiting toxicity against pancreatic
cancer cells in vitro.
Application of an optimised extraction protocol revealed nutrients to be the
key growth factor for the quality and quantity of Ulva FA. Neutral lipids can
be increased by nutrient starvation, however at a detriment to FA quality.
Under optimal growth (high nutrients) Ulva yields 56 mg of lipids per gram
of dried biomass (mg.g-1 d.w) that is rich in polyunsaturated fatty acids
(PUFA, 54%) with a low n-6/n-3 ratio (0.2) and high levels of C18:4n-3,

1

Species name withheld for proprietary reasons
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C20:5n-3 and C22:5n-3. The standardised preparation of samples was a
vital consideration as analysis of dried biomass, when compared to a fresh
extraction protocol, resulted in a loss of 84% in yield and therefore a
substantial underestimation of lipid content.
Under optimal growth conditions, Ulva can further yield 1.5 mg.g-1 d.w total
chlorophyll, 0.1 mg.g-1 d.w carotenoids, 1.6 mg.g-1 d.w phenolics and 0.2
mg.g-1 d.w flavonoids. Low nutrient growth conditions reduced the presence
of pigments by 98%, phenolics by 34% and anti-oxidant activity by 87%,
whilst substantially increasing flavonoid content (5-fold). All extracts from
cultivated Ulva samples inhibited NO (≥76%) although acetone extracts
demonstrated higher inhibition (94 - 97%) than ethanol extracts (76 - 91%).
Furthermore all pigment and phenolic yields were strongly influenced by
extraction solvent (e.g. acetone versus ethanol).
These results together present quantitative yields for two major and biofunctionally important metabolite classes from macroalgae (FA and
phenolics). The highest yield of FA with a nutritionally favourable profile
was 5.6% d.w. in Ulva sp. when extracted using chloroform and methanol
(2/1 v/v). Furthermore, when extracted with ethanol (100%) a yield of 4.1%
d.w. total FA can be achieved along with the highest yielding phenolic
content (0.2% d.w.) under optimised culture. This FA yield (% d.w.) for
Ulva is one of the highest yields reported in the literature. Thus the FA
content of this Australian cultivated macroalgal biomass together with its
xi
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high phenolic content and anti-inflammatory activities has the potential for
applications in food and health markets. This is an essential step forward in
delivering robust and reliable methods of production and analysis that can
be applied to deliver regulatory standards and nutritional or health claims
from macroalgal biomass.
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PREFACE

The work presented in this thesis is part of a collaboration with industry partner Venus
Shell Systems Pty. Ltd.3 This is a local company based in Nowra (NSW, Australia) that
grows quality controlled seaweed biomass targeted for use in high value products.
Venus Shell Systems collaborates with Manildra Group Pty. Ltd (Bomaderry, NSW,
Australia), which is home to the largest flour mill in Australia. Manildra Group strives
for constant innovation to supply industries with a diverse product range from food,
health ingredients, fuel and energy.4 As a result of this innovation carbon dioxide (CO2)
waste product from the Manildra plant is piped and pumped directly into the algal
cultivations, promoting a clean and sustainable industry practice. Venus Shell Systems
is also a partner of Blue Biotech Shoalhaven, an innovative industry group that has been
established to promote local innovation within the community (Shoalhaven, NSW,
Australia) and member businesses in aquatic biotechnology.5 All research presented
within this thesis contributes to the future product development opportunities that are
currently being scoped by Venus Shell Systems.
The macroalgae investigated within this thesis include species collected from the South
East coast of Australia, along with a cultivated Australian Ulva sp. (Chlorophyta).

3

http://www.venusshellsystems.com.au
http://www.manildra.com.au
5
http://www.bluebiotech.com.au
4
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Preface

The cultivated Ulva is provided by Venus Shell Systems and is cultured using
proprietary methods. Therefore the specific cultivation details and species information
are withheld.
This thesis consists of seven chapters with the work presented in journal article style.
Chapter 1 offers a general introduction to macroalgae and macroalgal chemistries,
highlighting the reported bioactivities of algal metabolites and extracts. It presents the
current state of the seaweed industry and the areas for future growth and expansion and
presents the aims of this thesis.
Following on from the introduction, Chapter 2 is a published book chapter that covers
the rationale and methods of two anti-cancer screening assays, one of which is routinely
used and referred to throughout this thesis, presented in thesis format. Following on,
each subsequent chapter (Chapters 3-6) is presented as a complete manuscript and is a
combination of both published (final accepted versions) and prepared manuscripts in
thesis format. The status of each manuscript will be defined in the foreword to each
chapter.
The foreword to each chapter will link the separate works together. Where necessary,
further unpublished findings that resulted from that body of work will be incorporated
as part of the relevant chapter and presented immediately after the manuscript titled
“Further Investigations”.
After the presentation of each manuscript (Chapter 3-6) a general discussion with
future recommendations is provided (Chapter 7). This is followed by a brief
xvi
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Conclusion and the Appendices. Due to the journal article style of this thesis
references are provided at the end of each chapter.
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Seaweed
Seaweeds inhabit the rocky intertidal and subtidal coastal zones all over the world
(Figure 1). Seaweed refers to all large macroalgal species that are either classified as
belonging to the class Ochrophyta or Phaeophyta (brown macroalgae), Rhodophyta (red
macroalgae) or Chlorophyta (green macroalgae). The aquatic environment of marine
macroalgae is competitive and constantly changing with many abiotic stressors.
Combined with complex reproduction cycles marine macroalgal species are highly
diversified with an estimated 72,500 species described [1]. This has resulted in
macroalgae exhibiting a large array of chemical constituents known as secondary
metabolites [2, 3] and includes terpenes, phenols, fatty acids (FA), lipopetides, amides,
alkaloids, terpenoids, lactones, pyrroles and sterols [4, 5].

i

ii

iii

iv

Figure 1 (i) Diversity hot spot for macroalgae at Seven Mile Beach, Gerringong, South East Coast of
NSW, Australia (04/04/2011); (ii) freshly washed ashore samples of Ecklonia Radiata and Phyllospora
comosa being collected from a drained intertidal rock swimming pool (iii) Hormosira banksii inhabiting
the intertidal rock pools (iv) Ecklonia radiata (bottom left) and Phyllospora comosa (top).
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Metabolites are classified as either secondary or primary. Primary metabolites include
carbohydrates, proteins and nucleic acids. These compounds occur via fundamental
biosynthetic pathways and are essential for survival. In contrast, secondary metabolites
are derived from these primary metabolites and occur via highly variable biosynthetic
pathways and shift more readily in response to environmental pressures [6-8].
Secondary metabolites have many roles in chemical signalling and can exhibit varying
degrees of bioactivity. Bioactivity has been defined as metabolic or physiological
response as a result of a molecule or ion binding to a ligand [9]. As macroalgae are
abundant and very easy to collect, they have been extensively explored in natural
product research. Their isolated secondary metabolites and/or extracts exhibit an array
of beneficial in vitro and in vivo biological activities. This is often accompanied with
minimal toxicities [10-12] when compared to other marine organisms, such as
dinoflagellates (harmful algae blooms) [13] or deep-sea marine organisms [14].
However, some macroalgal species do also produce toxins, such as domoic acid in
Chondria armata (Rhodophyceae) [15] and caulerpin in Caulerpa taxifolia
(Chlorophyceae) [16]. Thus as the opportunities for macroalgal cultivation increase,
improved knowledge of the diverse metabolites is of importance for both nutritional
safety, as well as natural product opportunities.
Considering the diversity of macroalgae only a handful of species have been thoroughly
investigated for isolation of their metabolites and determination of bioactivity (Table 1).
Such species include Laurencia sp. and other species from the order Ceramiales
(Rhodophyta); Sargassum and Dictyota sp. from the order Fucales and Dictyotales,
3
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respectively (Phaeophyta); and Ulva and Caulerpa sp. from the order Ulvales and
Bryopsidales, respectively (Chlorophyta). As chlorophyta are less explored, this
presents opportunities for further investigations (Figure 2).

4

Rhodophyta Genus
Laurencia
Symphyocladia
Rhodomela
Polysiphonia
Odonthalia
Neurymenia
Neorhodomela
Bostrychia
Osmundaria
Chondria
Bryothamnion
Osmundaria
Vertebrata
Hydrolithon
Jania
Gracilaria
Plocamium
Sphaerococcus
Callophycus
Peyssonnelia
Ceratodictyon
Grateloupia
Ceratodictyon
Lithothamnion
Galaxaura
Asparagopsis

%
45
5
3
3
2
2
1
1
1
1
1
1
1
2
1
6
4
4
4
2
1
1
1
1
1
1

Phaeophyta Order#
Fucales
Fucales
Fucales
Fucales
Fucales
Dictyotales
Dictyotales
Dictyotales
Dictyotales
Dictyotales
Dictyotales
Dictyotales
Dictyotales
Laminariales
Laminariales
Ishigeales
Ectocarpales
Sporochnales
Sphacelariales
Phaeophyta Genus
Sargassum
Cystoseira
Cystophora
Halidrys
Bifurcaria
Dictyota
Dilophus
Zonaria
Stypopodium
Dictyopteris
Lobophora
Canistrocarpus
Taonia
Ecklonia
Laminaria
Ishige
Leathsia
Perithalia
Cladostephus

%
27
6
6
2
2
14
8
4
4
2
2
2
2
8
2
4
2
2
2

Chlorophyta Order#
Ulvales
Bryopsidales
Bryopsidales
Bryopsidales
Bryopsidales
Bryopsidales
Cladophorales
Cladophorales
Chlorellales
Ulotrichales
Dasycladales

Chlorophyta Genus
Ulva
Caulerpa
Tydemania
Codium
Bryopsis
Avrainvillea
Cladophora
Chaetomorpha
Chlorella
Monostroma
Cymopolia

%
19
19
8
8
8
4
8
8
8
8
4

Table 1 The % distribution of reported bioactive metabolites from macroalgal species and their respective orders across each of the three phyla of marine macroalgae*, as
summarised from seven extensive review publications [10-12, 17-20].
Rhodophyta Order#
Ceramiales
Ceramiales
Ceramiales
Ceramiales
Ceramiales
Ceramiales
Ceramiales
Ceramiales
Ceramiales
Ceramiales
Ceramiales
Ceramiales
Ceramiales
Corallinales
Corallinales
Gracilariales
Plocamiales
Gigartinales
Incertae sedis
Peyssonneliales
Rhodymeniales
Halymeniales
Rhodymeniales
Hapalidiales
Nemaliales
Bonnemaisoniales
*Classification information obtained through Guiry and Guiry 2016 [21]
#Dominant Orders highlighted in bold
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Reported biological activities from macroalgae include anti-hypertensive, anti-oxidant,
anti-inflammatory, anti-allergic, anti-viral, anti-bacterial, cytotoxic, anti-mitogenic,
anti-cancer, anti-tumour, anti-thrombic and anti-coagulant activities [22-24]. As such, it
is frequently proposed that macroalgae either as a whole, a concentrated extract or an
individual macroalgal compound, have the potential for commercial applications as
bioactive ingredients in a range of areas including food products [25-27].
Caulerpa spp. 3%
Ulva spp. 3%

Rhodophyta
• Laurencia spp.

Chlorophyta
(others) 9%

Phaeophyta
• Sargassum spp.
• Dictyota spp.

Dictyota spp. 7%

Sargassum spp.
14%

Rhodophyta (others)
30%
Laurencia spp. 25%

Chlorophyta
• Ulva spp.
• Caulerpa spp.

Phaeophyta (others)
30%

Figure 2 The % distribution of reported bioactives across each of the three phyla of marine macroalgae as
summarised from seven extensive review publications [10-12, 17-20].

Seaweed industry
Currently the demand for seaweed product exceeds the supply of wild harvest. In 2014,
farmed algae produced 23.8 million tonnes with 1.1 million tonnes collected from wild
harvest [28]. To date, algal cultivation has an estimated total output of 27 million tonnes
annually with an estimated global net worth of US$6 billion [28, 29]. Thirty-one
countries are officially recognised as producers from algae aquaculture, yet it is
6
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estimated up to 50 countries actively participate in algae farming [29, 30]. However, the
majority of this cultivated algae production comes from just eight countries, with China
dominating (Figure 3) [30].

2.3%

2.3%

1.1%

0.7%

0.4%

4.7%

China
Indonesia
Phillippines

9.5%

20.6%

Republic of Korea

58.4%

Democratic People's
Republic of Korea
Japan
Malaysia
United Republic of
Tanzania
Other 23 countries

Figure 3 Global cultivated algal production. Represented countries with recorded algal production
farming [30].

The production in these countries is now well established and is scaling to meet the
fluctuating supply and demand, with the total world production of farmed seaweeds
doubling from 2000 to 2012 [28]. Considering the diversity of defined seaweed species
[1], the global seaweed demand is met with the cultivation of just a few select species
(Table 2). In particular, Kappaphycus alvarezii and Eucheuma aquaculture in Indonesia
was a major contributor to a recent growth in statistics of world aquatic plant production
and are a major source of carrageenan [29]. These species dominate international trade
and are primarily concerned with raw materials for phycocolloid extraction [31].
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Phycocolloids are polysaccharides and include alginates (Phaeophyta) and agars and
carrageenans (Rhodophyta), able to form highly viscous gels for use as gelling,
thickening and stabilizing agents in the food and pharmaceutical industries [32, 33].

Therefore, in considering current markets alongside the large number of macroalgal
species that have been defined and their reported bioactives, there exists a unique
opportunity to expand the current product range, particularly from cultivated green
seaweed as there are no major chlorophyta productions on the market.
Table 2 List of key seaweed species and major products of the current seaweed industry [28-31, 34].
Seaweed species

Group

Common Name

Product

Saccharina spp.

Phaeophyta

Laminaria spp.

Phaeophyta

Kombu, Japanese kelp

Wholefood6, Alginate

Undaria pinnatifida

Phaeophyta

Wakame

Wholefood, fucoidan

Ascophyllum spp.

Phaeophyta

Alginate, phenolics

Lessonia spp.

Phaeophyta

Alginate

Porphyra spp.

Rhodophyta

Eucheuma spp.

Rhodophyta

Carrageenan

Gracilaria spp.

Rhodophyta

Wholefood, Agar

Chondrus spp.

Rhodophyta

Wholefood, Carrageenan

Kappaphycus spp.

Rhodophyta

Carrageenan

Gelidium spp.

Rhodophyta

Agar

Alginate

Nori or laver

Wholefood

6

Wholefoods are foods that are refined as little as possible. Seaweed as a wholefood is often offered to
consumers as either a fresh, frozen or dried product.
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Biological Activities of Macroalgae (Inflammation)
Dietary Bioactives
One niche market area is functional food products and/or ingredients for optimisation of
health and disease prevention. As opposed to simply supplying nutrition, a functional
food has the ability to modulate in vivo physiological systems, for example immune,
endocrine, nervous, circulatory and digestive systems [35]. Dietary incorporation of
these foods and their metabolites has the potential to contribute to disease prevention by
interacting at a cellular level to modify physiological responses [35]. One particular area
for potential development is the application of algal-derived bioactives to target
inflammation.
In Western societies there is a rise in the number of disorders, collectively referred to as
chronic, inflammatory, noncommunicable diseases [36, 37], typically characterised by
slow progression and long duration [38]. Examples include allergies, asthma and
inflammatory bowel, cardiovascular, metabolic and neurological diseases [36]. These
afflictions have been linked to underlying low-grade inflammation and oxidative stress
[36-38]. The immune response of inflammation is a complex and multifactorial network
of chemical signals [39], wherein an important mediator of inflammation is the enzyme
nitric oxide synthase (NOS), which regulates nitric oxide (NO) production.
The enzyme exists in both inducible (iNOS) and constitutive isoforms, which includes
both endothelial NOS (eNOS) and neuronal NOS (nNOS) and it is important to
differentiate between the two isoforms. The two constitutive forms of this enzyme
9
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(eNOS and nNOS) are under enzymatic control as a result of calcium and calmodulin
binding and result in small amounts of NO with important physiological roles such as
acting as a vascular relaxing agent or neurotransmitter [40]. A third iNOS enzyme
however generates NO as a response to microbes, cytokines, and other activating
stimuli and can generate very high and toxic levels of NO [40, 41]. It is this elevated
and sustained NO production from iNOS that is characteristic of prolonged
inflammatory disorders resulting in tissue injury and subsequently cancer [39-41].
Experimental studies have suggested inflammatory cells and their associated mediators
such as interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α) and IL-23 combined
with reactive oxygen species (ROS) form a microenvironment that favours cancer
development [42-46]. As a result, compounds that exhibit anti-oxidant and antiinflammatory biological activities are said to have the ability to confer protection and
reduce the risk of or aid the healing of disease [47, 48].
Macroalgae are readily consumed as a whole food, particularly in many coastal
communities of Asia and have a history of being used in traditional medicines [49].
Evidence has shown that a number of bioactive metabolites isolated from macroalgae
can influence a number of key molecular events that are involved in the inflammation
pathway [22-24, 50]. For example polysaccharides, phenolics, pigments and terpenoid
derivatives have all shown the potential to counter-act the immune response to
inflammation. For example either via the reduction of NO and other pro-inflammatory
immune mediators [23], reduction of oxidative stress by scavenging of free radicals
[22], and/or inhibiting cancer via selectively inducing cancer cell death or cell
proliferation (demonstrated both in vivo and in vitro) [24].
10
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Fatty Acids
Another important dietary class that has been implicated as regulators and mediators of
inflammation are fatty acids (FA), specifically the omega-6 arachidonic acid (AA;
20:4n-6) and eicosapentaenoic acid (EPA; 20:5n-3) and docosahexaenoic acid (DHA;
22:6n-3) omega-3 polyunsaturated fatty acids (PUFA) [51-54]. Inflammatory cells
contain both n-6 and n-3 PUFA, which serve as substrates for either pro- or antiinflammatory eicosanoids, respectively. In relation to the other PUFA present, AA is far
more abundant and is the main substrate for the enzymatic synthesis of the proinflammatory eicosanoids [51]. Interestingly, it has been shown that increased dietary
consumption of either n-3 or n-6 long-chain PUFA (lc-PUFA) can directly modify the
proportion of their respective FA in these inflammatory cells. This indicates a
correlation between dietary intake and effect on immune modulation of inflammation
[51, 55]. This is due to n-3 EPA competing with the n-6 AA as a substrate for
cyclooxygenase and 5-lipoxygenase enzymes [56].
Western diets are characterised by excessively high n-6 PUFA due to the increased
consumption of meat, cereals (wheat, maize, rice) and seed based oils, which are high in
n-6 PUFA and low in both n-3 PUFA and anti-oxidants [57, 58]. This change in diet has
been linked to the increased prevalence of inflammatory and autoimmune diseases,
along with cardiovascular disease and cancer [57]. Fortunately, patients with preexisting inflammatory disorders can reduce their levels of inflammatory cytokines with
dietary incorporation of EPA and DHA [56].
The main dietary source of EPA and DHA is fish and seaweed and the current dietary
11
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recommendation for fish is 2-3 serves per week to meet their minimum dietary
requirements [58]. EPA and DHA can also be obtained by encapsulated fish oil
supplements. However, to date this demand for fish and fish oil is currently met with
limited and unsustainable captive based fisheries with low scope for growth to meet
future demands [29]. Marine algae are primary producers of EPA and DHA that fish
obtain through trophic bioaccumulation and therefore have the potential to offer an
alternative dietary source of these bioactive anti-inflammatory n-3 PUFA [59-61].
Target Macroalgal Species
For the utilisation of algal-derived ingredients as dietary bioactives to counteract
inflammation, target algal species with desirable and suitable chemistries need to be
selected. Numerous studies have identified the presence of biological activities across
the three phyla with the potential to enhance human and animal health by positively
influencing, modulating and/or eliminating certain risk factors of defined diseases
(Example Table 4).
As part of a preliminary screening assessment of algal bioactives and chemistries
specifically linked to targeting inflammatory disorders, a number or macroalgal species
were investigated in this thesis. These species consisted of unique native and endemic
Australian species of marine macroalgae, for which little biochemical and bioactivity
studies have been reported. These species were from the order Fucales (Hormosira
banksii and Phyllospora comosa), order Laminariales (Ecklonia radiata), order
Ectocarpales (Myriogloea sciurus), order Gigartinales (Solieria robusta) and order
Ulvales (Ulva sp.) (Table 3; Figure 4).
12
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Literature reviews of similar non-Australian species belonging to these macroalgal
orders show potential for these chosen Australian species to benefit health (Table 4 Table 8).
.

13

Phaeophyceae

Phaeophyta/Ochrophyta/ Heterokontophyta

Ulvophyceae

Chlorophyta

Gigartinales

Florideophyceae

Rhodophyta

Macroalgae

Table 3 Australian target species identified as having potential to positively benefit both animal and human health.
Kingdom
Phylum
Class

Ulvales

Seirococcaceae
Ecklonia

Lessoniaceae

M. sciurus

Myriogloea

Chordariaceae

U. species #

Ulva

Ulvaceae

S. robusta

Solieria

Solieriaceae

Ectocarpales

Hormosiraceae
Phyllospora
E. radiata

Laminariales

Family
Hormosira
P. comosa

Fucales

Genus
H. banksii

Order

Species
#Species name withheld (proprietary information)
Classification information provided by Guiry and Guiry 2016 [21]

Venus Shell Systems Pty. Ltd., Mundamia, NSW, 2540, Australia

Figure 4 Macroalgal species investigated herein: order Fucales (Hormosira
banksii (also known as Neptune’s necklace) and Phyllospora comosa; order
Laminariales (Ecklonia radiata); order Ectocarpales (Myriogloea sp.); order
Gigartinales (Solieria robusta) and order Ulvales (Ulva sp., also known as sea
lettuce). The photos of H. banksii, M. sciurus and S. robusta were provided
courtesy of Pia Winberg, Venus Shell Systems, Pty. Ltd.7
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Phaeophyta
A range of reported biological activities from species belonging to the phylum
Phaeophyta, order Laminariales are summarized in Table 4. Ecklonia is a commonly
investigated genus with regards to its biological activity. Anti-oxidant, antiinflammatory, anti-cancer, neuro-protective and acetyl (AChE) and butyrylcholinesterase (BChE) inhibitory activities dominate this phylum and order with many
of these activities attributed to isolated phlorotannins (Table 4). Acetyl- and butyrylcholinesterase inhibitors have the potential to be used as a therapeutic strategy to treat
and/or slow the progression of Alzheimer’s disease [62].

15
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Table 4 Identified bioactive components and biological activities from species belonging to the Phylum
Phaeophyta, order Laminariales.
Bioactive Component

Species
Ecklonia cava,
Ecklonia stolonifera

Ref

Ecklonia cava
Ecklonia stolonifera
Eisenia bicyclis

[63-70]

Ecklonia cava
Ecklonia stolonifera
Eisenia bicyclis

[63-66, 68,
69, 71]

Ecklonia cava
Ecklonia stolonifera
Eisenia arborea

[65, 66,
72-75]

6,8’-Bieckol

Activity
Anti-oxidant
Neuro-protective
AChE and BChE inhibitory*
Anti-oxidant
Neuro-protective
AChE and BChE inhibitory
Hepato-protective
Anti-hypertension,
Anti-diabetic
Radio-protective
Anti-oxidant
Neuro-protective
AChE and BChE inhibitory
Anti-hypertension
Radio-protective
Melanogenesis inhibiters
Anti-HIV-1
AChE and BChE inhibitory
Anti-oxidant
Anti-allergic
Anti-inflammatory
Anti-allergic

Eisenia arborea

[74, 76]

8,8’-Bieckol

Anti-allergic

Eisenia arborea

[74, 76]

Fucodiphlorethol G

AChE and BChE inhibitory
Anti-oxidant
Neuro-protective

Ecklonia stolonifera,
Ecklonia cava
Ecklonia cava

[65, 66]

AChE and BChE inhibitory
Algicidal
Anti-oxidant
Anti-hypertension
Anti-allergic
Anti-allergic

Ecklonia stolonifera,
Ecklonia kurome
Ecklonia cava
Eisenia arborea

[65, 66, 68,
74, 77]

Eisenia arborea

[74, 78,
79]

Ecklonia stolonifera,
Ecklonia cava

[65, 66,
80]

2-Phloroeckol

AChE and BChE inhibitory
Anti-oxidant
Melanogenesis inhibitors
Hepato-protective activity

Ecklonia stolonifera

[67]

Triphoroethol-A

Anti-oxidant

Ecklonia cava

[81]

Dioxinodehydroeckol

Anti-cancer

Ecklonia cava

[82]

2,7’’-Phloroglucinol6,6’-Bieckol

Anti-oxidant

Ecklonia cava

[83]

Triphlorethol A

Neuro-protective

Ecklonia cava

[64]

Phloroglucinol
Eckol

Dieckol

6,6’-Bieckol

Eckstolonol
Phlorofucofuroeckol A

Phlorofucofuroeckol B
7-Phloroeckol

Anti-inflammatory
Undaria pinnatifida,
Methanol Extract
*Acetyl- (AChE) and butyryl-cholinesterase (BChE) inhibitory

[63-66]

[64]

[84]
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The range of reported biologically active components from the phylum Phaeophyta,
order Fucales is summarized in Table 5. Anti-inflammatory, anti-cancer, anti-oxidant
and other immuno-modulating activities are commonly reported from the genus
Sargassum. These activities are often attributed to their unique sulfated polysaccharides,
known as fucoidan (Table 5).
Table 5 Identified biological activities from the Phylum Phaeophyta, order Fucales.
Bioactive Component
Fucotriphlorethol A

Polysaccharide
(Fucoidan)
Methanol Extract

Activity
Anti-oxidant
Anti-inflammatory
Anti-cancer
Anti-oxidant
Anti-inflammatory
Anti-cancer
Anti-oxidant
Anti-inflammatory
Anti-fouling
Anti-mitotic
Anti-cancer
Angiogenesis
Immuno-modulatory
Anti-tumor
Immuno-modulatory Immunopotentiating
Anti-tumor
Anti-oxidant
Immuno-modulatory
Anti-inflammatory
Anti-inflammatory

Water Extract

Anti-cancer

Trifucodiphlorethol A
Fucoxanthin
Meroditerpenoids
Diterpene
Fucoidan
Polysaccharides
(Fucoidan)

Species
Fucus vesiculosus

Ref
[85]

Fucus vesiculosus

[85]

Sargassum siliquastrum,
Myagropsis myagroides
Halidrys siliquosa
Bifurcaria Bifurcata
Fucus evanescens
Ascophyllum nodosum
Fucus vesiculosus
Sargassum fusiforme
Sargassum pallidum

[86-88]

Sargassum fusiforme
Sargassum hemiphyllum,
Sargassum hemiphyllum,
Sargassum wightii
Sargassum oligocystum

[97-99]

[89]
[90]
[91-93]
[94, 95] [96]

[100, 101]
[102]

Species from the order Ectocarpales have been less investigated for their biological
activity when compared to other Phaeophyta species. Similarly, bioactivities reported
are attributed to their sulfated polysaccharides (Fucoidan), extracted either from
Cladosiphon okamuranus or Adenocystis utricularis (Table 6). Fucoidan, the sulfated
polysaccharide from Phaeophyta species, is a well regarded bioactive. Reported
17
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activities

include

anti-cancer,

anti-coagulant,

anti-thrombotic,

anti-viral,

immunomodulatory, anti-oxidant and anti-inflammatory activities [103-106].
Table 6 Identified biological activities from the Phylum Phaeophyta, order Ectocarpales.
Bioactive Component
Fucoidan

Activity
Anti-viral
Anti-HSV-1, HSV-2*
Newcastle Disease Virus
Anti-tumor
Anti-proliferative
*Herpes Simplex Virus 1 and 2

Species
Cladosiphon okamuranus
Adenocystis utricularis

Ref
[107-112]

Rhodophyta

A number of biological activities from the phylum Rhodophyta, order Gigartinales are
presented in Table 7. The bioactivity is reported from a variety of species and includes
the commonly reported activities such as anti-oxidant, anti-cancer, anti-fungal, antiviral and anti-inflammatory. Interestingly, hypolipidemic activity was represented
within this phylum and order (Table 7). Hypolipidemic refers to the ability to modulate
lipid and lipoprotein levels in blood plasma. Hyperlipidemia is characterised by high
levels of low-density blood lipoproteins. This is a risk factor for atherosclerosis, an
inflammatory disorder resulting in the accumulation of lipids within artery walls [113].
The identified hypolipidemic activity listed in Table 7 was attributed to an ethanol
extract and a screen across a number of species indicated that Solieria robusta was the
most effective in reducing the lipid profile in diet-induced hyperlipidemic rats [114].
Ethanol extracts will contain, to an extent, both FA and polyphenols which can
influence lipid metabolism [115, 116].
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Table 7 Identified biological activities from the Phylum Rhodophyta, order Gigartinales.
Bioactive Component
Methanol, Ethanol,
Water & other Organic
Extracts

Polysaccharides

Activity
Anti-oxidant
Anti-viral (HSV-1, HSV-2*)
Hypolipidemic activity
Anti-cancer
AChE inhibitory
Alpha-amylase
Anti-inflammatory
Anti-oxidant
Anti-viral (HSV-1, HSV-2)
Anti-inflammatory

Protein (Lectin)
Anti-bacterial
*Herpes Simplex Virus 1 and 2

Species
Kappaphycus alvarezii
Hypnea musciformis
Solieria robusta
Hypnea musciformis,
Ochtodes secundiramea
Eucheuma denticulatum

Ref
[114, 117122]

Gigartina skottsbergii
Sphaerococcus
coronopifolius
Hypnea spinella
Schizymenia binderi
Kappaphycus striatum

[123-126]

[127]

Chlorophyta
Chlorophyta spp. as a whole have been less represented in the literature when compared
to Rhodophyta and Phaeophyta. However, the genus Ulva is well represented (Table 1).
Ulva species of macroalgae can have two different morphologies. For example, Ulva
can have a highly variable distromatic leafy thallus (Figure 5a) or a monostromatic
tubular or filamentous thallus (Figure 5b). Filamentous morphologies were once assigned
as belonging to the genus Enteromorpha [128, 129]. However, it has been defined that
Enteromorpha and Ulva are not distinct genera and therefore reported bioactives for
both Ulva and Enteromorpha have been included in this literature review [130, 131].
Identified biological activities from the most commonly reported Ulva species of
macroalgae are presented in Table 8. These species include the leafy distromatic species
Ulva fasciata, U. pertusa and U. lactuca and the monostromatic filamentous species U.
intestinalis. Less commonly reported species are represented in Table 9. The defined
bioactivities have been mainly attributed to extracts, as opposed to isolated compounds
(Table 4) with anti-oxidant, anti-inflammatory and anti-bacterial activities strongly
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represented (Table 8 and Table 9). The numerous reported biological activities of Ulva
and its ability to grow rapidly in culture makes it an attractive target to pursue for
investigation [132, 133].

Figure 5 Ulva species of macroalgae (Chlorophyta) can exist as either a (a) distromatic, leafy thallus or
(b) monostromatic tubular or filamentous thallus. Both morphologies can be found in close proximities to
one another, as shown above, with leafy morphologies found habiting the exposed intertidal rock pools
and filamentous morphologies on exposed intertidal rock substrates (Seven Mile Beach, Gerringong,
NSW, Australia)
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Methanol Extracts
Chloroform & Alcohol Extracts
Ethanol Extracts

Methanol Extracts
Chloroform & Alcohol Extracts
Methanol & Water
Polyunsaturated Fatty Acid (C16:4 n-3)

Water, Alcohol & Organic Extracts
Water Extract
Methanol Extracts

Guaiane Sesquiterpenes
Labdane Diterpenoids
Sesquiterpenoids
Sulfolipids
Glycolipids
Ethyl Alcohol Extracts
Methanol & Butanol Extracts
Dichloromethane Extracts
Ethanol Extracts
Dichloromethane & Methanol Extracts

Component

Anti-oxidant
Neutralise reactive oxygen species (ROS) via Nrf2-ARE pathway*
Anti-oxidant; Anti-bacterial
Anti-bacterial

Anti-oxidant
Anti-bacterial, Anti-oxidant, Anti-AChE
Anti-genotoxic; Anti-hyperglycaemic; Anti-genotoxic

Anti-bacterial; Anti-fungal; Anti-inflammatory
Anti-tumor
Anti-bacterial
Anti-Inflammatory

Anti-oxidant
Anti-oxidant
Anti-proliferative; Anti-bacterial and anti-fungal; Phytotoxic; Insecticidal

Anti-bacterial
Anti-bacterial
Anti-oxidant
Anti-viral; Anti-tumor; Anti-microbial
Anti-cancer; Anti-microbial; Anti-viral
Anti-viral
Anti-microbial; Haemolytic activity
Anti-tumor
Anti-inflammatory; Anti-oxidant; Anti-microbial
Anti-viral

Activity

[146]
[159]
[160, 161]
[162]

[154]
[155, 156]
[157, 158]

[84, 148, 150]
[151]
[152]
[153]

[145]
[146]
[147-149]

[134]
[135]
[136]
[137]
[138]
[139]
[140]
[141]
[142, 143]
[144]

Reference

Table 8 Biological activities from commonly investigated species of Ulva, order Ulvales, phylum Chlorophyta (* including Enteromorpha intestinalis assigned species).
Species
Ulva fasciata

Ulva intestinalis*

Ulva pertusa

Ulva rigida

Ulva lactuca
Water Extracts
Monounsaturated Fatty Acid Derivatives
Methanol Extract
Water, Alcohol & Organic Extracts
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Chloroform & Alcohol Extracts
Methanol Extracts

Acidic Extract
Peptide SECMA1
Methanol Extracts

Methanol Extracts
Methanol & Water Extracts
Polyunsaturated Fatty Acids (C18:4 n-3 & C18:3 n-6)

Methanol Extracts
Chloroform & Alcohol Extracts
Methanol & Organic Extracts

Pheophytin
Enzyme Assisted Extract
Methanol Extracts

Component

Anti-oxidant; Larvicidal
Anti-proliferative; Anti-oxidant

Anti-bacterial
Cholinesterase inhibitory

Antioxidant
Mitogenic
Anti-oxidant

Anti-inflammatory; Anti-proliferative; Anti-oxidant
Anti-bacterial
Anti-bacterial

Anti-inflammatory
Anti-bacterial
Anti-oxidant

Anti-oxidant
Cholinesterase; Anti-oxidant; Anti-inflammatory
Anti-oxidant

Activity

[167, 175]
[165, 168]

[173]
[174]

[170]
[171]
[172]

[84, 168]
[152]
[169]

[84]
[166]
[167]

[163]
[164]
[165]

Reference

Table 9 Biological activities from less commonly investigated species of Ulva, order Ulvales, phylum Chlorophyta (* including Enteromorpha prolifera assigned species).
Species
Ulva prolifera*

Ulva compressa

Ulva linza

Ulva sp. (not defined)

Ulva reticulata
Other species (Enteromorpha tubulosa, E.
flexuosa, E. antenna, U. clathrata)
Methanol & Organic Extracts
Methanol Extracts
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Thesis Aims
Currently, the utilisation of algal-derived dietary bioactives is yet to be realised at any
level of significance [27]. South Eastern Australia is a diversity hot spot for algal flora
and species endemism [176, 177]. Thus, there is a unique opportunity in Australia for
the cultivation of selected Australian seaweed species to deliver quality controlled,
traceable, high-value dietary bioactives for both human and animal nutrition,
particularly in the area of inflammation.
Thus, the aims of this thesis are to:
1. Screen Australian macroalgal species for metabolites of interest relating to antiinflammatory, anti-oxidant and anti-cancer functionalities;
2. To develop and test robust methods for effective extraction and characterisation
of the metabolites of interest and;
3. To test the environmental effects of cultivation on biomass fractions that include
FA and pigments, and to demonstrate that these fractions have different effects
on anti-oxidant, anti-inflammatory and anti-cancer potential.
These aims were addressed across the following five chapters that have resulted in one
published book chapter, two published manuscripts and two prepared manuscripts for
submission. Chapter 2 presents two commonly utilised methods in anti-cancer
screening, one of which is used and referred to throughout this thesis in subsequent
chapters. Chapter 3 presents the results for the anti-inflammatory and metabolite
screening of six endemic Australian seaweeds across the three phyla and tests the safety
23

Chapter 1 General Introduction

and efficacy of these crude extracts. Chapter 4 explores the variability of metabolic
profiles for FA for Ulva sp. as they can vary to a large extent based on environmental
stimuli and therefore cultivation conditions. This chapter also explores methods for FA
profile characterisation. Chapter 5 explores the distribution of these FA for Ulva sp.
across neutral and phospholipids. In Chapter 6, the pigment, phenolic and flavonoid
variability across cultivation conditions is similarly explored for Ulva sp. with an
increased emphasis on the specific fractions to which oxidative functions could be
linked. Finally a discussion is provided in Chapter 7, which ties together the overall
assessment of Australian seaweed candidates for the extraction of metabolites and
development of products that can offset the chronic inflammatory disorders that are
increasingly prevalent in western societies.
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FOREWORD TO CHAPTER 2

This thesis assesses a number of Australian seaweed candidates for potential bioactives
that can offset chronic inflammatory disorders. Ideally, these bioactives are to be
incorporated as dietary components for both animal and human nutrition, as a whole
food, fraction, or concentrated extract. Therefore, the level of toxicity of the sample
must be determined alongside other biological assays.
Here, Chapter 2 presents the final accepted version of a published book chapter8 (2013)
that describes enzyme- and cell-based anti-cancer assays presented in thesis format. The
title page of the final published version has been provided in Appendix A. The cellbased assays described are used to determine the level of toxicity as a measure of
inhibition of cell proliferation and thus cell metabolism. Note, it is not a measure of
absolute cell death, which must be determined by complementary Trypan blue staining
(non-viable cells will stain blue) and cell counting if necessary. In addition to evaluation
of end-point data, cells should be monitored during the assay for morphological
changes. Photographing cells is also highly recommended and aids enormously when
revisiting results for discussion at later dates.

8

McCauley, J., Zivanovic, A., and Skropeta, D., Bioassays for Anticancer Activities, in Metabolomics
Tools for Natural Product Discovery Methods and Protocols, U. Roessner and D.A. Dias, Editors. 2013,
Humana Press. p. 191-205.
Permissions regarding copyrights have been obtained.
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Secondly, it is also important to consider anti-cancer screening against both an
established cell line and primary cell line. Established cell lines are immortal cancer cell
lines allowing for an indefinite number of subcultures in vitro. In contrast, a primary
cell line has finite division potential and is more representative of a normal cell.
Therefore any determined cytotoxicity for potential anti-cancer agents should ideally be
selective for an immortal cancer cell line. Nevertheless, it is a useful preliminary screen
for extract or metabolite toxicity and to determine whether or not the more expensive
and limited primary cell cultures should be included in future investigations.
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Summary
The MTT/MTS in vitro cell proliferation assay is one of the most widely used assays
for evaluating preliminary anti-cancer activity of both synthetic derivatives and natural
products and natural product extracts. The highly reliable, colorimetric based assay is
readily performed on a wide range of cell lines. This assay gives an indication of whole
cell cytotoxicity, however to determine the exact molecular target further assays need to
be performed. Of these, kinase inhibition assays are also one of the most widespread
enzyme inhibition screening assays performed. Kinases are enzymes that play a key role
in a number of physiological processes and their inhibitors have been found to exhibit
anti-cancer activity against various human cancer cell lines. Herein, we describe the
methods for performing both in vitro MTT/MTS cytotoxicity and kinase enzyme
inhibition assays. These are two of the most useful anti-cancer screening techniques
available that are relatively economical and can be easily and routinely performed in the
laboratory to characterise anti-cancer activity. Both assays are highly versatile and can
be modified to test against targeted disease processes by using specific kinase enzymes
or cell lines.
Key words: MTS/MTT assays, cytotoxicity, anti-cancer activity, human cancer cell
lines, enzyme inhibition, kinases
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Introduction
A goal of many natural product chemistry and organic synthesis laboratories is
ultimately drug discovery. An important aspect of the drug development process is
testing both natural products and synthesised compounds for bioactivities that are
involved in targeted diseases processes. Cancer is a general term to define a number of
diseases that are characterised by the uncontrolled proliferation of cells resulting from
the disruption or dysfunction of regulatory signaling pathways that are normally under
tight control [1, 2]. Cancer can spread rapidly and invade other tissues and organs and
different cancers are recognized to have unique characteristics or markers [3].
To assess for preliminary anti-cancer activity in terms of cell viability, the 3-(4,5dimethylthiazol-2-yl)-2,5-diphenyltetrazolium

bromide

(MTT)

and

3-(4,5-

dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium
inner salt (MTS) in vitro cytotoxicity assays are considered two of the most economic,
reliable and convenient methods. This is based on their ease of use, accuracy and rapid
indication of toxicity [4], as well as their sensitivity and specificity [5]. Both assays are
in vitro whole cell toxicity assays that employ colorimetric methods for determining the
number of viable cells based on mitochondrial dehydrogenase activity measurement and
differ only in the reagent employed. In the MTT assay, 3-(4,5-dimethylthiazol-2-yl)2,5-diphenyltetrazolium bromide is bioreduced by dehydrogenase inside living cells to
form a coloured formazan dye, while in the MTS assay, a similar bioconversion takes
places

utilising

3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-

sulfophenyl)-2H-tetrazo-lium, inner salt and an electron coupling reagent (phenazine
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ethosulfate) PES (Figure 6).
The MTT assay requires the addition of solubilising agents to dissolve the insoluble
formazan product formed, while the MTS assay generates a water-soluble formazan
product, thus simplifying the assay. The number of viable cells is measured through
colorimetry and works on the principle that the mitochondrial dehydrogenase enzymes
which produces NADH or NADHP, reduces the colourless tetrazolium salt into a
coloured aqueous soluble formazan product by the mitochondrial activity of viable cells
at 37°C (Figure 6). The quantity of the coloured product is directly proportional to the
number of live cells in the culture since the MTT/MTS reagent can only be reduced to
formazan by metabolically active cells.

Figure 6 The reduction of the MTS tetrazolium salt to the red formazan product by viable cells.

This is a useful assay to characterise potential anti-cancer agents and can be performed
routinely and easily in the laboratory without the need to forego intellectual property.
The MTT and MTS assays assess for toxicity to the particular cell under investigation
(not anti-cancer activity per se). Therefore, most researchers screen for cytotoxicity
against either murine or human cancer cell lines, as well as against a normal cell line
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such as peripheral blood lymphocytes. A selectivity index of the compound for cancer
cells over normal cells can then be determined. It is also advisable to confirm
MTS/MTT results with qualitative observations under the microscope of the cell
morphology both before and after the assay. This can often assist in identifying
potential modes of actions and deciding which further assays should be performed such
as caspase activation, assessing stage of cell cycle arrest and microtubule stabilisation or
destabilisation [6]. In addition to performing MTT or MTS assays against specific cell
types, many researchers worldwide also submit their compounds to screening by the
National Cancer Institute (NCI, http://www.cancer.gov), which is part of the US
Government National Institutes of Health (NIH). The NCI offers a rapid in vitro
primary anti-cancer drug screen to support cancer researchers worldwide [7]. The
screen, which is performed at no cost to the researcher other than shipping of their
sample, consists of a panel of 60 different human tumour cell lines from several cancer
types including leukaemia, melanoma and cancers of the lung, colon, brain, ovary,
breast, prostate and kidney. The NCI60 screen tests the degree of growth, inhibition or
cytotoxicity of a compound against each cell line over a range of concentrations to
generate a characteristic profile or fingerprint of cellular response [8]. A computer
program (COMPARE) is used to assess the pattern of response across the cell lines,
which can point towards a likely mechanism of action or identify compounds with
unique modes of activity and/or selectivity’s for specific cell types. Operational details
are provided by the NCI Developmental Therapeutics Program (DTP) and can be found
at http://dtp.nci.nih.gov and for information regarding the submission of compounds for
testing

in

the

NCI

screens

see
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http://dtp.nci.nih.gov/docs/misc/common_files/submit_compounds.html [9]. Only pure
compounds are screened in the assay and the supplier of the sample is required to
provide the molecular structure of any compounds submitted, which are then reviewed
and considered for testing.
The above assays are whole cell assays, however, often a researcher will want to
determine activity against a specific molecular or cellular target in order to confirm the
mechanism of action and to assess for selectivity towards different targets and any offtarget effects. This can be achieved using in vitro inhibition assays against either
purified enzymes or cell-free extracts enriched in the enzyme target of interest. One
such anti-cancer screening method that can be easily and routinely performed in the
laboratory in low-, medium- or high-throughput format is protein kinase inhibition [10].
After G protein-coupled receptors (GPCRs), protein kinases are the second most
important anti-cancer drug target being pursued today.
Unlike MTS-type assays, which are cell based, these assays are based on detecting the
degree to which the potential drug compound can inhibit an enzyme’s activity. Most
drugs used today demonstrate their bioactivity by acting as either receptor antagonists
or as enzyme inhibitors. Enzymes are popular drug targets as they play a significant role
in a number of disease processes and are susceptible to inhibition by small drug-like
molecules [11].
Protein kinases are an abundant group of enzymes in the human body with
approximately 518 different protein kinases encoded in the human genome [12].
Kinases catalyse the chemical transfer of a phosphate group from a high-energy
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molecule such as adenine triphosphate (ATP) to a hydroxyl-containing substrate such as
serine, threonine and tyrosine, and are divided into different families based on their
selectivity for these amino acids.
As one of the most abundant groups of enzymes in the human body, protein kinases are
important in almost every major pathway in eukaryotic cells. They play a central role in
the regulation of cellular activities and in signal transduction in signal transmission
pathways. Moreover, kinases have important roles in metabolism, cell growth,
apoptosis, immune response, gene expression, oncogenesis, cell differentiation and
proliferation, metabolism, DNA damage repair and cell motility [2]. As a result, the
deregulation of kinases has been identified to be the main cause in an increasing list of
diseases [13]. An estimated one-third of pharma drug discovery programs now focus on
targeting cancer-related kinases with the aim of developing potent and selective
inhibitors with lower side effects than treatments that traditionally focus on DNA and
chromosome regulation [14-17]. An example of a kinase inhibitor that has successfully
proceeded onto the pharmaceutical market is Imitinib (Gleevec, Novartis), which is a
tyrosine kinase inhibitor that has dramatically improved the prognosis for sufferers of
chronic myeloid leukaemia after being the first small-molecule kinase inhibitor to be
approved for human use [13].
c-AMP Dependent protein kinase A (protein kinase A, PKA) is an enzyme involved in
the phosphorylation of a wide range of proteins, ion channels and transcription factors
[18]. It has been demonstrated to regulate a number of physiological processes
including cardiovascular function, steroid biosynthesis, reproductive function,
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myogenesis, adipocyte metabolism, exocytotic processes and immune function [19, 20].
PKA was also found to play a key role in memory processes [21]. The cAMP-PKA
pathway has been linked to the promotion of malignant phenotypes of head and neck
squamous cell carcinoma [22] and demonstrated to be activated in a range of tumours
[23]. Conversely, PKA inhibitors have been found to display both in vitro and in vivo
anti-tumour activity against various human cancer cell lines and to enhance monocyte
function in HIV-infected patients [24]. Thus, it is becoming increasingly apparent that
the ability to selectively inhibit PKA provides a new way of potentially modulating
cancer, immune function, and memory disorders such as Alzheimer’s disease,
Parkinson’s disease and schizophrenia [19, 21, 25].
Herein, we describe methods for performing both the MTT/MTS cell proliferation
cytotoxicity assay and for screening against the enzyme PKA. Both methods are widely
used in our laboratory [6, 26, 27].
Materials
Carry out all procedures at room temperature unless otherwise specified.
Protein kinase assay
This protocol is for the analysis of 14 samples per plate – each sample is run twice at
100 µg/mL and in triplicate. This gives six data points per % inhibition reading.
Alternatively, 14 samples can be run once at two different concentrations (100 µg/mL, 1
µg/mL) in triplicate. This will give three data points per % inhibition reading (adjust
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protocol accordingly). The volumes provided in this protocol are intended for a 96-well
plate. The actual volumes used can be adjusted as needed.
1. Prepare sample solutions: Prepare a 5 mg/mL stock solution of sample in 100%
dimethyl sulfoxide (DMSO).
2. Sample dilution: Make 1 mL of a 1 mg/mL secondary stock solution (in 20%
DMSO) of the sample by taking 200 µL of the above 5 mg/mL stock and adding
800 µL of Milli Q water. During the assay, this will be diluted by 1:10 to give a
final concentration of 100 µg/mL in 2% DMSO [see Notes 1 & 2].
3. Prepare

kinase

reaction

buffer:

Dissolve

48.5

mg

of

tris(hydroxymethyl)aminomethane (Tris), 19.0 mg of magnesium chloride
(MgCl2) and 1.0 mg of bovine serum albumin (BSA) in 2 mL of ultra-pure H2O
and then make up to 10 mL in a falcon tube. Adjust the pH to 7.5 using aqueous
hydrochloric acid (HCl) if required. This will make 10 mL of reaction buffer
that is sufficient for 1 x 96-well plate (i.e. 45 µL x 96 wells = 4.3 mL, plus 5 mL
for adenosine triphosphate (ATP) stock) [see Note 3].
4. Enzyme preparation: The PKA enzyme (Promega) used herein is supplied in
buffer as 2500 units at 114 units/µL. Dissolve whole contents of tube containing
enzyme in a total of 2 mL of kinase reaction buffer (see step 3 above). Aliquot
out 10 x 200 µL of this solution into labeled Eppendorf tubes and store at -70
°C, to give 250 units of activity per tube. The assay described herein utilises
2.50 units per well, i.e. 2.50 units x 96 wells = 240 units in total. Thus the
supplied enzyme will enable testing of 10 x 96-well plates [see Note 4].

50

Chapter 2 Bioassays for Anti-cancer Activities

5. Kemptide (PKA) specific substrate (Promega, Australia) (10 mg/mL). The
substrate is used as supplied and stored at -20 ºC [see Note 5].
6. Prepare ATP solution: Label 3 tubes: ATP stock 1, ATP stock 2 and ATP stock
3 (the last one is used in the assay). Weigh 5.51 mg of ATP and make up to 500
µL with kinase reaction buffer to give a 20 mM solution of ATP (stock 1). Take
100 µL of ATP stock 1 and dilute to 500 µL in kinase reaction buffer to give a 4
mM solution. Take 15 µL of the ATP stock 2 and dilute to 3000 µL in kinase
reaction buffer to give a 20 µM solution. This last solution is used in the assay to
give a final concentration of 10 µM [see Note 6].
7. 96-well opaque white (non-sterile) plates (Corning #3912).
8. Micropipettes.
9. Luminometer compatible for 96-well plates.
10. 20% DMSO solution: Add 800 µL of distilled water to 200 µL of pure DMSO.
11. A known kinase inhibitor standard reference for positive control, e.g.
staurosporine, H-9 or H-89 (Sigma-Aldrich) [see Note 7].
12. Kinase-Glo® Reagents:

Kinase-Glo® Buffer and Kinase-Glo® Substrate

(Promega Corporation, Australia). Store at -20°C.
MTS assay
Plates containing compound dilutions should be discarded in cytotoxic waste bins. All
pipette tips that came into contact with the test compounds should also be disposed of in
cytotoxic waste bins
1. Sample preparation: Prepare a 4 mg/mL stock solution of sample in DMSO.
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2. MTS reagent: Should be stored at -20 ºC for long-term storage and protected
from light. Reagent should be warmed up to room temperature before use in the
assay.
3. RPMI tissue culture medium containing 5% fetal bovine serum (FBS) [see Note
8].
4. Stock cultures of cells should be maintained in RPMI medium containing 5%
FBS (fetal bovine serum).
5. Clear, sterile 96-well microplates.
6. Trypan blue solution (0.4%, liquid, sterile-filtered, suitable for cell culture).
7. Dimethyl sulfoxide (DMSO).
8. Human, leukemic, monocyte-like, histolytic lymphoma (U937) and human,
metastatic breast adenocarcinoma (MDA-MB-231) cancer cell lines, or other
cell lines as required [see Note 9]
9. Haemocytometer.
10. Centrifuge.
11. Sterile incubator.
12. UV spectrophotometer compatible for 96-well plate.
Methods
The kinase assay described here utilises the Kinase-Glo® Luminsecent Kinase Assay
Platform from Promega and is performed according to the manufacturer’s instructions
[28] with minor modifications as used in our laboratory. The method below is relevant
to screening against PKA, however a wide range of kinases can be used in this assay
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including GSK-3β, PI3K, Src and MAPK [28, 29]. In theory, potentially any kinase
could be used, provided the appropriate substrate is also utilised.
Kinase Assay
1. To wells A/F1-12 of a 96-well plate, add 5 µL of the 1 mg/mL stock solution of
the test compounds, which will give a final concentration of 100 µg/mL sample
in 2% DMSO (Table 10). To the positive control wells (G1-6) and the negative
control wells (H1-6), add 5 µL of the 20% DMSO solution.
Table 10 Kinase assay plate preparation: wells A-F[1-12] are the test compounds; wells G1-6 are positive
controls; wells H1-6 are negative controls; and H7-12 and G7-12 are internal reference standards (Std).
The plate below shows the set-up for 12 test compounds run twice (samples a and b) in triplicate. This
gives six data points per % inhibition reading.
A
B
C
D
E
F
G
H

1
2
3
4
5
6
1a
1b
2a
2b
3a
3b
1a
1b
2a
2b
3a
3b
1a
1b
2a
2b
3a
3b
7a
7b
8a
8b
9a
9b
7a
7b
8a
8b
9a
9b
7a
7b
8a
8b
9a
9b
Positive Control (100% Luminescence)
Negative Control (0% Luminescence)

7
4a
4a
4a
10a
10a
10a
Std1a
Std1b

8
4b
4b
4b
10b
10b
10b
Std1a
Std1b

9
5a
5a
5a
11a
11a
11a
Std1a
Std1b

10
5b
5b
5b
11b
11b
11b
Std2a
Std2b

11
6a
6a
6a
12a
12a
12a
Std2a
Std2b

12
6b
6b
6b
12b
12b
12b
Std2a
Std2b

2. To wells G/H7-12, add 5 µL of the internal standard (e.g. staurosporine).
3. Thaw a single tube of the enzyme (250 units per tube) and make up to 2 mL with
the kinase reaction buffer to give a concentration of 125 units/mL. This will give
a final concentration of 50 units/mL (or 2.50 units/well).
4. To six of the positive control wells (G1-6), add 20 µL of the reaction mixture
containing 2.5 X the optimal concentration of kinase in kinase reaction buffer.
The positive control should provide 100% luminescence. There will be 1880 µL
of this reaction mixture remaining.
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5. Add 20 µL of the kemptide (PKA peptide substrate, 10 mg/mL) to the remaining
1880 µL of kinase mixture. This will provide 200 µg of the kinase substrate in
1900 mL to give a 140 µM substrate/enzyme solution in buffer. This amount is
sufficient for 1 x 96-well plate, giving a final concentration of 56 µM in each
well per 50 µL reaction.
6. To all remaining wells, add 20 µL of the above reaction mixture (step 5)
containing 2.5 X the optimal concentration of kinase and kinase substrate in 1X
kinase reaction buffer. (Negative controls, 0% luminescence).
7. To all wells, add 25 µL of the ATP solution (20 µM, stock 3 ATP solution). This
will give a final concentration of 10 µM in each well per 50 µL reaction. See
Table 11

for a summary of the reagent volumes added to the 96-well plate.

8. Using a plate shaker, gently shake the plate and incubate at room temperature for
the optimal amount of time [see Note 10].
9. Prepare Kinase-Glo® reagent: The kinase buffer should be stored in the freezer
and thawed at room temperature. Add the Kinase-Glo® Substrate to the KinaseGlo® Buffer and add 50 µL of this mixture to each well [see Note 11].
10. Mix the plate and incubate for 10 minutes at room temperature. Due to the long
half-life of the Kinase-Glo® signal, the plates may be left longer before reading,
if desired. Record luminescence, which will be directly proportional to percent
inhibition of the controls [see Notes 12-14].
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Table 11 Kinase assay summary of reagent concentrations and volumes added to plate.

Sample
DMSO solution
Enzyme/no substrate
(2.5X)
Enzyme/substrate
(2.5X)
ATP solution (2X)
Total reaction volume
Kinase-Glo® reagent

Initial
Stock
Conc.
1 mg/mL

Standard
Wells
(µL)
-

Positive
Control
(µL)
-

Negative
Control
(µL)
-

20 %
125
units/mL
140 µM

-

5
20

5
-

20

-

20

25
50
50

25
50
50

25
50
50

20 µM

Final
Conc.
(in 50 µL)
100
µg/mL
2%
50
units/mL
56 µM
10 µM

MTS Assay
The MTS assay described here utilises Promega’s MTS CellTiter 96® AQueous One
Solution Cell Proliferation assay and is performed according to the manufacturer’s
instructions [30, 31].
1. Determination of cell number and viability: Place 20 µL cells + 20 µL Trypan
blue on parafilm and place 20 µL of this mixture under a cover-slip on the
haemocytometer. Count the number of cells using the equation provided [see
Note 15] to determine the volume required to get a cell concentration of 111,000
cells/mL.
2. Day 1 - Setting Up the Plate: Pipette 610 µL of cells (as determined in Step 1 of
the procedure) into a new Falcon tube and centrifuge at 1600 rpm for five min.
(For four plates, pipette 2.44 mL of cells).
3. Drain off supernatant and resuspend the pellet into 2.5 mL of media. This will
give you 2.5 mL of cell solution at 111,000 cells/mL. (For four plates, you
would resuspend in 10 mL of media).
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4. Pipette 100 µL of media into wells A1-A12, H1-H12, B1-G1, B11-G11, B12G12, B5-B7, E5-E7, F5-F7 and G5-G7 as per Figure 7. These wells are used as
blanks to stop any interference that may occur when the spectrophotometer reads
the absorbance values for the test wells.

Figure 7 96-Well microplate set-up for the MTS assay.

5. Pipette 90 µL of media into wells B8-G8, B9-G9, B10-G10. These wells will
form the sample background controls.
6. Pipette 90 µL of cell solution into wells B2-G2, B3-G3, B4-G4. These wells will
form the sample wells.
7. Pipette 90 µL of cell solution into wells D5-D7. These wells will form the 2.5%
DMSO controls.
8. Pipette 100 µL of cell solution into wells C5-C7. These wells will form the cell
controls.
9. Incubate plates for 24 hours at 37 ºC with 5% carbon dioxide (CO2).
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10. Day Two - Diluting Test Compounds: Prepare a microtitre plate for serial
dilutions of the test compounds as shown in Figure 8 for each compound to be
tested. Wells A3-G3 should all contain a final volume of 100 µL.

Figure 8 Preparation of microtitre plate for 1:2 serial dilutions. Add 100 µL of DMSO and 100 µL of
the test compound (4 mg/mL in DMSO) to well A1. Next, add 100 µL of DMSO to wells B1 to G1.
Then, 100 µL is transferred from A1 to B1; B1 to C1 and so forth until F1, where 100 µL is removed
and discarded. G1 should contain just 100 µL of 100% DMSO. Next 50 µL of media is added to
wells A2-G2 and A3-G3 and 50 µL transferred from A1 to A2 and then from A2 to A3 to give 100
µL of the sample at a concentration of 500 µg/mL in 25% DMSO in media. This is repeated for wells
B2-B3, C2-C3, etc to give a series of 1:2 dilutions of the sample.

11. Adding serial dilutions of samples to cells: Using the plate of cells prepared on
Day 1, pipette 10 µL of each sample dilution of the test compound in 25%
DMSO (i.e. A3-F3, step 11) in triplicate into the 18 wells containing 90 µL of
cell solution (i.e. 10 µL of the sample at 500 ug/mL in triplicate into wells B2B4, 250 ug/mL sample into C2-C4 etc. (Figure 7), down to the 15.5 µg/mL
sample into G2-4). Repeat this step, by adding 10 µL of the serial dilutions of
the sample in triplicate to the 18 wells containing 90 µL of media (e.g. wells B8G8, B9-G9, B10-G10). The test compounds will now have a final concentration
of 2.5% DMSO in all wells.
57

Chapter 2 Bioassays for Anti-cancer Activities

12. Pipette 10 µL of the 0 µg/mL in 25% DMSO (i.e. G3 from step 11) into the
three remaining wells containing 90 µL cells (wells D5-D7). This will be the
2.5% DMSO control.
13. Incubate plate for 24 hours at 37 ºC and 5% CO2 [see Note 16].
14. Day Three - Adding MTS Reagent and Plate Reading: Thaw MTS reagent
before use (~1 mL MTS reagent required per plate).
15. Pipette 20 µL of the MTS reagent into all sample wells (e.g. B2-G2, B3-G3, B4G4, B5-D5, B6-D6, B7-G7, B8-G8, B9-G9, B10-G10) [see Note 17].
16. Incubate for three hours at 37 ºC and 5% CO2.
17. Wrap the plates in aluminium foil and take to the spectrophotometer. Read the
absorbance of the whole plate at 490 nm [see Note 18].
Notes
1. A final concentration of 2% DMSO was used for the sample and was found not
to interfere with results at this concentration. Standards and controls used in the
assay were also dissolved in a final concentration of 2% DMSO. Other solvents
such as 2% ethanol can be used, provided all standards/controls are also
prepared in this solvent.
2. We found that a starting stock solution of 1 mg/mL of sample (diluted to 100
µg/mL in the assay) was appropriate to identify kinase inhibitory activity.
Samples can be tested at lower concentrations or over a range of different
concentrations to determine IC50 values.
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3. We found that it is best to prepare the buffer solution fresh each time and to
store the buffer at room temperature.
4. For kinases other than PKA, the optimum amount of kinase enzyme will need to
be determined and the quantity of other reagents adjusted accordingly [28].
5. Kemptide (PKA Peptide Substrate) is a synthetic peptide substrate for PKA
derived from the PKA phosphorylation site in liver pyruvate kinase.
6. This assay can be used to identify whether the kinase inhibitor is ATP
competitive or non-competitive, by utilising various ratios of ATP (e.g. <10 µM
ATP for ATP-competitive inhibitors and >100 µM for ATP non-competitive
inhibitors). In general, we found it is best to prepare ATP solutions fresh, while
the ATP reagent itself should be stored in the freezer.
7. We include an internal reference of a known kinase inhibitor such as
staurosporine in our assays (IC50 = 7 nM vs PKA; IC50 = 0.7 nM vs PKC ) by
adding 5 µL of a 1 mg/mL solution of the inhibitor (in 20% DMSO) to six of the
wells in place of a sample set. Staurosporine is a potent inhibitor of PKC and
can induce apoptosis in Jurkat cells. Other PKA inhibitors include the
isoquinoline sulfonamides H-9 (IC50 = 2 µM) and H-89 (IC50 = 48 nM).
8. RPMI-1640 was developed by Moore et al. [32, 33] at Roswell Park Memorial
Institute.
9. Human, leukemic, monocyte-like, histolytic lymphoma (U937) and human,
metastatic breast adenocarcinoma (MDA-MB-231) cancer cells were obtained
from American Type Culture Collection (ATCC, VA, USA) distributed by
Cryosite, NSW, Australia. Cells were regularly cultured in vitro in culture
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medium consisting of RPMI-1640 medium, along with 2 mM L-glutamine,
5.6% (2 g/L) NaHCO3 and 5% foetal calf serum. The cells were maintained in a
Huracell incubator (Kendro Laboratory Products, Langenselbold, Germany) at
37 °C with a humidified atmosphere containing 5% CO2. However, a wide range
of both normal and cancer cell lines can be used in this assay.
10. We found that thawing the Kinase-Glo® reagents (Kinase-Glo® substrate and
Kinase-Glo® buffer) generally took one hour and we also allowed an hour for
the incubation time. We strongly advise optimizing the kinase reaction
conditions so that the reaction can be run at room temperature to avoid
formation of temperature gradients. Information regarding optimization of
kinase reaction conditions can be found in the manufacturer’s Technical Bulletin
[28].
11. The choice of Kinase-Glo® reagent will depend on the desired ATP
concentration to be used in the assay. This information can be found in the
manufacturer’s protocol, Promega Corporation, Australia [28, 34].
12. We find that it is best to read the plate within 15 mins after the addition of the
Kinase-Glo® reaction mixture.
13. Instrument settings depend on the manufacturer. An integration time of 0.25–1
second per well should serve as a guideline. We found that the best plate reading
is immediately after adding the Kinase-Glo® Buffer and when the incubation is
performed at room temperature.
14. The most common assay detection methods are colorimetric or fluorescencebased. However, luminescent-based detection is particularly desirable for
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coloured products such as natural products, as coloured extracts and compounds
can lead to false results when using absorbance as the end point. Utilization of
luminescence can be more beneficial for biological screening by identifying hits
with a lower number of false positives [35].
15. An example calculation of cell concentration of which the values obtained will
be used in the method protocol described herein:
!". !" !"##$ =

(# !" !"##$ !" 4 !"#$%)
× 2 × 10000
4

For example if we count 91* cells:
!". !" !"##$ =

91 ∗
× 2 × 10000 = 455000 !"##$
4

Therefore, to get a cell concentration of 111,000 cells/mL, you will need:
111000 !"##$/!"
= 0.244 !" = 244 µ!
455000!"##$
For the preparation of one plate the cells will be resuspended in 2.5 mL media
therefore the volume of cells required would be:
244 µ! × 2.5 = 610 µ!
Adjust accordingly if more plates are required.
For example, the preparation of 4 plates will require:
244 !" ! 10 !" (2.5 !" !"# !"#$% ! 4 !"#$%&) = 2.44 !"
16. Longer incubation times of 48 – 72 hours are also routinely employed in this
assay.
17. The MTS reagent is light sensitive so this step should be performed with the
lights off in the cytotoxic cabinet.
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18. As this is a colorimetric assay, it should be kept in mind that both coloured
compounds and natural product extracts may interfere with the absorbance
reading, and appropriate background controls should always be performed.
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FOREWORD TO CHAPTER 3

The previous Chapter 2 explored an anti-cancer cell based method that can be used as a
preliminary assessment of a sample’s toxicity. This assay was first established in order
to proceed with the following work (Chapter 3), which involved screening wild
collections of macroalgae, including one cultivated species of Australian macroalgae for
anti-inflammatory and anti-cancer activities and determination of their fatty acid
profiles. An anti-inflammatory assay was also established in house to measure the
amount of nitric oxide produced in cell supernatants in bacterial lipopolysaccharide
stimulated inflammatory cells. A thorough explanation of the methods for this antiinflammatory cell-based assay is provided in Appendix B.
This chapter presents the final accepted version (in thesis format) of a published
manuscript9 (2015) within the Journal of Applied of Phycology (Impact factor 2.372).
The title page of the article, as it appears in the printed journal can be found in
Appendix C.

9

McCauley, J.I., et al., Selecting Australian marine macroalgae based on the fatty acid composition and
anti-inflammatory activity. Journal of Applied Phycology, 2015. 27: p. 2111-2121.
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Abstract
Increasingly macroalgae are being recognized as a growth opportunity for functional
foods and nutritional security in the future. Dominating traits of interest are metabolites
that function as anti-inflammatories and are anti-proliferative. However seaweeds
cultivated in the northern hemisphere dominate this field of research. Australia has a
unique flora of macroalgae and it is poorly understood which species should be targeted
for cultivation towards food and health markets. Herein, six Australian marine
macroalgae were selected for screening of one anti-inflammatory group; n-3
polyunsaturated fatty acids (PUFA). PUFA profiles were determined using gas
chromatography - mass spectrometry and multivariate analysis. Thirty-one fatty acids
(FA) were identified across the six macroalgal species with C16:0 the dominant FA in
all samples with variations across taxa in the saturated FA C10:0, C14:0, C16:0, C18:0
and C20:0 and variations in monounsaturated FA attributed to C16:1 n-7 and C18:1 n-9.
For PUFA profiles, all six species had significantly different n-6/n-3 ratios, while the
green seaweed Ulva sp. possessed the lowest n-6/n-3 ratio of 0.4, along with a 2-fold
higher C18:3 n-3 to C18:2 n-6 content. Ulva sp. was the only species that contained
docosahexaenoic acid. Extracts of both the Ulva sp. and H. banksii showed selective
cytotoxicity towards a human pancreatic cancer cell line, while the non-polar extracts of
all six algal species strongly inhibited production of the inflammatory-mediator nitric
oxide.
Keywords Seaweeds, Fatty acid profiles, PUFA, Omega-3, Inflammation, Functional
foods
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Introduction
Macroalgae are a large and growing multi-billion dollar food and biotechnology
industry [1, 2]. Increasingly they are being recognised as a rich source of biologically
active metabolites for utilisation in functional foods, nutritional supplements and/or
pharmaceuticals [3]. This is due to important functional roles of these metabolites in a
range of biological processes including cell mediation and immune responses [4-9].
Research in medical and health applications of seaweed metabolites now dominate the
publication of phycology related scientific literature [10]. There is particular promise
for chronic inflammatory diseases and cancers of the digestive system [11, 12] (Figure
9).

Metabolites that contribute to anti-inflammatory function include essential

polyunsaturated fatty acids (PUFA) such as alpha-linolenic acid (ALA, C18:3 n-3) that
cannot be synthesised by humans and therefore must be obtained from dietary sources,
as well as the essential n-3 long-chain PUFA such as eicosapentaenoic acid (EPA,
C20:5 n-3), docosapentaenoic acid (DPA, C22:5 n-3), and docosahexaenoic acid (DHA,
C22:6 n-3) [13]. These PUFA function as competitors to the pro-inflammatory
metabolism of linoleic acid (LA, C18:2 n-6) as the parent fatty acids (FA) for the proinflammatory metabolism of the n-6 PUFA arachidonic acid (AA). n-6 AA is a
biosynthetic precursor to prostaglandin E2 (PGE2) and leukotriene B4 (LTB4)
inflammation pathways and inflammatory eicosanoids such as prostaglandins and
leukotrienes [13]. Conversely, n-3 PUFA can be enzymatically converted to bioactive
autacoids with inflammatory-resolving properties that compete with and offset
inflammation status [14, 15]. Thus, a reduced ratio of n-6/n-3 PUFA is considered
70

Chapter 3 Metabolite and Bioactivity Screening

important to suppress chronic inflammatory disease triggered by a higher intake of n-6
PUFA in modern diets [16, 17]. The pathogenesis of diseases includes cardiovascular
disease, cancer and other inflammatory disorders [17, 18]. Thus, a greater consumption
of long chain n-3 FA may offer protective effects by suppressing proinflammatory
activity [18, 19].

Figure 9 The distribution of published research effort in terms of reference to macroalgae and each of the
health application terminologies (e.g. anti-inflammatory) as found in Google Scholar database of
scientific literature.

Of the n-3 PUFA, ALA is predominately found in vegetable oils and nuts, and EPA and
DHA in marine fish and fish oils [16]. Conversion of ALA to EPA and DHA is limited
and therefore dietary consumption of these two long-chain PUFA is highly
recommended [20, 21]. The proposed health benefits of n-3 PUFA have led to increased
demand for their use as animal feed additives to promote bioaccumulation, and for
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direct human consumption [22, 23]. Because of increasing costs and availability of fish
derived PUFA from fish oil, there is a need to develop alternative sources.
Marine algae are primary producers of PUFA that fish obtain through trophic
bioaccumulation and represent a promising new PUFA source. This presents an
opportunity to target whole seaweed as a food and animal feed, not only for trace
elements like iron and iodine, but also for lipids that are deficient in the Western diet
[16, 24]. However, a challenge remains to understand which species contain optimal
PUFA profiles that could balance current dietary practice and the profile variablility
between taxa.
Inflammation is a complex and multifactorial network of chemical signals [25]. Nitric
oxide (NO), an important biological mediator, is one chemical molecule that is
generated by the enzyme inducible nitric oxide synthase (iNOS) during immune and
inflammatory responses [26]. Elevated and chronic NO production, as seen in persistent
inflammatory disorders is associated with dysregulation of signaling events and immune
response resulting in cell and tissue injury [27] and subsequently cancer [25].
Suppression of NO production has been observed with n-3 PUFA via inhibition of
iNOS [28]. Further anti-inflammatory compounds are diverse across fractions of
metabolites and function in different inflammation pathways including iNOS,
cyclooxygenase (COX) and reactive oxygen species (ROS) metabolism [11]. For algae,
these fractions include both non-polar and polar extracts and have been shown to
function differently across assays for these different inflammatory processes. For
example non-polar algal extracts include phlorotannins that have been shown to reduce
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the production of NO and reduce edema, along with anti-inflammatory PUFA,
carotenoids, terpenoids and xanthophylls [15].
The metabolic profiles and biological activity of extracts from northern hemisphere
macroalgal species have been well described including both genetic and
spatial/temporal variations [29, 30]. However in Australia, which is a macroalgal
biodiversity hotspot [31] with high species richness and endemism of benthic flora [32],
a legacy of little use in food has resulted in a paucity of knowledge of Australian
species with the potential for applications in health. Australia has been seeking to grow
its aquatic production industries, and macroalgae have been selected based on existing
market (colloid) or bioremediation potential, but little has been done to select species
based on the potential applications in targeted health markets. Herein, six Australian
macroalgal species were screened for their FA profiles and organic extracts of varying
polarity from each species were evaluated for both anti-inflammatory activity and
selective cytotoxicity for prioritising candidates from a human health context.
Materials and Methods
Collection
Macroalgal species for biological assessment and FA profiling were collected
seasonally from a number of locations along the South East coast of New South Wales
(NSW) Australia. For biological assessment, the algal species: Hormosira banksii
(Turner) Decaisne, Phyllospora comosa (Labillardière) C.Agardh and Ecklonia radiata
(C.Agardh) J.Agardh were collected from Gerringong, Solieria robusta (Greville) Kylin
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was collected from Callala Beach and Myriogloea sciurus (Harvey) Kuckuck ex
Oltmanns was collected from Manyana. Samples were cleaned from epiphytes and sand
and dried (70 °C), pulverized and vacuumed sealed until analysis. For FA profiling
fresh samples were collected, cleaned and freeze-dried immediately prior to analysis.
The Ulva sp. used herein was obtained from culture, kept and maintained for several
months (Table 12).
Table 12 Summary of samples collected seasonally from various locations along the South East cost of
NSW Australia, including species, phylum, order, collection site (latitude & longitude) and/or date of
harvest or collection.
Species

Phylum

Order

Location

Latitude

Longitude

Date

Ecklonia radiata

Ochrophyta

Laminariales

Jervis Bay

150.7347

35.0653

10/4/14

Hormosira banksii

Ochrophyta

Fucales

Jervis Bay

150.7347

35.0653

10/4/14

Phyllospora comosa

Ochrophyta

Fucales

Jervis Bay

150.7347

35.0653

10/4/14

Solieria robusta

Rhodophyta

Gigartinales

Jervis Bay

150.7347

35.0653

10/4/14

Ecklonia radiata

Ochrophyta

Laminariales

Gerringong

150.8271

34.7423

04/4/12

Hormosira banksia

Ochrophyta

Fucales

Gerringong

150.8271

34.7423

04/412

Phyllospora comosa

Ochrophyta

Fucales

Gerringong

150.8271

34.7423

04/4/12

Solieria robusta

Rhodophyta

Gigartinales

Callala Beach

150.6899

35.0086

29/4/12

Myriogloea sciurus

Ochrophyta

Ectocarpales

Manyana

150.5167

35.2500

01/11/12

Ulva sp. ♯

Chlorophyta

Ulvales

Cultivated#

-

-

-

♮Fresh

samples collected and immediately freeze-dried for species fatty acid profiling; ♭Freeze-dried
sample prepared from frozen voucher sample; #Species name withheld; species maintained in culture.

Extraction and Transesterification of Fatty Acids
Lipids were extracted using the method of Folch et al. [33] with modifications by
Kumari et al. [34]. In brief, 250 mg dry weight was extracted with 3x3 mL of
chloroform/methanol (2/1, v/v) with 0.001% butylated hydroxytoluene (BHT) by
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vortexing (~1 min) and centrifugation (3000 rpm, RT, 15 mins). Combined supernatants
were washed with 2 mL of Milli-Q water (3000 rpm, RT, 5 mins). The extract was
evaporated to dryness in pre-weighed 9 mL Teflon lined screw top glass culture tubes
under a stream of nitrogen. Crude lipid extracts were transesterified according to the
method of Lepage and Roy [35] with added BHT (0.01% w/v). Extractions performed
in triplicate using homogenized powder of the whole algae sample.
FA Analysis
FA were analysed by flame-ionization GC (model GC-17A; Shimadzu, Rydalmere,
NSW, Australia) using a 50 m x 0.25 mm internal diameter capillary column. One
microliter of the transesterified sample was auto-injected into the column, and
individual FA were quantified using the Shimadzu analysis software (Class-VP 7.2.1
SP1). FA were identified by comparison with known standards (Nu-chek or Sigma,
Sydney, Australia). Heneicosanoic acid (0.2 mg.mL-1 in toluene) was used as an
internal standard for quantification and samples were analysed in triplicate. Relative
compositional data is represented as molar % composition of total FA taking into
account the molecular weight of the identified FA. Quantified data is represented as
mg.g-1 dry weight (d.w.).
Biological Assays
For biological assays samples were dried at 70 °C for 48 h, pulverised to a fine powder
and extracted in a 1:1 dichloromethane (DCM): methanol solution using a modified
version of Ebada et al. [36]. The crude extract was partitioned into DCM, ethyl acetate
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(EtOAc) and butanol (BuOH) and organic phases evaporated to dryness. Stock solutions
were dissolved in 100% dimethyl sulfoxide (DMSO) (10 mg.mL-1) and diluted with
culture medium to obtain testing concentrations of 100 ug.mL-1 in 1% DMSO.
Extracts were assessed for cytotoxicity at 100 µg.mL-1 on human pancreatic carcinoma
(MIA-PaCa-2) cell line, Abelson murine leukemia virus-induced tumor macrophage
(RAW 264.7) and wild-type murine embryo fibroblasts cell lines (WT-MEF).
Cytotoxicity was determined as % inhibition of cell proliferation, measured by
colorimetric markers (MTS Reagent) of dehydrogenase enzyme activity, relative to
controls (24-48 hr incubations) [37]. RAW 264.7 macrophage cells were either pre- or
co–incubated with lipopolysaccharides (LPS) (1 µg.mL-1) and the extracts (100 µg.mL-1)
for 24 hrs (37 ºC, 5% CO2), including controls.
The quantity of nitrite (NO2-) accumulated in the supernatant, as a measure of positive
inflammation response (NO production), was measured by mixing equal volumes of
supernatant

with

Griess

reagent

(1%

sulphanilamide

and

1%

N-(1-

Naphthyl)ethylenediamine dihydrochloride solution). After 10 mins incubation at rt
absorbance was measured. NO2- concentrations were calculated using a standard curve.
NO inhibition was determined as % of LPS induced inflammatory controls [38].
Statistical Analysis
Multivariate FA profiles across macroalgal taxa were visualised in multidimensional
scaling (MDS) plots using Euclidean distances due to a large number of zeros in the
data. Apparent groupings were tested using Analysis of Similarity (ANOSIM) with
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PRIMER-E V6 software (Plymouth Marine Laboratories [39]. Data was analysed in
both untransformed raw format, to compare the relative abundance of different FA to
chemical profiles differences, as well as presence/absence transformation (either a 1 or a
0 value) to compare the overall FA composition. This is a rapid method to objectively
identify key groups of or specific FA that differ across taxa, which could then be tested
in univariate analyses. Identification of the FA or groups of FA that contributed most to
differences between taxa was done using the PRIMER-E Similarity Percentages
Analysis (SIMPER) tool in PRIMER-E.

One-way Anova, Tukey’s multiple

comparisons test, and Students t-Test were used to determine significantly different
means for individual fatty acids of interest using GraphPad Prism version 6.00,
GraphPad Software, La Jolla California USA, www.graphpad.com.
Results
Key differences in FA composition across species
A total of 31 FA were identified across the six algal species (Table 13). The highest
number of FA (26) were identified in the both the brown algae Hormosira banksii and
the green algae Ulva sp.; followed by the three brown algal species with 18 FA
identified in both Myriogloea sciurus and Phyllospora comosa, 15 in Ecklonia radiata;
and the lowest number (14 FA) in the lipid extract of the red algae Solieria robusta.
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Table 13 FA composition of six Australian macroalgal species. Data presented as % molar area of total
FA. Means with different letters are significantly different (p < 0.05).
Fatty Acid
% Molar Area

Ochrophyta

Rhodophyta

Chlorophyta

E. radiata

M. sciurus.

H. banksii

P. comosa

S. robusta

Ulva sp.

10:0
11:0
12:0
14:0
14:1 n-7
15:0
15:1
16:0
16:1 n-7
17:0
17:1 n-7
18:0
18:1 n-9
18:1 n-7
18:2 n-6 (LA)
18:3 n-6
18:3 n-3 (ALA)
20:0
20:1 n-9
20:2 n-6
20:3 n-6
20:4 n-6 (AA)
20:3 n-3 (ETA)
20:5 n-3 (EPA)
22:0
22:1 n-9
22:2 n-6
22:5 n-6
24:0
22:6 n-3 (DHA)
24:1 n-9

8.5b
0.0
0.0
10.7a
0.0a
0.6
0.2
27.9b
11.4a
0.0
0.0a
1.8a
20.2a
0.0a
3.0a
0.5
1.8a
2.4b
0.0
0.0
0.0
8.7d
0.0
2.3acd
0.0
1.2
0.0
0.0
0.0
0.0
0.0

4.3ad
0.0
0.0
9.4a
0.0a
0.6
0.3
46.3a
6.5cd
0.2
< 0.1a
3.8b
19.7a
0.0a
3.7ab
< 0.1
1.9a
1.2b
0.1
0.0
0.0
1.3b
0.0
0.9a
0.3
0.0
0.0
0.0
0.0
0.0
0.0

3.6a
0.0
0.0
4.8b
0.0a
0.6
0.1
27.5b
3.7b
0.2
0.1a
1.5a
18.7a
0.3ac
5.5bc
0.1
7.4b
1.5b
0.1
0.8
1.3
13.2 c
0.7
5.8b
1.3
1.7
0.1
< 0.1
0.1
0.0
0.0

5.3ad
0.0
0.0
7.5d
0.0a
0.5
0.9
25.4c
6.1cd
0.1
0.2a
1.7a
13.7b
0.0a
7.0c
0.6
3.9d
1.8b
0.0
0.0
0.7
21.1a
0.0
3.9de
0.1
0.0
0.0
0.0
0.0
0.0
0.0

17.1c
0.0
0.0
1.0c
0.0a
0.0
0.0
26.4bc
9.9ae
0.0
3.5b
16.7c
1.5c
2.3b
0.2d
0.0
0.1a
2.6b
0.0
0.0
0.1
20.6a
0.0
0.9a
0.0
0.0
0.0
0.0
0.0
0.0
0.0

5.6d
0.1
0.7
3.1b
2.5b
0.6
0.5
20.5d
9.1e
1.2
0.6a
6.6d
10.6d
1.9bc
5.4b
0.6
12.2c
5.8a
0.0
0.0
0.1
0.8b
0.0
5.3be
0.3
0.3
0.0
0.1
0.0
0.5
0.6

Σ SFA
Σ MUFA
Σ PUFA
n-6/n-3

50.7a
33.0b
16.3d
3.0a

65.5b
26.7ac
7.8c
1.8b

40.6c
24.6cd
34.8a
1.5c

42.0c
20.8def
37.2a
3.8d

60.8b
17.2e
22.0b
15.7e

47.4a
26.0f
26.5b
0.4f

LA/ALA

1.7

1.94

0.74

1.8

2

0.44

AA: arachidonic acid; ALA: alpha-linolenic acid; DHA: docosahexaenoic acid; EPA: eicosapentaenoic
acid; ETA: eicosatrienoic acid; LA: linoleic acid
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Key differences in abundance across species
Analysis of the quantified FA data (mg.g-1 d.w. whole biomass) showed significant
differences were observed between phyla (analysis of similarity, R < 0.9, p < 0.01) and
between species within the Ochrophyta (analysis of similarity R < 0.9, p < 0.02) (Figure
10).

Transformation of the data to reduce the effect of abundance indicated that phyla

differences are significantly distinct in terms of the composition of FA profiles (analysis
of similarity R < 0.9, p < 0.01). However, species differences were not significant
within the Ochrophyta (p = 0.10) despite some evident clustering (data not shown).

Figure 10 Multivariate Dimentional Scaling plot comparing similarities of species FA profiles (mg.g-1
d.w.). Samples are from triplicate lipid extracts of six Australian native and endemic macroalgae. Data is
untransformed.
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SIMPER analysis revealed that C18:0, C20:0 and C22:0 were the three main SFA that
determined species variation in terms of both composition and abundance (Figure 10).
C18:0 is most abundant in S. robusta followed by Ulva sp. along with higher C20:0
content for the latter species. C22:0 was not present in E. radiata or S. robusta and was
most abundant in H. banksii. In regards to PUFA, SIMPER analysis showed that species
variations were primarily due to C18:2 n-6 (LA), C18:3 n-3 (ALA), C20:4 n-6 (AA),
C20:3 n-3 (ETA) and C20:5 n-3 (EPA). Oleic acid (C18:1 n-9) was most abundant in H.
banksii and M. sciurus with trace amounts in S. robusta. Ulva sp. showed the highest
abundance of essential ALA (C18:3 n-3) as a proportion of total significantly identified
PUFA. This was followed by H. banksii, which had the second highest ALA content
along with a significantly higher proportion of AA (C20:4 n-6) and EPA (C20:5 n-3).
On a molar % basis, palmitic acid (C16:0) was the predominant FA in all six samples
ranging from 20.5% in the Ulva sp. to more than double that amount (46.3%) in M.
sciurus. The second most dominant FA was oleic acid (C18:1 n-9) for E. radiata, M.
sciurus and H. banskii (20.2, 19.7 and 18.7% resp.); AA (C20:4 n-6) for P. comosa and
S. robusta (21.2 and 20.6% resp.); and ALA (18:3 n-3) for Ulva sp (12.2%). The third
most abundant FA ranging from 9.4-17.1% differed for each species from saturated FA
for M. sciurus and S. robusta (myrisitic acid (C14:0) and capric acid (C10:0) resp.); to
MUFA for E. radiata (C16:1 n-7), P. comosa and Ulva sp. (C18:1 n-9) and AA
(C20:4 n-6) for H. banksii. The latter species also had a relatively high abundance of
other desirable FA such as ALA, LA and EPA (7.4%, 5.5% and 5.8% resp.), identifying
this as a key species to pursue further.
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Along with high C16:0, S. robusta was characterised by a high C18:0 and C10:0 SFA,
the latter 2 to 5-fold greater than for all other species, coupled with low oleic acid
(C18:1 n-9) levels (Figure 11). Ulva sp. was characterised by a high proportion of C16:0,
oleic acid (C18:1 n-9) and C20:0 SFA, and moderate, essentially equivalent palmitoleic
(C16:1 n-7) levels (Figure 11). Conversely, all four Ochrophyta species were
characterised by moderate C14:0 and low C18:0 SFA content, instead dominated by a
high proportion of oleic acid (C18:1 n-9), 10-fold greater than S. robusta and 2 to 3-fold
greater than Ulva sp.
The predominant PUFA across all six species were the n-3 FA, ALA (C18:3 n-3) and
EPA (C20:5 n-3) and the n-6 FA LA (C18:2 n-6) and AA (C20:4 n-6) (Figure 11). The
most desirable ALA to LA ratio was observed for the Ulva sp. with a 2-fold higher
ALA content compared to LA; followed by H. banksii with 1.3-fold higher ALA than
LA; and then conversely P. comosa showing a 2-fold higher LA to ALA content. AA
(C20:4 n-6) was the second most abundant FA for S. robusta and P. comosa, and third
most abundant for H. banksii, and lowest in the Ulva sp. The DHA precursor, EPA
(C20:5 n-3) was highest in H. banksii (5.8%), followed by Ulva sp. (5.3%) and P.
comosa (3.9%). H. banksii also showed traces of eicosatrienoic acid (ETA; C20:3 n-3),
while the long-chain n-3 DHA (C22:6 n-3) was only detected in the green macroalgae
Ulva sp., albeit in trace amounts (0.5%).
The lowest ratio of n-6/n-3 PUFA was observed for the Ulva sp. (0.4), with the ratio
ranging from 1.5-3.8 for the four brown species, and 5-fold higher for the red seaweed
S. robusta (15.7).
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Figure 11 Key differences in FA content (mg.g-1 d.w.) across the six Australian marine macroalgae of
both total and individual SFA, MUFA and PUFA.

Anti-inflammatory activity
A qualitative summary of the percent reduction of NO production in LPS stimulated
macrophage RAW 264.7 cells relative to controls (Table 14), showed a significant
reduction in NO production across almost all of the 18 extracts. The order of activity
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was greatest in the non-polar, lipid-rich dichloromethane (DCM) extracts (>76%
activity for all species), followed by the intermediate polarity ethyl acetate (EtOAc)
extracts (>50% activity for all species except H. banksii), with the lowest activity
observed in the polar butanol (BuOH) extracts (Table 14). Although the non-polar DCM
extracts were the most active, those of P. comosa and S. robusta also exhibited high
cytotoxicity towards all three cell lines investigated, including the normal (WT-MEF)
cell line. In general, the EtOAc extracts, in particular P. comosa, M. sciurus and Ulva
sp. showed promising NO reducing activity, coupled with low toxicity towards the
normal cell line, with the exception of M. sciurus.
Cytotoxicity
A qualitative summary of 24 and 48 hr cytotoxicity data for three cell lines is presented
in Table 14. The non-polar DCM extracts of P. comosa and S. robusta showed high
cytotoxicity (>76%) across all cell lines investigated (i.e. macrophage RAW 264.7,
wild-type murine embryonic fibroblast WT-MEF and human pancreatic carcinoma
MIA-PaCa-2 cell lines). In addition to strongly reduced NO production, the DCM and
EtOAc extracts of Ulva sp. showed preferential cytotoxicity towards the MIA-PaCa-2
human pancreatic carcinoma cell line. The EtOAc extract of H. banksii showed the
greatest selectivity towards the pancreatic cancer cell line, along with a moderate
reduction in NO production.
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Table 14 Cytotoxicity and anti-inflammatory activity (via inhibition of nitric oxide (NO)) of 18 algal
extracts from six macroalgae. Data are presented as % activity at 100 µg.mL-1 from two independent trials
done in duplicate.

Species

E. radiata

M. sciurus

H. banksii

P. comosa

S. robusta

Ulva sp.

Extract

RAW
264.7

WT MEF

MIA
PaCa-2

% ↓ NO

DCM
EtOAc
BuOH
DCM
EtOAc
BuOH
DCM
EtOAc
BuOH
DCM
EtOAc
BuOH
DCM
EtOAc
BuOH
DCM
EtOAc
BuOH

+
+
+
+++
+++
nt
+
+
+
-

+
+
+++
+++
nt
+
-

+++
+++
+++
+++
+++
+++
-

+++
++
+++
+++
++
+++
+
+++
+++
+++
++
+
+++
+++
+

Key: (-) 0 - 24% activity; (+) 25 - 50%; (++) 51 - 75%; (+++) 76 - 100% activity; (nt); not tested, no
available extract. Investigated cell lines include human pancreatic carcinoma (MIA-PaCa-2), Abelson
murine leukemia virus-induced tumor macrophage (RAW 264.7) and wild-type murine embryo
fibroblasts cell lines (WT-MEF)

Discussion
Herein this study presents key differences from the screening process of six taxa of
Australian macroalgae for prioritizing future work towards anti-inflammatory
applications. To this end, consistent anti-inflammatory activity was observed for all taxa
in terms of decreased NO production, predominantly in the DCM and EtOAc extracts.
However, the species were highly diverse in the abundance of FA, with approximately
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30% more types of FA in Ulva sp. and H. banksii than in the other taxa. The highest
abundance of PUFA was in H. banksii and the 4th lowest in Ulva, while the more
preferable n-6/n-3 ratio and LA/ALA ratio was found for Ulva. In addition, the selective
cancer cell toxicity was greatest for Ulva and H. banksii (Table 15).
Table 15 Summary of key differences from the screening process of six taxa of Australian macroalgae for
prioritizing future work towards anti-inflammatory applications with a focus on PUFA content.
PUFA
content
Ecklonia radiata
Myriogloea sciurus
Hormosira banksii
Phyllospora
comosa
Solieria robusta
Ulva sp.#
#

Abundance

Low n6/n-3
ratios

LA/ALA
<1

Selective
cancer cell
toxicity

YES
HIGH
MED

YES

YES

YES

YES

YES

iNOS
inflammatory
response
YES
YES
YES
YES
YES
YES

Species name withheld.

With the exception of the well-studied green macroalgae genus Ulva [40-42] the five
other macroalgal species described herein have been studied in other contexts such as
their protein, trace element and carbohydrate content [43], but rarely in terms of their
FA profiles and anti-inflammatory activity. Investigation of a different sample of P.
comosa from South Eastern Australia has been reported by us previously with an
analogous profile to that described here [44]. The FA profile of a red seaweed belonging
to the genus Solieria has been described as dominated by C16:0 and C20:5 n-3, with the
EPA content differing from our results [45].
Apart from palmitic acid (C16:0), which was the dominant FA in all six species and is
consistent with other macroalgae [29, 30, 44] the remainder of the FA profiles were
significantly different for the three phyla investigated herein. This is consistent with
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previous reports where FA signatures have been used to distinguish taxonomic groups
up to the family level but not at the level of species [46, 47].
From the four Ochrophyta species, the two fucales species showed comparable total
SFA, MUFA and PUFA levels [47, 48]. M. sciurus (order Ectocarpales) and E. radiata
(order Laminariales) reported herein however showed reduced levels of total PUFA
when compared to similar species previously reported from the same order [47, 48].
Overall, the four Ochrophyta species were characterised by high C16:0, moderate C14:0
and low C18:0 SFA; the highest levels of oleic acid, particularly for E. radiata, M.
sciurus and H. banksii; but varying PUFA profiles and abundance with H. banksii and
P. comosa containing amongst the highest amounts of the long-chain PUFA AA
(C20:4 n-6) and EPA (C20:5 n-3) and M. sciurus and E. radiata containing the lowest
abundance of PUFA of all the six species. The dominant C18:1 n-9, C20:4 n-6 and
C20:5 n-3 is consistent with average abundances reported for the Class Phaeophyceae
[49].
The red seaweed S. robusta (order Gigartinales) was characterized by the highest
amount of capric acid (C10:0), along with other SFA in high amounts (C16:0 and
C18:0); the lowest abundance of MUFA; and a PUFA profile comprised almost entirely
of AA, consistent with other reports that Rhodophyta are dominated by the presence of
C20 PUFA [49, 50]. EPA (C20:5 n-3) levels herein were comparable to results reported
for a number of species belonging to the order Gigartinales from the Senegalese coast
by Aknin et al [51]. However, EPA has been reported in higher amounts in other red
algae (order Gigartinales) from the Pacific coast of North California [48]. In terms of
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total SFA, MUFA, PUFA, the results obtained were comparable to reported values for
Rhodophyta species [47]. On the other hand, the green seaweed Ulva sp. was
characterized by a high proportion of longer chain SFA such as C20:0; higher amounts
of oleic (C18:1 n-9) (cf. to C18:0) and equivalent amounts of palmitoleic acid (C16:1 n7), both dominant MUFA; and a PUFA profile rich in ALA (C18:3 n-3), the highest
proportion of all species, LA (C18:2 n-6) and EPA (C20:5 n-3), with the LA and ALA
content a defining feature of Chlorophyta species [49].
The species differences in PUFA composition contributed to significantly different n6/n-3 ratios for each of the six species investigated. With the exception of S. robusta,
the n-6/n-3 ratios were between 0 and 4, which is consistent with previous reports for
the FA profiles of diverse species of macroalgae [30, 52, 53]. As a desirable ratio for
human health is around 1 [16, 17], this further highlights the potential health benefits
available from large-scale cultivation of macroalgae such as Ulva sp. as a source of
beneficial PUFA with n-6/n-3 < 1 along with a ratio of LA/ALA <1.
It is important to note that chemical composition, including FA profiles can exhibit
clear seasonal and within plant variation, particularly in regards to total lipid content
rather than the lipid profile [3, 54, 55]. Thus any future algal cultivation would need to
consider cultivation conditions that best enhance PUFA profiles for target algal species
and total lipid content, along with rigorous measures to ensure quality control.
Biological evaluation of the organic extracts generated from oven dried biomass of all
six species was also performed. All 18 extracts exhibited a degree of inhibition of
production of the inflammatory mediator NO, whereby the activity followed the order:
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non-polar extracts > intermediate polarity extracts > polar extracts. Non-polar (DCM)
extracts are the FA-rich fraction and also known to contain phenolic compounds as well
as pigments; all of which have unique functions in inflammatory metabolism [15, 56].
Interestingly, n-3 PUFA have been reported as modulators of the activity of nitric oxide
synthase (NOS) [57], one of the primary enzymes involved in NO production. MUFA
derivatives have also been isolated from Ulva lactuca which act as activators of the
cytoprotective Nrf2 –ARE pathway [58], linked to suppression of inflammatory
responses [59]. Furthermore, the brown alga Eisenia bicyclis (order Laminariales) was
evaluated for anti-inflammatory activity via inhibition against LPS-induced NO and
other inflammatory mediators in RAW 264.7 cells, as in this study. Similar to our
findings, the activity was found to be greatest in the non-polar DCM extract [60]. In
their case the activity was attributed to fucosterol, which has also been shown to
suppress production of NO and the inflammatory cytokines TNF-α and IL-6 in the
brown alga Undaria pinnatifida (order Laminariales) [61].
Anti-inflammatory activity has been reported for a range of other algal metabolites
isolated from non-polar and DCM extracts including the chromene sargachromanol G
from the Korean brown alga Sargassum siliquastrum (order Fucales) [62]; halogenated
compounds from the Malaysian red alga Laurencia snackeyi [63] and the porphyrin
derivatives, pheophorbide a and pheophytin a, along with the xanthophyll fucoxanthin,
from the edible brown alga Saccharina japonica (order Laminariales) [64]. Other
bioactive algal metabolites isolated from non-polar extracts include cytotoxic,
antibacterial linear sesquiterpenoids from the green alga Penicillus capitatus (class
Ulvophyceae, order Bryopsidales) [65]; antibacterial labdane diterpenoids from Ulva
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fasciata [66]; and antiatherosclerotic phytosterols from the brown alga Sargassum
fusiforme (order Fucules) [67].
Most extracts displayed minimal toxicity to the cell lines investigated. However, six
algal extracts showed high cytotoxicity towards a human pancreatic cancer cell line,
with the EtOAc extracts of Ulva sp. and H. banksii showing the greatest selectivity with
no toxicity towards a normal murine cell line. Marine algae are well known as rich
sources of unique, structurally diverse, biologically active natural products with a range
of reported activities including anti-cancer, anti-viral, anti-bacterial, anti-fungal and
immunomodulating activities [8, 68, 69]. In particular, a number of promising anticancer compounds have been isolated from algae including the anti-mitotic stypoldione
from the brown alga Stypodium zonale and the cytotoxic dehydrothysiferol from the red
alga Laurencia viridis (Brown et al. 2014). Thus, further investigation to identify the
active component of the selectively cytotoxic extracts is needed.
In summary, six Australian macroalgal species were evaluated for their FA composition
and anti-inflammatory activity. From these studies, the green seaweed Ulva sp. emerged
with one of the highest number of different FA identified and exhibited a favourable n6/n-3 ratio of 0.4, as well as a 2-fold higher ALA (C18:3n-3) to LA (C18:2n-6) content.
Ulva was also the only species to contain the desirable long-chain n-3 DHA with the
lowest amounts of AA. The brown seaweed H. banksii was also of interest in terms of
its rich FA profile with the highest EPA and ETA content of all six species, the latter
known to have anti-inflammatory properties [70], the second lowest n-6/n-3 ratio of 1.5,
the second best ALA to LA ratio of 1.3:1, although accompanied by the highest
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abundance of AA. These results have implications in product development by
highlighting target species such as Ulva sp. and H. banksii with both desirable n-3
PUFA and biological activity profiles.
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FOREWORD TO CHAPTER 4
The metabolite and bioactivity screening of wild and cultivated macroalgal species
presented in the previous Chapter 3 established a number of key species of interest for
future investigations (Figure 12).

P. comosa

E. radiata

M. sciurus H. banksii

S. robusta

• Selective anti-cancer

• High anti-inflammatory
activity

Ulva sp.

• Desirable omega-6/omega-3
• Diverse fatty acid profile
• Desirable linoleic acid/αlinolenic acid
• Low levels of proinflammatory substrate
arachidonic acid
• Selective anti-cancer

Figure 12 A summary of the major findings and most interesting macroalgal candidates presented in
Chapter 2, as a result of preliminary metabolite and bioactivity screening of five macroalgal species
obtained from wild collection and one cultivated Ulva sp. (provided by Venus Shell Systems Pty. Ltd.10)

Myriogloea sciurus and Hormosira banksii
Myriogloea sciurus showed anti-inflammatory activity at a consistently high level
across all extracts with little toxicity. Interestingly, Hormosira banksii showed selective

10

Venus Shell Systems, Narrawallee, NSW, 2539, Australia
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anti-cancer activity against pancreatic cancer. Whilst cancer and natural product
isolation for potential anti-cancer drug compounds is beyond the scope of this thesis,
this finding was subsequently explored and the active extract was purified into 24
fractions using column chromatography (Supplementary Methods Appendix D) (Figure
13).
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Figure 13 The % cytotoxicity on pancreatic cancer (MIAPaCa-2) cells (as a measure of inhibition of cell
proliferation) of 24 fractions generated by silica-gel chromatography purification of the active Hormosira
banksia extract which was identified by bioactivity screening work presented in Chapter 2. High anticancer activity was retained in 4 fractions (F9, F10, F11 and F22).

As fraction 10 had one of the highest yields (mg) of product it was chosen for further
analysis by analytical high-pressure liquid chromatography (HPLC), which revealed 9
minor and 2 major peaks (Supplementary Results Appendix E). This indicates the
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presence of 12 compounds. Further preparative HPLC revealed the most dominant peak
to be two compounds indicating the presence of 13 compounds in fraction 10, in which
one or all may be responsible for selectively inhibiting pancreatic cancer
(Supplementary Results Appendix E) However, poor yields (< 1 mg) of the final
isolated compound(s) limited further structural characterisation via mass spectrometry
and nuclear magnetic resonance spectroscopy (NMR). However, these preliminary
investigations of Hormosira banksia highlight this macroalgae as a novel and unique
Australian species to pursue, particular as part of a future natural product focused
project. Myriogloea sciurus also warrants further investigations as species from the
order Ectocarpales have mainly been investigated with regards to their water-soluble
polysaccharides or Fucoidan (as outlined in Chapter 1) and herein we demonstrate high
anti-inflammatory potential across three organic extracts of differing polarities with
limited to zero toxicity against both established and primary cells lines.
Ulva sp.
Of greater interest herein were the positive results obtained for the cultivated Ulva
sample, which not only showed high anti-inflammatory functionalities across all three
organic extracts, but also a diverse fatty acid profile. The nonpolar dichloromethane
extract and the more polar ethyl acetate extract showed the strongest anti-inflammatory
activities and it was hypothesised that that this could be due to the presence of antiinflammatory fatty acids and pigments. As the metabolism of macroalgae responds
readily to their environment it is important to determine the cultivations conditions that
enhance that metabolite and bioactivity profile of interest, particular in regard to their
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fatty acids. Fatty acids are one of the most variable compositional categories that differ
across taxa but they also readily change within taxa in response to the environment. The
analysis of fatty acids and pigments were undertaken to determine if variability due to
cultivation of different biomass fractions was significant and quantifiable.
Furthermore, due to the variability found in the reporting of fatty acids for Ulva sp. in
the literature, along with first-hand experience with fatty acid variability across different
protocols in-house, it was considered necessary to consider the extraction protocols and
analytical methods and their affect on the fatty acid profile.
Therefore work was undertaken to determine the effect of cultivation conditions and
extraction method on the fatty acid profiles of a cultivated Ulva sp. This work presented
in Chapter 4, is the final accepted version in thesis format of a published manuscript11
(2016) within the journal Food Chemistry (Impact factor 3.391). The title page of the
article as it appears in the printed journal can be found in Appendix F.

11

McCauley, J.I., et al., Parameters affecting the analytical profile of fatty acids in the macroalgal genus
Ulva. Food Chemistry, 2016. 209: p. 332-340.
Permissions regarding copyrights have been obtained
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Abstract
The fatty acids (FA) of Ulva have potential to contribute to nutrition. However the
large variability of FA profiles of Ulva species; thus the quality and quantity of
FA in relation to nutrition is poorly defined. Herein we investigate the FA profile
of 74 cultured Ulva samples crossing five culture regimes, six extraction regimes
and four post-harvesting processes. This is compared alongside a comprehensive
review of FA profiles of Ulva spp. With regard to the literature, Ulva is
characterised by C16:0 (30.5 ± 11.5 %), C18:3 n-3 (14.5 ± 6.3 %), C18:4 n-3
(12.5 ± 5.4 %), C16:4 n-3 (8.9 ± 4.8 %) and C18:1 n-7 (10.1 ± 4.0 %). The
investigated Ulva fell within the reported range of specific FA. High nutrient
conditions showed the most desirable FA profile for health, along with the highest
total FA content (56 mg.g-1 dry weight equivalent) when extracted with an
optimised protocol.
Key words: PUFA, desiccation, extraction, cultivation, environment, nutrition,
health
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Introduction
The marine macroalgal genus Ulva (Chlorophyta) is a source of valuable long-chain
polyunsaturated fatty acid (LC-PUFA) profiles, in particular the biologically important
eicosapentaenoic acid (C20:5 n-3, EPA) [1]. Ulva spp. also show the presence of trace
amounts of docosahexaenoic acid (C22:6 n-3, DHA), however more abundant LCPUFA include the DHA precursor, docosapentaenoic acid (C22:5 n-3, DPA), along with
the more unique C18:4 n-3 and C16:4 n-3 PUFA [1]. Ulva grows abundantly in waters
enriched by nutrients and is frequently involved in green tides in eutrophicated coastal
areas producing a high quantity of biomass [2]. This characteristic of Ulva means that it
is well suited for cultivation. Therefore as whole biomass or as part of a sequential
biorefinery system of production, cultivated Ulva biomass has the potential to offer a
sustainable source of essential FA for human and animal consumption and nutrition.
The feasibility of cultivating marine macroalgae, as a sustainable source of high value
products is largely dependent on the cost-effectiveness and scalability of cultivation to
deliver high yields of quality controlled biomass. Ulva is a cosmopolitan genus (Figure
14)

and can readily adjust its metabolism under specific environmental conditions,

wherein the lipids and FA play an important role in this adaptation [3]. As such, the
profiles of reported FA for Ulva show a wide degree of natural variation. For example
U. intestinalis has demonstrated an increase in unsaturation with increasing
mineralisation in a study of a number of abiotic factors [3].
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Figure 14 World map indicating the various world locations where samples from the genus Ulva were
collected and subsequently analysed for FA content as reported in the literature.

Seasonal comparison of U. lactuca samples collected in Western Ireland showed a
notable decrease in the n-6/n-3 ratio when collected in November (cf. June) [4].
Furthermore, the range of reported n-6/n-3 values were also more favourable when
compared to an U. lactuca specimen collected from Northern Chile [5]. However, one
of the appeals of Ulva in particular as a target genus, is its ability to be grown
effectively and rapidly in culture, while tailoring PUFA profiles through nutrient replete
conditions, which have been demonstrated on the laboratory scale [6]. It has also been
shown that culture conditions including temperature [7], pH [8] and nutrient availability
along with the presence of organic carbon [6], will also influence the lipid profile of
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many algae including Ulva spp. Despite this, there are species-specific patterns within
that variability that can be determined with experimental means and comprehensive
review of the data. Yet little has been done beyond the laboratory scale in developing
controlled commercial production systems. Therefore it is important to demonstrate the
degree to which scaled cultivation conditions can be controlled to deliver the desired
compositional profiles. A second consideration that could drive the variability of
reported FA content and profiles is whether or not there are effects on the FA
composition due to post-harvest processing, and in particular the drying process, along
with effects due to variations in analysis methods on the quantification of these desired
traits. This is important in delivering, from the farm to the consumer, a high quality
health food product and/or ingredient with well-established processing and/or quality
controlled testing criteria.
For example a number of studies have demonstrated that the choice of analytical
method and any deviations of the method can significantly influence the FA yield and
profile. For example, comparisons across standard extraction and transesterification
techniques such as the International Organization for Standardization (ISO) method, the
Association of Official Analytical Chemists (AOAC) method and the Folch method [9]
found no significant differences in regards to total FA recoveries of flaxseed oil [10].
However, monounsaturated fatty acids (MUFA) and PUFA were found to be
underestimated after extraction with the ISO method when compared with AOAC and
Folch methods [10].

106

Chapter 4 Ulva Fatty Acids

In terms of the effects from extraction methods on FA yields, the comparison of
extraction-transesterification techniques versus direct transesterification showed
significantly increased FA yields in lipid-producing microheterotrophs for direct
transesterification methods [11]. Various solvents and solvent combinations have also
been explored with higher FA recoveries found with either the Folch or Bligh and Dyer
extractions protocols [12]. These protocols both use a ratio of the nonpolar solvent
chloroform with the more polar methanol [12]. In macroalgae specifically, Kumari et al
(2011) did a comparative evaluation of Bligh and Dyer, Folch and Cequier-Sánchez
methods for the quantitative determination of total lipids and FA, along with
investigating the effect of sonication and addition of a buffer in the solvent system. For
U. fasciata no added benefit was observed for a buffered solvent system with high lipid
and FA yields obtained for the traditional Folch extraction. Therefore, for the
development of a nutritionally valuable, high yielding algal-derived oil, it is important
to investigate both environmental effects of cultivation and effects due to post-harvest
processing and analysis methods.
Herein we present the FA profile of a medium-scaled production of a genetically
identified strain of one sp. of Ulva as a model to test the effects of environment and
processing. The FA profile is presented and compared against a comprehensive
literature review for the FA profile of the genus Ulva. The effects of environmental
conditions were compared across five different medium-scale (5 m3) culture conditions;
low nutrients, high nutrients, shaded, added glucose and acetic acid boost. Thirdly, this
research explores the effects of post-harvesting processes and analysis methods on the
FA composition and total content of the cultured algae. The findings presented have
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important implications for the application of Ulva spp. in nutrition. This includes the
development of diverse techniques to establish the best practices for analysis of FA in
Ulva spp. as well as understanding the scale and type of effects from the environment.
Materials and Methods
Analysis of the literature
A literature review of the reported FA profiles for the genus Ulva was conducted. The
search was conduced using Web of Science with “Ulva” and “fatty acids” as key search
terms. The review was comprised of 40 FA profiles from 23 references. Only papers
reporting profiles as a percentage of total FA were considered. Due to large variations in
the level of reporting of Ulva FA profiles, data was modified for analysis. All structural
variations of identified C14, C16, C17 and C20 MUFA were grouped and identified at
the level of C14:1, C16:1, C17:1 and C20:1 respectively. Similarly, this was applied to
all identified C16:2 and C20:2 PUFA. Identified cis and trans isomers of the C18:1 n-9
were also analysed collectively as C18:1 n-9. Furthermore, a number of identified FA
were excluded due to (1) the bond position not being specified for a commonly reported
FA and/or (2) FA is uncommon and/or appears less than 3 times out of the 40 profiles
reviewed. Data was aligned and visualised using GraphPad Prism version 6.00,
GraphPad Software.
Experimental Samples
A total of 74 Ulva samples were analysed over the course of two yearly cultivation
periods. The Ulva samples were from scaled, cultivated stock, provided by Venus Shell
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Systems Pty. Ltd. Samples were from controlled cultivation conditions of high nutrient
(natural sunlight with nutrient-rich media); low nutrient (natural sunlight with reduced
nutrients); low light (reduced natural sunlight with nutrient-rich media), added acetic
acid (natural sunlight with nutrient-rich media supplemented with acetic acid) and
added glucose (natural sunlight with nutrient-rich media supplemented with glucose).
For investigations into desiccation effects, samples were oven-dried (70 °C, 48 hrs),
freeze-dried (liquid nitrogen followed by lyophilisation for 48 hrs), fresh (stored -4 °C,
48 hrs) or frozen (-18 °C). Samples were extracted directly, or milled using a mortar
and pestle (5 mins, continuously), sonicated (15 mins, rt) or co-incubated with enzyme
(Onozuka R10, 2% w/v, rt, 15 mins) to test for effects of processing techniques.
Extraction and Transesterification
Lipids were extracted based on a standard method (referred to as extraction regime E1)
of Folch et al. [9], with modifications based on Kumari, Reddy [13]. In brief, two grams
of non-homogenized fresh sample was extracted with 3 x 6 mL of chloroform/methanol
(2/1, v/v) with 0.001% butylated hydroxytoluene (BHT) by vortexing (~1 min) and
centrifugation (3000 rpm, rt, 15 mins), with two extracts left overnight. The extract was
evaporated to a consistent weight (dryness) in pre-weighed 9 mL Teflon lined screw top
glass tubes under a stream of nitrogen. Crude lipid extracts were transesterified
according to the method of Lepage and Roy [14] with added BHT (0.01% w/v).
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Extraction Regimes
Further modifications to the standard method (E1) were also investigated and involved
alterations to the solvent and mass ratio, extraction time and number of extractions, as
well as the inclusion of a pre-treatment step. Specific modifications to the method (E1)
involved pre-homogenization of the biomass with a mortar and pestle (5 mins,
continuously) and the removal of one overnight incubation (E2); pre-treatment of the
biomass with an enzyme (Onozuka R10, 2% w/v, rt, 15 mins) before extraction (E3);
pre-treatment of the biomass with sonication (15 mins, rt) before extraction (E4); prehomogenization of the biomass with a mortar and pestle (5 mins, continuously) and an
increase in the number of consecutive reactions from 3 to 6 (limit observed where no
more colour could be extracted) (E5) and; increase in the solvent to mass ratio from 3:1
to 6:1 with the removal of two overnight incubations (E6).
FA Analysis
FA were analysed by flame-ionization gas chromatography (GC-FID) (model GC-17A;
Shimadzu, Rydalmere, NSW, Australia) using a 50 m x 0.25 mm internal diameter
capillary column. One microlitre of the transesterified sample was auto-injected into the
column, and individual FA were quantified using the Shimadzu analysis software
(Class-VP 7.2.1 SP1). Samples were also analysed by GC mass spectrometry (GC-MS),
performed on a Shimadzu QP-5050A GC-MS system equipped with a BP-5 fused silica
Rxi-5ms capillary column (5% phenyl/95% polysiloxane, 30 m x 0.25 mm, 0.25 um
film thickness, Restek), using helium carrier gas (1.0 mL.min-1) and samples of one
microlitre over the temperature range of 80 - 300 °C. FA were identified by comparison
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with known standards (Nu-chek or Sigma, Sydney, Australia) and comparison with
mass spectral database library. Heneicosanoic acid (0.2 mg.mL-1 in toluene) was used
as an internal standard for quantification and samples were analysed in triplicate.
Relative compositional data is represented as molar % composition of total FA taking
into account the molecular weight of the identified FA. Quantified data is represented as
mg.g-1 dry weight equivalent (d.w. equiv.).
Statistical Analysis
The relative compositional profiles and content of FA across the five cultivation
conditions, six extraction regimes and four post-harvesting processes were assessed
using Two-way ANOVA and Tukey’s multiple comparisons to determine significantly
different means using GraphPad Prism version 6.00, GraphPad Software.

111

Chapter 4 Ulva Fatty Acids

Results and Discussion
FA Profile of the genus Ulva
A review of 40 reported FA profiles from 23 references of the genus Ulva was used to
establish a generic FA profile for the genus Ulva and to determine the degree of
variability that can occur if spp., environment and/or processing variables are viewed
collectively. Furthermore, it provides a reference upon which to base our comparisons.
Figure 14

shows the diverse locations of the collected Ulva samples that were reviewed

and analysed. The number of FA reported varied between 7 and 31, with an average of
16. From the 12 spp. of Ulva that were reported, U. lactuca and U. pertusa were heavily
represented (33 % and 25 % respectively). Furthermore, the most commonly used
extraction method was the traditional extraction protocol of Bligh and Dyer (55 %)
followed by the Folch method (23 %). Analyses were more commonly conducted on
fresh samples (30 %), followed by dried and frozen samples (both 23 %), with
extraction on freeze-dried biomass representing 20 %. A number of publications
reported a pre-treatment step of boiling in water or isopropyl alcohol to inactivate
enzymes or for de-proteinisation of the sample (Table 16).
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Location
Nagasaki Prefecture, Japan
Brittany, France
Nagasaki Prefecture, Japan
Alert Bay, Cormorani Island, Canada
Nagasaki Prefecture, Japan
Amur Bay, Sea of Japan
Stark Strait, Japan
Stark Strait, Japan
Elton Lake Basin, Russia
Eastern Gulf of Finland
Caspian basin, Russia
Caspian basin, Russia
Romanian Black sea coast
Monastir-Tunisia
Baja California Peninsula, Mexico
Baja California Peninsula, Mexico
Baja California Peninsula, Mexico
Baja California Peninsula, Mexico
Baja California Peninsula, Mexico
Baja California Peninsula, Mexico
Bohai Sea, China
Persian Gulf of Iran
Galway Bay, Western Ireland
Galway Bay, Western Ireland
Bodega Bay, California
Coastal area, Northern Chile
Egyptian Mediterranean
Mission Bay, San Diego, California
Nagasaki Prefecture, Japan
Algal Culture
Algal Culture
Algal Culture
Algal Culture
Algal Culture
Algal Culture
Bohai Sea, China
Fukuyama Cho, Southern Japan
Fukuyama Cho, Southern Japan
Algal Culture Filamentous. sp.
Algarve coast, Portugal

Extraction
Methanol
Bligh & Dyer
Methanol
Folch
Methanol
Bligh & Dyer
Bligh & Dyer
Bligh & Dyer
Bligh & Dyer
Folch
Bligh & Dyer
Bligh & Dyer
Hexane
AFNOR, 1984
Folch
Folch
Folch
Folch
Folch
Folch
Bligh & Dyer
Bligh & Dyer
Direct transesterification
Direct transesterification
Bligh & Dyer
Folch
Bligh & Dyer
Bligh & Dyer
Methanol
Bligh & Dyer
Bligh & Dyer
Bligh & Dyer
Bligh & Dyer
Bligh & Dyer
Bligh & Dyer
Bligh & Dyer
Bligh & Dyer
Bligh & Dyer
Bligh & Dyer
Direct transesterification

Biomass Extracted
Dried powder
Frozen
Dried powder
Lyophilised
Dried powder
Fresh
Not specified
Not specified
Inactivated fresh (boiled 10 mins i-PrOH)
Fresh
De-proteinisation in i-PrOH 15 mins 80 degrees
De-proteinisation in i-PrOH 15 mins 80 degrees
Freeze-dried powder
Dried powder
Fresh
Fresh
Fresh
Fresh
Fresh
Fresh
Boiled water then dried and ground
Freeze-dried powder
Freeze-dried
Freeze-dried
Boiling water (2 mins) to inactivate enzymes
Dried powder
Dried powder
Rehydrated lyophilised
Dried powder
Inactivated (boiling water) then frozen -20 under N
Inactivated (boiling water) then frozen -20 under N
Inactivated (boiling water) then frozen -20 under N
Inactivated (boiling water) then frozen -20 under N
Inactivated (boiling water) then frozen -20 under N
Inactivated (boiling water) then frozen -20 under N
Boiled in water then dried and ground
Inactivated (boiling water) then frozen -20 under N
Inactivated (boiling water) then frozen -20 under N
Freeze-dried
Freeze-dried powder

Table 16 Summary of the literature reviewed for the FA profile of the genus Ulva.
Spp.
U. arasakii
U. armoricana
U. congloboto
U. fenestrata
U. fasciata
U. fenestrata
U. fenestrata
U. fenestrata
U. intestinalis
U. intestinalis
U. intestinalis
U. intestinalis
U. intestinalis
U. lactuca
U. lactuca
U. lactuca
U. lactuca
U. lactuca
U. lactuca
U. lactuca
U. lactuca
U. lactuca
U. lactuca
U. lactuca
U. lactuca
U. lactuca
U. linza
U. lobata
U. pertusa
U. pertusa
U. pertusa
U. pertusa
U. pertusa
U. pertusa
U. pertusa
U. pertusa
U. pertusa
U. pertusa
Ulva. sp.
Ulva. sp.

Ref
Alamsjah, Hirao [15]
Kendel, Wielgosz-Collin [16]
Alamsjah, Hirao [15]
Colombo, Risé [17]
Alamsjah, Hirao [15]
Khotimchenko [18]
Hotimchenko [19]
Hotimchenko [19]
Nesterov, Rozentsvet [3]
Gubelit, Makhutova [20]
Rozentsvet and Nesterov [21]
Rozentsvet and Nesterov [21]
Horincar, Parfene [22]
Yaich, Garna [23]
Serviere-Zaragoza, Hurtado [24]
Serviere-Zaragoza, Hurtado [24]
Serviere-Zaragoza, Hurtado [24]
Serviere-Zaragoza, Hurtado [24]
Serviere-Zaragoza, Hurtado [24]
Serviere-Zaragoza, Hurtado [24]
Li, Fan [25]
Rohani-Ghadikolaei and Abdulalian [26]
Schmid, Guihéneuf [4]
Schmid, Guihéneuf [4]
Khotimchenko, Vaskovsky [27]
Ortiz, Romero [5]
El Maghraby and Fakhry [28]
Nelson, Phleger [29]
Alamsjah, Hirao [15]
Floreto, Teshima [30]
Floreto, Teshima [30]
Floreto, Teshima [30]
Floreto, Teshima [30]
Floreto, Hirata [31]
Floreto, Hirata [31]
Li, Fan [25]
Floreto, Hirata [32]
Floreto, Hirata [32]
McCauley, Meyer [33]
Pereira, Barreira [34]

Other Notes

Collected shade
Collected Light

10.9 g/L salinity
31.2 g/L salinity

May 2002
May 2003
Aug 2003
Nov 2003
Feb 2004
May 2004

Temp 14 °C (June)
Temp 12 °C (Nov)

N = 0 mM
N = 0.5 mM
P = 0 µM
P = 75 µM
Light Int. 195 µE/m2/s
Light Int. 15 µE/m2/s

10th April 17.8 °C
22nd July 28.4 °C
Cultured

113

Chapter 4 Ulva Fatty Acids

Consolidation of the literature, shown in Figure 15, shows the FA profile of Ulva
macroalgae

being

comprised

of

35.3

±

13.7

%

saturated

fatty

acids

(average ± standard deviation, SFA), 15.9 ± 6.6 % MUFA and 41.8 ± 15.6 % PUFA.
The lowest degree of variation occurs within the MUFA. Notably larger increases in
total SFA with reduced PUFA content has been reported. For example samples
collected from Tunisia [23], the Egyptian Mediterranean [28], Persian gulf of Iran [26]
and the Algarve coast, Portugal [34] report SFA between 59 - 72 % of total FA with
PUFA between 6 - 24%. In contrast, FA profiles of Ulva collected from the sea of
Japan [18, 19] and the Chinese Bohai sea [25] showed a reported range of SFA between
21 - 33 % and PUFA between 49 - 61 %. Herein, analysis of the FA composition of 74
samples of one cultured Ulva sp. over the course of two years fell well within the ranges
of the reported literature (SFA 32.8 ± 5.8 %, MUFA 16.5 ± 4.3 % and
PUFA 51.0 ± 7.3 %) (Figure 15).
The most commonly reported SFA for Ulva spp. were found to be C14:0 (1.8 % ± 2.1),
C16:0 (30.5 % ± 11.5), C18:0 (1.5 % ± 1.8) and C22:0 (1.7 % ± 1.5) with C16:0 being
the most dominant FA, a main characteristic of all macroalga in general [34].
The cultured Ulva sample reported similar values: C14:0 (1.1 ± 0.7 %), C16:0 (26.5 ±
5.2 %), C18:0 (0.8 ± 0.7 %) and C22:0 (0.5 ± 0.2 %) (Figure 15). In general, C16:0 was
also the most variable FA, with the lowest content (14 %) reported in an Ulva sample
from Chile [5] and the highest content (59.4 %) reported from a Tunisian sample [23].

114

Figure 15 Summary of the characteristic FA and their representative abundance (as a percentage of total FA) for the genus Ulva as reported in the literature (review of 40
profiles from 23 references as outlined in Table 1). Graph represents reported values alongside literature average ± standard deviation. This is further compared with a
cultured filamentous Ulva sp. (*) as reported herein and represents the average of 74 analysed samples which included five different culture regimes, six extraction regimes
and four post-harvesting processes.
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Commonly reported MUFA from least abundant to most abundant were
C14:1 (1.5 ± 1.2 %), C18:1 n-9 (4.1 ± 4.1 %), C16:1 (4.4 ± 3.2 %) and C18:1 n-7
(10.1 ± 4.0 %), with comparable findings for our cultured Ulva sp. (Figure 15). There
was little variability in the literature in regards to MUFA content, although some
discrepancy in regards to the reporting and level of identification of C18:1 was
apparent. For example, in some cases bond position is not specified [3, 23]. In other
cases, only C18:1 n-7 [30] or C18:1 n-9 is reported [26]. In these cases the abundance
of the respective C18:1 showed variation between 4.9 and 15.9 % of total FA. In
instances where both FA were identified [19, 20, 25], the abundance of C18:1 n-7 to
C18:1 n-9 was often greater than 1-fold and reflects the literature trend as shown in
Figure 15.

Notably, papers identifying only C18:1 n-9, show it to be more abundant than

the literature average. For example Rohani-Ghadikolaei and Abdulalian [26] reported an
abundance of C18:1 n-9 of 11.5 % representing a 2-fold increase when compared to the
literature average. This raises the question as to whether or not the bond position of the
C18:1 MUFA is being correctly identified or is simply a matter of intra-species
variation that is known to occur [4, 24, 30]. Indeed we found that comparison of our
sample with a standard FA methyl ester mixture lacking C18:1 n-7, C18:1 n-9 can be
easily assigned to the more dominant C18 MUFA due to similar retention times. Only
upon running an additional C18:1 n-7 standard were we able to assign both C18:1 n-9
and C18:1 n-7.
Ulva was further characterised by abundant C16 and C18 PUFA comprising about 45 %
and 40 % of total FA respectively. Of note C18:4 n-3, a characteristic FA of marine
algae and C16:4 n-3 a distinguishing characteristic FA for green algae, along with high
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levels of C18:2 n-3 and C18:3 n-3 [1]. The FA in order of increasing abundance were
C18:2 n-6 (5.3 ± 3.6 %), C16:4 n-3 (8.9 ± 4.8 %), C18:4 n-3 (12.5 ± 5.4 %) and C18:3
n-3 (14.5 ± 6.3 %). The FA C18:2 n-6 (8.3 ± 3.5 %) and C18:3 n-3 (19.5 ± 3.4 %) for
the investigated cultured Ulva were marginally above the literature average. However,
C18:2 n-6 and C18:3 n-3 have been reported to be as high as 21 % of total FA for C18:2
n-6 [15] and 28.8 % for C18:3 n-3 [21].
LC-PUFA combined, as reported in the literature for Ulva comprised approximately
6.0 % of total FA. Most commonly reported LC-PUFA from least abundant to most
abundant are C20:4 n-6 (0.9 ± 0.6), C22:6 n-3 (1.1 ± 2.3), C20:5 n-3 (1.6 ± 1.2) and
C22:5 n-3 (2.2 ± 1.0). The cultivated Ulva sample fell well within the reported range of
the literature (Figure 15). It was found that DHA content (C22:6 n-3) is often reported to
be present in trace amounts, on average < 2 %, however DHA content has been reported
to be as high as 9 % [28] from the only reported FA profile for U. linza.
Effect of environmental conditions on FA profile (% total FA)
Over the course of two years the FA profile of a cultured filamentous sp. of Ulva was
analysed to investigate the effect of different medium-scale open pool outdoor
cultivation conditions. The 74 samples investigated included five different culture
regimes; high nutrients, low nutrients, low light, added acetic acid and added glucose
and also included samples prepared by six different extraction regimes and four
different post-harvesting processes. FA profiles from the respective culture conditions
are presented in Table 17. The most notable shifts occurred between the low nutrient and
high nutrient treatments. Multiple comparisons indicated a significant increase in the
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proportion of total SFA (41 %) and decrease in PUFA (25 %) for the low nutrient group
when compared to the high nutrient group (P < 0.005). This is due to changes in C16:0
content (Table 17).
Table 17 The FA profile of a filamentous Ulva sp. from five different culture treatments. Data is
expressed as the % of total FA. Data represents the average ± se of 74 Ulva samples investigated over a
two-year period. Means with different letters are significantly different (Tukey’s multiple comparisons, p
< 0.05).
High Nutrients
(n = 35)

Low Nutrients
(n = 9)

C8:0
C10:0
C11:0
C12:0
C14:0
C14:1 n-7
C15:0
C15:1
C16:0
C16:1 n-7
C17:0
C17:1 n-7
C16:4 n-3
C18:0
C18:1 n-9
C18:1 n-7
C18:2 n-6
C18:3 n-6
C18:3 n-3
C18:4 n-3
C20:1 n-9
C20:4 n-6
C20:3 n-6
C20:5 n-3
C22:0
C22:1 n-9
C22:5 n-3
C22:6 n-3

0.11 ±
1.41 ±
0.27 ±
0.74 ±
1.19 ±
0.41 ±
0.26 ±
0.47 ±
24.46 ±
5.25 ±
0.70 ±
0.35 ±
12.11 ±
0.61 ±
0.83 ±
8.62 ±
6.61 ±
0.84 ±
20.95 ±
9.02 ±
0.04 ±
0.74 ±
0.19 ±
1.49 ±
0.56 ±
0.05 ±
1.81 ±
0.09 ±

0.05
0.31
0.04
0.06
0.14
0.12
0.03
0.06
0.67a
0.53
0.09
0.05
0.40a
0.07
0.11
0.76a
0.30a
0.06
0.60a
0.27a
0.01
0.08
0.03
0.24
0.05
0.03
0.13a
0.03

0.15 ±
0.79 ±
2.20 ±
0.45 ±
1.27 ±
0.27 ±
0.25 ±
0.47 ±
35.22 ±
4.30 ±
0.63 ±
0.34 ±
4.79 ±
1.36 ±
2.09 ±
9.70 ±
12.90 ±
0.90 ±
14.17 ±
4.13 ±
0.14 ±
0.86 ±
0.36 ±
1.28 ±
0.49 ±
0.31 ±
1.03 ±
0.01 ±

0.12
0.35
0.03
0.09
0.13
0.24
0.07
0.09
0.11b
0.26
0.12
0.08
0.19b
0.06
0.08
0.24ab
0.08b
0.06
0.16b
0.13b
0.03
0.09
0.05
0.21
0.07
0.05
0.13b
0.27

1.76 ±
0.44 ±
0.75 ±
1.15 ±
0.46 ±
0.34 ±
0.50 ±
25.33 ±
5.22 ±
1.56 ±
0.69 ±
10.92 ±
0.99 ±
0.78 ±
7.16 ±
9.51 ±
0.97 ±
19.65 ±
7.35 ±
0.03 ±
1.19 ±
0.36 ±
1.44 ±
0.42 ±
0.29 ±
1.09 ±
0.03 ±

0.33
0.13
0.07
0.18
0.09
0.02
0.09
0.83a
0.64
0.12
0.08
0.57ac
0.21
0.09
0.75a
0.86c
0.15
0.35a
0.40a
0.01
0.19
0.06
0.23
0.04
0.23
0.06 b
0.02

0.72 ±
0.46 ±
0.97 ±
0.55 ±
0.81
0.03 ±
0.20 ±
0.42 ±
28.22 ±
4.22 ±
0.25 ±
0.18 ±
10.37 ±
0.34 ±
0.42 ±
12.30 ±
6.90 ±
0.42 ±
20.09 ±
7.80 ±
0.08 ±
0.31 ±
0.10 ±
1.30 ±
0.55 ±
0.06 ±
2.20 ±
0.15 ±

0.12
0.09
0.32
0.09
0.02
0.02
0.03
0.07
1.01c
0.29
0.05
0.04
0.44ac
0.01
0.04
0.08b
0.15a
0.02
0.31a
0.35a
0.02
0.01
0.02
0.06
0.05
0.01
0.22c
0.15

1.68 ±
0.29 ±
0.88 ±
1.05 ±
0.76 ±
0.38 ±
0.26 ±
24.75 ±
4.56 ±
1.25 ±
0.41 ±
8.49 ±
1.71 ±
1.23 ±
10.79 ±
11.62 ±
1.32 ±
17.81 ±
5.68 ±
0.16 ±
1.53 ±
0.53 ±
1.10 ±
0.38 ±
0.17 ±
1.01 ±
0.01 ±

0.37
0.05
0.12
0.17
0.19
0.02
0.06
1.27a
0.79
0.23
0.14
0.66c
0.27
0.08
1.20b
1.71b
0.11
0.62c
0.26b
0.03
0.15
0.01
0.06
0.02
0.10
0.10 b
0.00

% SFA
% MUFA
% PUFA

30.30 ±
16.03 ±
53.90 ±

0.75a
0.89
1.22a

42.83 ±
17.61 ±
40.63 ±

0.11b
0.21
0.19b

32.74 ±
15.14 ±
52.66 ±

0.56c
0.84
1.42a

33.08 ±
17.73 ±
49.72 ±

1.43c
0.29
1.33c

32.36 ±
18.33 ±
49.32 ±

0.96a
2.13
0.94c

0.23 ±

0.01a

0.74 ±

0.01b

0.37 ±

0.05c

0.23 ±

0.01a

0.55 ±

0.08bc

n-6/n-3

Low Light
(n = 12)

+Acetic Acid
(n = 12)

+Glucose
(n = 6)
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It is regarded that nitrogen is an important factor in algal lipid metabolism and that
nitrogen

starvation

can

contribute

to

the

formation

and

accumulation

of

triacylglycerides, comprising of predominantly SFA [35]. This is often considered in a
positive context with applications such as biodiesel production. Results here suggest
that for the development of an algal-derived oil for human and animal nutrition,
nitrogen-deplete conditions are unfavourable due to this shift of PUFA to SFA. Also
unfavourable was a significant shift in C18:3 n-3 to C18:2 n-6, with the low nutrient
group showing a reduction in C18:3 n-3 of 32 % and an increase in C18:2 n-6 of 95 %
when compared to the high nutrient group. The relative abundance of C16:4 n-3 and
C18:4 n-3 PUFA were also shown to be affected by environmental conditions.
Stearidonic acid (C18:4 n-3) showed a lower relative abundance for the added glucose
and low nutrient groups. For example, low nutrients showed a reduction in C18:4 n-3 of
54 % compared to the high nutrient treatment. Similarly C16:4 n-3 showed a decrease
of 60 % for the low nutrient group when compared to the high nutrient group. These
results suggest that the high nutrient treatment has the most desirable FA profile and
importantly, a lower n-6/n-3 ratio, for human and animal health applications. We found
no added benefit with regard to the FA profile of Ulva with either glucose
supplementation or acetic acid supplementation, except for a slight increase in n-3 DPA
content with acetic acid supplementation when compared to the high nutrient group.
Effect of freezing, drying and homogenisation on the FA profile (% total FA) and total
FA content (mg.g-1 d.w. equiv.)
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Freeze-drying is a drying process in which the solvent (usually water) is crystallized at
low temperature and thereafter sublimated from the solid state directly into the vapor
phase [36]. Freeze-drying is a common technique to preserve diverse sources of fresh
material before analysis and extraction of bioactives. Reviews of the effects of freezedrying on extraction efficiencies of plant phytochemicals reveal highly variable results
[37].
From the analysis of 74 samples, including five cultivation regimes; four different
extraction regimes and four different post-harvesting processes, no significant effects of
drying (freeze-dried or oven-dried) were found on the relative FA composition, (F (3,
210) = 0.041, P = 0.99). There is an underlying assumption that freeze-drying, as
opposed to oven or air-drying, best preserves the bioactive chemical constituents of
plant biomass [37]. Our results suggest that both oven and freeze-drying are effective
for FA preservation and do not alter the relative FA composition of the Ulva
macroalgae. This is in agreement with Molina Grima et al. [38] who showed that freezedrying did not affect the FA profiles of microalgal samples.
Effects were seen with homogenisation in regards to FA total content (mg.g-1 d.w.
equiv.). As expected, the FA yields increased by 2- and 19-fold for both freeze-dried
and oven-dried homogenised samples respectively when compared to non-homogenised
samples (Figure 16a). However, no benefit from homogenisation was observed for
extracted fresh biomass and even showed a slight decrease (Figure 16a). The highest
yield was obtained from the extraction of non-homogenised fresh biomass, which
achieved a total FA content of 51 mg.g-1 d.w. equiv. Our results suggest that non120
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homogenised fresh biomass for the filamentous Ulva sp. investigated herein is the most
efficient method for determination of total FA content, as it eliminates both a drying
and processing step. We found that by using fresh non-homogenised Ulva, we were able
to significantly double the extraction yields from 3.1 to 6.6 mg.g-1 fresh weight when
compared to the extraction of homogenised pre-frozen biomass, Figure 16b. Furthermore
it is more convenient, particularly for high throughput analysis, as it removes a
processing step. If the biomass is to be dried and stored, homogenisation before analysis
is necessary to maximise yields and avoid underestimation of total content. We found
milled oven-dried biomass preferable, as it showed an increase in yield of 49.9 % when
compared to milled lyophilised biomass (Figure 16a).

Figure 16 (a) Comparison of total FA content of non-homogenised freeze-dried, fresh and oven-dried
samples versus homogenised samples and (b) comparison of the total FA content of non-homogenised
fresh samples compared to homogenised frozen samples when extracted with the same protocol. Dotted
line represents reported literature value for frozen, homogenised equivalent extracted under a similar
protocol [13].
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In contrast, Ryckebosch et al. [39] reported no significant difference in FA yields for
freeze-dried algae when compared to fresh. However it is important to consider that
different extraction protocols were employed and extractions were performed on
microalgae, as opposed to macroalgae with an extensive extracellular matrix [13].
Martins et al (2012) also noted the presence of significant matrix effects between
macroalgal species and suggest that the analysis method for different organisms should
be selected carefully. This highlights that the pre-treatment of Ulva biomass, or other
samples of interest, is an important consideration when quantifying algal FA from the
macroalgal genus Ulva.
Effect of extraction regimes and environmental conditioning on total FA content
(mg.g-1 d.w. equiv.)
From the analysis of 36 fresh-only samples significant differences in the extraction
efficiency of different protocols were observed. As shown in Figure 17a, extraction
protocols E1, E3 and E6 exhibited significantly higher yields than E2, E4 and E5
(F (5,120) = 37.17, P < 0.0001). Compared to a standard regime (E1), which involved
three consecutive extractions of a 3:1 solvent to mass ratio with two over-night
incubations, the removal of one over-night incubation (E2) reduced the yield by 59%.
The addition of a membrane disruption step using either an enzyme (E3) or sonication
(E4) did not have any benefit when compared to the control (E1). Similarly, Lewis,
Nichols [11] found no significant effect of sonication on extracted FA. Furthermore,
increasing the number of consecutive extracts per sample from three (E1) to six (E5) did
not significantly increase yields. The most efficient extraction method was found to be
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E6, which involved extraction of three immediate consecutive extractions with a higher
solvent to mass ratio (6:1), providing yields comparable to both the standard (E1) and
extended extraction (E5) regimes. As a result, E6 is the method of choice for high
throughput analysis as extraction can be complete in under an hour. The variations in
total FA contents observed highlight the importance of method optimisation for the
sample of interest. This is potentially due to cellular matrix effects [11, 40]. Extraction
methods have also been highlighted as another key element in the quantification of
lipids and FA [13].

Figure 17 (a) The total FA yields (mg.g-1 d.w. equiv) from fresh Ulva samples from six different
extraction protocols. Extraction 1 (E1) represents the standard extraction involving 3 extractions with a
3:1 solvent to mass ratio with 2 over-night incubations; E2 involves the removal of one over-night
incubation; E3 involves a pre-treatment step with an enzyme; E4 involves a pre-treatment step with
sonication; E5 shows an extended extraction involving 6 extractions with a 3:1 solvent to mass ration
with 2 over-night incubations and E6 represents three immediate consecutive extractions with a 6:1
solvent to mass ratio; (b) total FA yields (mg.g-1 d.w. equiv.) of samples from four different culture
treatments extracted with E6 protocol. Means with different letters are significantly different (Tukey’s
multiple comparisons, p < 0.05).

As a result, cultured samples that were extracted using the E6 protocol were compared
to determine the effect of culture on total content (Figure 17b). High nutrients showed
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significantly higher total FA content with an increase of 23 mg.g-1 d.w. equiv. when
compared to the low nutrient treatment (F (3, 32) = 78.74, P = < 0.0001). High nutrient
levels have been shown to increase crude lipid content [30]. Furthermore a study by Ak,
Öztaşkent [6] showed no effect of low sodium nitrate (NaNO3) concentrations (0.02 0.11 g/L) on lipid content with increased lipid content observed for control regimes
which had a much higher concentration of NaNO3 (1.5 g/L). Our results indicate that
the high nutrient regime, at this scale of cultivation, in terms of total FA content,
desirable PUFA profile and n-6/n-3 ratios, is the optimal growth environment for
potential biomass biorefinery of an algal-oil for human and/or animal nutrition.
Monitoring of FA profile consistency of treatments and time.
The potential utilisation of cultured algal biomass for higher value products, such as an
algal-derived oil for human and animal nutrition, is ensuring batch-to-batch
reproducibility between harvests. The tests for reproducibility of results using two
variables with similar SFA and PUFA ratios showed no significant change in the overall
FA profile in terms of total SFA, MUFA and PUFA as a percentage of total extract
composition (F (3,33)= 0.05 P = 0.98) (Figure 18).
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Figure 18 The relative FA profile of Ulva sp. as a percentage of total extract composition of two harvest
dates for two culture conditions to test for reproducibility of results.

Conclusion
Production controlled Ulva biomass through cultivation has future potential to generate
an algal-based oil for human and/or animal nutrition, as part of a biorefinery process for
high value products. Here we demonstrate that despite inconsistencies in the analysis of
FA of Ulva in the literature, there is a key profile of abundant and some unique FA for
the genus, which is high in unsaturated FA (about 60%) compared to SFA. These
include C16:4 n-3, C18:4 n-3, C18:2 n-6 and C18:3 n-3 FA which are thought to
contribute to the algicidal and competitive strategy of Ulva spp. [15]. We found that the
literature was not consistent in reporting all potential FA in Ulva spp. and that it is
important to include standards, or other identification techniques such as GC-MS, for
feature FA such as C16:4 n-3 and C18:4 n-3 as well as C18:1 n-7, the latter likely to
have been under reported in the literature. Despite some clear characteristics of the FA
profiles of Ulva spp. there is a range of variation in the relative amounts of different FA.
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One reason for this could be the environment as our work here demonstrated. We found
C16:0, C16:4 n-3, C18:1 n-7, C18:2 n-6, C18:3 n-3 and C18:4 n-3 FA to be most
affected by the environment. Notably, Ulva cultivated under low nutrient conditions
showed accumulation of specific fatty acids, in particular C16:0 and C18:2 n-6 at the
detriment of n-3 PUFA. However, this did not translate into greater total FA content.
Future research may consider conditioning the low nutrient treated algae to the point of
suspended growth, often accompanied with significant loss of pigments to see if a boost
in content can be observed. However, from a commercial production point of view, any
stressed condition is unfavourable as it dramatically reduces cell division. High nutrient
conditions on the other hand showed the most desirable FA profile for health
applications. This environmental condition also displayed the highest total FA content
achieving 56 mg per gram of dry weight, 30 mg of which is comprised of PUFA. From
a nutritional perspective, the appeal of this FA profile from the high nutrient condition
lies in the low n-6/n-3 ratio. It is rich in C18:3 n-3, in contrast to plant derived oils
which are high in C18:2 n-6. Ulva is also unique from plant and fish derived oils due to
high levels of C18:4 n-3, as well as offering essential dietary EPA and DHA, which are
generally absent in land plants. From a commercial production point of view, high
nutrient conditions are more favourable for achieving a higher turnover and such
biomass could have considerable future value for FA supplementation in the diet of
animals or humans.
We have demonstrated that post-harvest processing and extraction methods are
important considerations in FA quantification and should be selected carefully to avoid
underestimation of total content. Future work should consider the scalability and
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logistics of post-harvest treatments and processing, along with exploration of safer and
less toxic extraction alternatives, such as supercritical CO2 extraction.
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FOREWORD TO CHAPTER 5

The previous Chapter 4 explored the fatty acid profiles of cultivated Ulva to determine
the optimal growth conditions to achieve high quality fatty acids that are optimal for
human and animal nutrition. In particular, emphasis was placed on the effect of the
methods on the fatty acid profiles and yields as a dominant theme of the previous
chapter and manuscript.
The fresh cultivation experiments that were investigated as part of Chapter 4 were
harvested and the biomass stored as a finely milled powder. These dried samples were
subsequently analysed for all the following investigations herein. Interestingly, at the
time of harvesting, the biomass from nutrient starved treatment showed a dramatic loss
of pigments, differing from the nutrient starved biomass analysed previously in
Chapter 4. This had a dramatic affect on total lipid yields and this is explored in the
following Chapter 5, along with investigating the effect of cultivation on the
distribution of fatty acids across both neutral and phospholipid fractions. In particular,
emphasis is placed on the potential health benefits an algal-derived oil may offer human
and animal nutrition. The chapter is presented as a prepared short communication for
submission.12 In addition, results of further investigations that were not incorporated

12

McCauley, J.I., et al., Fatty acid composition of neutral and phospholipids of an emerging
algal-based and sustainable omega-3 oil alternative, Prepared Short Communication for Submission
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in the short communication are presented at the end of the chapter
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Abstract
Ulva has a high quality omega-3 fatty acid (n-3 FA) profile that can respond to the
environment yet it is poorly understood which lipids are affected. This has implications
for FA bioavailability and processing. Here nutrient-rich conditions resulted in 61-69%
of total FA (2.6-3.4 mg.g-1) bound within neutral lipids, characterised by 16:0 (1826%), 18:3n-3 (24-25%), 16:4n-3 (13-17%), 18:2n-6 (11-15%), 18:1n-7 (6-9%) and
18:4n-3 (4-6%). Low-pigment (nutrient-starved) conditions increased neutral lipids (10
mg.g-1) with increased 16:0, 18:1n-7, 18:2n-6, 18:3n-3 and reduced 16:4n-3 and 18:4n-3
(p<0.0001). Despite the increased yield of 18:3n-3, it represented a lower percentage
(10%) of total extract leading to an unfavourable n-6/n-3 ratio (1.6 c.f. 0.3 for the
nutrient-rich, high-pigment culture). All phospholipid fractions were characterised by
the presence of 16:0, 16:1n-7, 18:1n-7, 18:2n-6 and 18:3n-3. However, the low-pigment
(nutrient-starved) biomass showed reduced phospholipids (12%) as a percentage of total
lipids (c.f. nutrient-rich conditions 31-38%). In summary, the n-6/n-3 ratio,
phospholipid fraction and relative amounts of unique n-3 FA (18:4n-3) are significantly
higher in nutrient-rich conditioned biomass and are potentially more optimal for health.
Thus it may be important to optimise the high quality rather than the quantity of fatty
acids for nutritional applications through the cultivation of Ulva.
Key words: Ulva, chlorophyta, PUFA, health, nutrition, cultivation
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Introduction
Fish oil is a highly priced commodity. The recommendation for the consumption of 2-3
serves of fish per week has led to increased awareness of the health benefits of omega-3
fatty acids (n-3 FA) [1]. These recommendations can be obtained through diet, however
this is not always practical and has created the demand for encapsulated fish oil
supplements [2]. Fish oils are also sought for aquaculture, along with high protein
fishmeal. To date, this demand is currently met with limited captive based fisheries [3]
but has low scope for growth to meet future demands. Typical fish oil preparations are
high in n-3 long chain (≥ 20 carbons) polyunsaturated fatty acids (LC n-3 PUFA)
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (Table 18).
Whilst EPA and DHA are high in certain microalgae, it is typically low in the green
macroalgae Ulva (Table 18). However, Ulva spp. have a unique fatty acid profile
characterised by high levels of alpha-linolenic acid (18:3n-3, ALA) and stearidonic acid
(18:4n-3, SDA) [4]. SDA is the first metabolite of ALA in the metabolic pathway
leading to EPA and DHA and has been identified as an efficient precursor of EPA
synthesis (Figure 19) [3]. The metabolic conversion of ALA represents approximately
6% for EPA and 3.8% for DHA with a further loss in efficiency up to 50% with a high
n-6 diet [5]. Adequate dietary provision of EPA and DHA can be obtained through
direct

supplementation

[5].

However,

studies

have

indicated

that

dietary

supplementation with SDA can increase human tissue EPA levels much more
effectively than ALA [2]. As a result, it has been proposed that SDA oils could offer an
attractive alternative to EPA-containing fish oils [6].
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Ref.

% Extract

Various Fish*

De Silva, Francis
[7]

Typical Fish-oil
Preparations

Seed

Özcan [8]

Echium
plantagineum

Microalgae

Custódio,
Soares [9]

Isochrysis
galbana

Microalgae

Vidyashankar,
Sireesha [10]

Synechocystis sp.

Macroalgae

McCauley, Meyer
[11]

Ulva sp.

Table 18 Typical range and composition (% extract) of fish oil preparations compared alongside seed-based
and algal-derived oils.

Source

14:0
4.6 - 12.1
0.1
18.3
5.4
1.2
16:0
10.1 - 25.6
7.7
14.4
35.5
24.5
18:0
1.2 - 4.2
2.8
0.3
2.3
0.6
16:1
6.2 -15.8
0.1
20.5
21.6
5.3
16:4n-3
12.1
18:1n-9
8.3 - 25.2
13.4
15.2
9.6
0.8
18:1n-7
8.6
18:2n-6 (LA)
0.1 - 2.8
15.2
12.1
1.1
6.6
18:3n-3 (ALA)
0 - 2.3
33.3
21.0
18:4n-3 (SDA)
13.35
9.0
20:1
0 - 19.9
0.9
22:1
0 - 30.6
0.2
0.4
20:4n-6 (AA)
0-1
0.7
0.7
20:5n-3 (EPA)
3.9 - 22
2.8
11.0
1.5
22:5n-3 (DPA)
0.6 - 2.0
1.8
22:6n-3 (DHA)
2.0-13.8
12.7
0.1
AA: arachidonic acid; ALA: alpha-linolenic acid; DHA: docosahexaenoic acid; DPA: docosapentaenoic acid;
EPA: eicosapentaenoic acid; LA: linoleic acid; SDA: stearidonic acid
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Dietary Lipids

18:2n-6 (LA)

18:3n-3 (ALA)
Delta 6-desaturase

18:3n-6 (GLA)

18:4n-3 (SDA)
Elongase

20:3n-6

20:4n-3
Delta 5-desaturase

20:4n-6 (AA)

20:5n-3 (EPA)
Elongase

22:4n-6

22:5n-3 (n-3 DPA)
Elongase
24:5n-3

24:4n-6
Delta 6-desaturase
24:5n-6

22:5n-6 (n-6 DPA)

24:6n-3

22:6n-3 (DHA)

Figure 19 Biosynthesis pathways of n-6 and n-3 polyunsaturated fatty acids. Adapted from Pereira,
Barreira [12]. AA: arachidonic acid; ALA: alpha-linolenic acid; DHA: docosahexaenoic acid; DPA:
docosapentaenoic acid; EPA: eicosapentaenoic acid; GLA: gamma-linolenic acid; LA: linoleic acid;
SDA: stearidonic acid

Ulva is readily cultivated at scale for commercialisation and together with its unique
and relatively abundant n-3 content offers an attractive source of quality controlled and
traceable biomass for nutritional applications [11]. Furthermore, green algae are
138

Chapter 5 Ulva Lipids

naturally rich in neutral polar glycolipids (up to 50%) with various levels of charged
polar phospholipids (typically between 10-20%) [13] (Figure 20) differing from
traditional fish oils.

Figure 20 Typical lipid composition (%) of neutral polar glycolipids and highly polar charged
phospholipids of green algae of whole cells, chloroplast envelopes and thylakoids. Representative
glycolipids: monogalactosyldiacylglycerol (MGDG); digalactosyldiacylglycerol (DGDG). Adapted from
Harwood (1998).

This has implications for FA bioavailability as marine derived PUFA from fish oil are
commonly bound within triacylglycerides, which are bioavailable, however they may
not be as efficient as other lipids classes [14]. For example, Krill oil is unique in that as
it has a substantial proportion of EPA and DHA in abundant phospholipids and there is
evidence to suggest that polar lipids have a higher bioavailability than nonpolar
triacylglycerides [15]. More recently it was shown that tissue uptake of LC n-3 PUFA
from an algal oil containing EPA partly conjugated to 15% phospholipids, as well as
glycolipids was found to be equivalent to krill oil containing EPA partly conjugated to
40% phospholipids, demonstrating a promising bioavailability for algal derived oils
[14].
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Limited studies have explored the fatty acid composition of Ulva phospholipids [16], as
the characterisation of major glycolipids is more common [17-19]. Previously we
demonstrated that PUFA and n-6/n-3 ratios can be optimised through cultivation,
influencing these profiles by up to 2-fold [11]. However it is unclear what lipid classes
comprise these fatty acid shifts and this has implications for the bioavailability and
extraction optimisation of these lipid classes. Therefore in scoping the potential of an
Ulva-derived n-3 alternative, this communication further develops the understanding of
the composition of fatty acids across the phospholipid and neutral fractions from a
cultivated Australian Ulva species.
Materials and Methods
Samples
The samples (dried, milled) were provided by Venus Shell Systems Pty. Ltd and
represented four culture regimes (5m2): (1) control (natural sunlight with nutrient-rich
media); (2) nitrogen starved, low pigment (natural sunlight with reduced nutrients); (3)
shaded (reduced natural sunlight with nutrient-rich media) and; (4) acetic acid nutrient
boost (natural sunlight with nutrient-rich media supplemented with acetic acid).
Extractions and Transesterification
The lipids were extracted twice in triplicate as described by Kumari et al. 2011 with
modifications

[20].

In

brief,

samples

(250

mg)

were

extracted

with

chloroform/methanol (3 x 3 mL; 2/1, v/v) with butylated hydroxytoluene (0.001%) by
brief vortexing and centrifugation (3000 rpm, rt, 15 mins). The phospholipids were
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isolated from the crude extract by the addition of cold acetone (2 x 3 mL) with added
magnesium chloride (4 % in ethanol) and centrifugation (3000 rpm, 4 ºC, 15 mins). The
decanted acetone soluble (neutral) lipids and the insoluble residue (phospholipids) were
dried under nitrogen and transesterified as per Lepage and Roy [21]. Extract
compositions were qualitatively assessed by thin layer chromatography to confirm
isolation of phospholipids.
Pigments
The pigments (250mg) were extracted with methanol (3 x 3 mL) by brief vortexing and
centrifugation (3000 rpm, rt, 15 mins) and quantified as per Lichtenthaler [22].
Fatty acid analysis
The samples (1µL) were analysed by flame-ionization gas chromatography (GC-FID)
(GC-17A; Shimadzu) using a 50m x 0.25mm internal diameter capillary column and
analysis performed using Shimadzu software (Class-VP 7.2.1 SP1). Fatty acids were
identified with known standards (Sigma) and an internal standard (heneicosanoic acid)
was used for quantification. The data are represented as molar % extract composition ±
standard deviation Quantified fatty acid data are represented as mg.g-1 dry weight (d.w.)
± standard error.
Statistical Analysis
The data were assessed using Two-way ANOVA and Tukey’s multiple comparisons
using GraphPad Prism version 6.00.
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Results and Discussion
Previously we have shown that Ulva is characterised by abundant C16:0, C18:3n-3,
C18:4n-3, C16:4n-3 and C18:1n-7 fatty acids with high nutrient conditions delivering
biomass with the most desirable fatty acid profile for health and nutritional applications
[11]. Here we determine the effect of these cultivation conditions on the distribution of
fatty acids across the neutral and phospholipid fractions (Table 19). The low nutrient
treated

algae

showed

a

significant

loss

of

pigments

both

visually

and

spectrophotometrically (Figure 21).

Figure 21 Chlorophyll a/b and total carotenoid content (ug.mL-1) of methanol extracts for control (highnutrient) versus nutrient-starved cultivated Ulva samples (F (1,12) = 625.0, P < 0.0001).

Total Content (mg.g-1 d.w.)
The combined neutral and phospholipids in this experiment yielded an average of 3.03
mg.g-1 d.w total fatty acids across the nutrient-rich conditions which included the
control, shaded and acetic acid cultures (Figure 22), although we have previously
reported that we can obtain 56 mg.g-1 d.w. equivalent using an optimised extraction for
fresh biomass cultivated under nutrient-rich conditions [11]. The low pigment (nutrientstarved) samples showed a significant 3-fold increase in total content (12.01 mg.g-1
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d.w.) when compared to the other samples (Figure 22) (p < 0.0001). This increase in
content occurred within the neutral fraction, which represented 88% of the total lipids,
suggesting accumulation of triacylglycerols. The major contributing fatty acids to this
increase in total content within the neutral fraction of low-pigment (nutrient-starved)
biomass were 16:0 (4.02 ± 0.15 mg.g-1 d.w.), 18:1n-7 (1.79 ± 0.06 mg.g-1 d.w.), 18:2n-6
(2.30 ± 0.08 mg.g-1 d.w.) and 18:3n-3 (1.09 ± 0.03 mg.g-1 d.w). Although 18:3n-3
increased in yield it represented a lower percentage of total extract composition (10.0%)
when compared to the nutrient-rich conditions (24.3 - 24.7%) (Table 2) resulting in a
higher and unfavourable n6/n3 ratio (Figure 22). Due to the increase in neutral lipids in
the low-pigment (nutrient-starved) biomass, phospholipids represented only 12% of
total lipids, a 65% reduction in phospholipids when compared to remaining nutrient-rich
samples (31 - 38%), which contained between 61-69% neutral lipids. Elsewhere Ulva
neutral lipids have been shown to represent up to 76% with phospholipids constituting
24% [16], however phospholipid content in Ulva sp. has been reported to be as high as
50% [23].
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15

PUFA

mg.g-1 d.w.

n6/n3 1.6

MUFA

*

10

SFA

5

n6/n3 0.3
0

Nutrient-Rich

Low Pigment

Neutral Lipid Fraction

n6/n3 0.7

n6/n3 1.6

Nutrient-Rich

Low Pigment

Phospholipid Fraction

Figure 22 Total content (mg.g-1 d.w.) of saturated fatty acid (SFA), monounsaturated fatty acids (MUFA)
and polyunsaturated fatty acids (PUFA) of neutral and phospholipid fractions for the average yield (±
standard error) of nutrient-rich cultivation conditions (control, shaded, acetic acid cultivations) versus the
yield for low pigment (nutrient-starved) conditions. *Significantly different (p < 0.0001)

Phospholipid Fractions
The acetone insoluble Ulva phospholipid extract (highly charged polar lipids) was
characterised by high levels of saturated FA (SFA) (51.2 - 59.5%) with lower PUFA
(21.3 - 29.7%) when compared with the corresponding neutral fractions (Table 19).
Samples showed abundant 16:0 (49.6 - 58.8%), 16:1n-7 (1.4 - 5.8%), 18:1n-7 (11.8 17.5%), 18:2n-6 (8.6 - 13.1%) and 18:3n-3 (7.9 - 13.9%), in agreement with similar
findings for Ulva [16]. The n-3 PUFA 16:4n-3 and 18:4n-3 were present in trace
amounts (< 2.2%) but have been reported as high as 2.2% and 3.3% respectively [16].
The low pigment (nutrient-starved) samples showed reduced 16:1n-7 (1.4%) when
compared to the other samples (3.3 - 5.8%). Low pigment and acetic acid samples also
showed higher 16:0 (56.9% and 58.8 respectively) compared to the control (nutrientrich) and shaded cultures (49.6 and 52.8% respectively). Low pigment samples were
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significantly higher in 18:1n-7 (17.5%) with a significant reduction in 18:3n-3 (7.9%)
when compared to the other nutrient-rich samples (13.3 - 13.9%). No significant
differences were observed in the LC PUFA across the different cultures for the
phospholipid fractions (F (3,102) = 1.841, P = 0.1444). The PUFA 20:4n-6 was present
in trace amounts (≤ 0.6%) across control, low pigment and shaded culture regimes
whilst 20:5n-3 was slightly more abundant in the control and low pigment cultures
(1.1% and 1.5% respectively) (Table 19).
Neutral Lipid Fractions
The neutral lipid fraction (acetone soluble), which represented between 61-88% of total
lipid yield comprised between 37.3 - 66.1% of total PUFA across samples, indicating
that most PUFA reside within the neutral lipid fraction (Table 19). Ulva commonly
exhibits high PUFA due to abundant 18:3n-3 [24] and herein represents approximately
25% of the neutral fraction for nutrient-rich conditions which include the control,
shaded and acetic acid cultivations. An increase in total content in the neutral fraction
under starved conditions (Figure 22) suggests an accumulation of triacylglycerols for
energy storage, although neutral glycolipids are also present in this fraction. In lowpigment (nutrient-starved) conditions the relative amount of 18:3n-3 is significantly
lower (10%), although the absolute amount in dried biomass is higher, contributing to
an increase in PUFA content (Figure 22). Higher relative abundance of 18:4n-3 (4.4 5.8%) and 16:4n-3 (13.1 - 16.6%) were evident across the remaining samples and
represent two characteristic fatty acids of Ulva [4]. High 18:4n-3 in neutral glycolipids
has also been reported by Sanina et al. [17].
145

14:00
14:1n-7
15:00
15:1
16:00
16:1n-7
17:0
17:1n-7
16:4n3
18:0
18:1n-9
18:1n-7
18:2n-6
18:3n-6
18:3n-3
18:4n-3
20:3n-6
20:4n-6
20:5n-3
22:0
22:4n-6
22:5n-3

Mol %

24 ± 1.3a
11.8 ± 1.1a
64.2 ± 2.2a
0.3 ± 0.1a

1.0 ± 0.7
1.0 ± 0.1
18.7 ± 0.5a
1.8 ± 0.3
2.2 ± 0.2a
0.6 ± 0.6
16.6 ± 1a
0.9 ± 0.3
1.1 ± 0.2
7.9 ± 0.3a
11.5 ± 0.3a
0.7 ± 0.1
24.5 ± 0.9a
5.8 ± 0.3a
0.8 ± 0.1a
2.2 ± 0.2a
1.4 ± 0.1a
0.2 ± 0.3
0.7 ± 0.1ab

Control

42.1 ± 0.5b
20.6 ± 0.5b
37.3 ± 0.6b
1.6 ± 0.1b

0.6 ± 0.1
0.3 ± 0.1
40.1 ± 0.6b
1.9 ± 0.2
0.4 ± 0.1b
0.4 ± 0.1
2.1 ± 0.1b
0.7 ± 0.1
1.6 ± 0.1
16.2 ± 0.2b
21 ± 0.2b
0.4 ± 0.1
10 ± 0.2b
1.1 ± 0.1b
0.7 ± 0.1a
1.1 ± 0b
0.7 ± 0b
0.3 ± 0
0.3 ± 0.1bc
24.9 ± 0.6a
9.0 ± 0.4c
66.1 ± 0.9c
0.4 ± 0.1a

0.8 ± 0.6
0.3 ± 0.5
20.6 ± 0.9c
2.2 ± 0.1
2.4 ± 0.2a
0.1 ± 0.3
17.1 ± 0.9a
0.7 ± 0.4
0.8 ± 0.4
6.0 ± 0.4c
15.1 ± 0.2c
0.7 ± 0.5
24.3 ± 0.3a
4.6 ± 0.3ac
0.5 ± 0.4ab
2.4 ± 0.1a
1.2 ± 0.1a
0.1 ± 0.3c

Ulva Neutral Lipid Fraction
Low Pigment
Shaded

28.9 ± 1.8c
11.5 ± 0.4a
59.6 ± 2d
0.3 ± 0.1a

0.9 ± 1
0.2 ± 0.4
26.1 ± 0.9d
1.8 ± 0.3
0.7 ± 0.5b
13.1 ± 0.8c
1.1 ± 0.1
1.0 ± 0.1
8.5 ± 0.1a
12.2 ± 0.5a
0.3 ± 0.4
24.7 ± 0.8a
4.4 ± 0.3c
0.1 ± 0.3b
2.2 ± 0.2a
1.6 ± 0.2a
0.3 ± 0.4
0.1 ± 0.3
0.8 ± 0.1a

Acetic Acid

51.2 ± 1.3a
20.4 ± 0.9a
28.3 ± 0.6a
0.7 ± 0.1a

49.6 ± 1.1a
5.8 ± 0.8a
0.5 ± 0.7
1.8 ± 0.1
14.6 ± 0.3a
11 ± 0.5a
13.6 ± 0.4a
1.3 ± 0.1
0.6 ± 0.6
1.1 ± 0.1a
-

Control

58.8 ± 3.7b
19.9 ± 1.6a
21.3 ± 3.3b
1.6 ± 0.3b

0.1 ± 0.3
0.8 ± 1.7
56.9 ± 4.3b
1.4 ± 0.9b
0.1 ± 0.3
0.2 ± 0.5
0.1 ± 0.3
0.2 ± 0.5
17.5 ± 0.8b
12.8 ± 2a
7.9 ± 0.7b
0.1 ± 0.2
0.1 ± 0.2
0.2 ± 0.4
1.5 ± 0.4a
-

54.8 ± 1.8c
15.5 ± 0.7b
29.7 ± 1.8a
0.8 ± 0.1a

52.8 ± 2c
3.7 ± 0.5ab
2 ± 0.3
2.2 ± 0.1
11.8 ± 0.8c
13.1 ± 0.9a
13.9 ± 0.9a
0.2 ± 0.5
0.2 ± 0.5
-

Ulva Phospholipid Fraction
Low Pigment
Shaded

59.5 ± 1.6bd
16.8 ± 0.4b
23.7 ± 1.9c
0.6 ± 0.1a

58.8 ± 2b
3.3 ± 0.3b
1.6 ± 1.4
0.3 ± 0.7
13.5 ± 0.4ac
8.6 ± 0.6b
13.3 ± 1.4a
0.3 ± 0.7
0.5 ± 0.7b
-

Acetic Acid

Table 19 Fatty acid composition of the neutral and phospholipids of Ulva from four different cultivations. Means with different letters are significantly different (Tukey’s
multiple comparisons, p < 0.001). Values: average ± standard deviation. SFA: saturated fatty acids; MUFA: monounsaturated fatty acids; PUFA: polyunsaturated fatty acids

SFA
MUFA
PUFA
n-6/n-3
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The marked relative and absolute reduction of 16:4n-3 (2.1%) and 18:4n-3 (1.1%) in the
low-pigment (nutrient-starved) samples indicate that PUFA can be shifted by the
environment, consistent with our previous report [11]. Herein we show that this occurs
primarily in the neutral lipid fraction and only for these specific PUFA. Indeed most of
the other PUFA increased in content per gram of dry weight in nutrient-starved
material. Green macroalgae do not naturally accumulate significant amounts of
triacylglycerols [25]. Ulva is one of the few species that can be pushed to accumulate
triacylglycerols with a subsequent relative increase in SFA and relatively lower PUFA
content as a percentage of total extract composition [26]. This is evident in Table 19,
although we also show that there is an absolute increase in PUFA content per gram of
seaweed dry weight (Figure 22). The low pigment nutrient-starved samples showed
significantly higher 16:0 (40.1%) and 18:1n-7 (16.2%) when compared to the other
samples along with a 7-fold increase in the absolute amount of 18:2n-6 subsequently
increasing the n-6/n3 ratio (Table 19; Figure 22). This is consistent with nitrogen
starvation effects reported for Ulva [23, 27]. Significant effects of culture were
observed on the extract composition of LC PUFA within the neutral fractions (F (3,114)
= 46.61, P < 0.0001) with the control (nutrient-rich) culture having significantly higher
relative abundance of 20:4n-6, 20:5n-3 and 22:5n-3 when compared to the low pigment
(nutrient-starved) biomass.
Conclusion
High nutrient cultivation (control regime) provided biomass with desirable n-6/n-3 (0.3)
and 18:2n-6/18:3n-3 (0.5) ratios, along with higher relative levels of 18:4n-3, 20:5n-3,
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22:5n-3 (Table 20). This fatty acid profile was predominant in the more abundant neutral
lipid fraction, which comprised 62% of the total lipid extracted (3.4 mg.g-1 d.w.). In
contrast the phospholipid fraction had a higher ratio of SFA, although the n-6/n-3 ratio
was still reasonable (0.7), and comprised 38% of the biomass for the high nutrient
cultivation. The low pigment (nutrient-starved) Ulva provided for a 3-fold increase in
overall lipid yields (12.0 mg.g-1 d.w.) and included both increased SFA,
monounsaturated FA (MUFA) and PUFA per gram of seaweed dry weight, as has been
found for other algae and we demonstrate that this increase is primarily in the neutral
lipid fraction. This increase however was at a detriment to the oil’s profile with
increases in SFA content being far greater than increases in MUFA and PUFA. This
also resulted in less desirable n-6/n-3 ratios, as well as a lower ratio of phospholipids
(12%).
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Table 20 A qualitative summary of the neutral and phospholipid fractions of Ulva from four cultivation
regimes
Neutral Fraction

Control

Low n-6/n-3

Low pigment

Shaded

Acetic Acid

Yes

Yes

Yes

Low 18:2n-6/18:3n-3

Yes

Yes

Yes

LC-PUFA Content

++++

+

+++

++++

n-3 Content

++++

+

++++

+++

18:4n-3 Content

++++

++

+++

+++

Total Content

+++

++++

++

++

Phospholipid Fraction
Low n-6/n-3

Yes

Yes

Yes

Low 18:2n-6/18:3n-3

Yes

Yes

Yes

LC-PUFA Content

++++

++++

+

++

n-3 Content

+++

+

++++

++

18:4n-3 Content

++

+

+

+

Total Content

++

++

++

+

Key Neutral: LC-PUFA (++++) > 5 % total extract; (+++) 4 - 5 %; (++) 2 - 3 %; (+) < 2 % and n-3
content: (++++) > 40 % total extract; (+++) 30-40 %; (++) 20 - 29 %: (+) < 20 %
Key Phospholipid: LC-PUFA: (++++) 1.5 - 2 % total extract; (+++) 1 - 1.5 %; (++) 0.5 - 1 %; (+) < 0.5
% and n-3 content: (++++) >15 %; (+++) 14-15%; (++) 12 - 13 %; (+) < 12 %
Key 18:4n-3: (++++) > 5% total extract; (+++) 3 - 5 %; (++) 1 - 2 %; (+) < 1 %
Key Total Content: (++++) > 5 mg.g-1 d.w.; (+++) > 2 mg.g-1 d.w; (++) 1 - 2 mg.g-1 d.w; (+) < 1 mg.g-1
d.w

These results highlight that Ulva cultivated under high nutrient conditions offers a
unique and sustainable source of biomass rich in n-3 PUFA (Table 20). The neutral lipid
fraction is highlighted as the richest fraction and target for a nutritionally potent PUFA
extract and could direct the future choice of extraction protocol, although it is not yet
understood how these are distributed across the different neutral lipid classes such as
glycolipids and triacylglycerols. For example a one-step neat super-critical carbon
dioxide (SC-CO2) extraction without ethanol supplementation could optimise a
sequential biorefinery process that concentrates the neutral lipids fractions, such as
glycolipids, to deliver a nutritionally valuable high-end product [28]. However
increased content of PUFA can also be achieved with nutrient starvations but with a
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consequence of less desirable n-6/n-3 ratios and these would have to be altered through
a selective biorefinery process.
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Method Optimisation
The optimisation of the fatty acid extraction of fresh filamentous Ulva was a key
finding presented in Chapter 4 (p. 101-130). Key aspects of this optimisation for fresh
biomass involved:
1. Removal of the homogenisation step
2. Increasing the solvent to mass ratio from 3:1 (2 g fresh in 6 ml solvent) to 6:1
(0.5 g fresh in 3 mL solvent)
3. Removing two overnight incubations from three sequential extractions thereby
reducing extraction time from 3 days to 1 day.
Chapter 5 then employed this optimised extraction protocol for the extraction of the
harvested, and subsequently oven-dried and milled biomass from these same four
different cultivation regimes:
1. High nutrients with natural sunlight;
2. Low nutrients with natural sunlight;
3. High nutrients with reduced natural sunlight (low light) and;
4. High nutrients plus acetic acid supplementation with natural sunlight
The extraction is quick and convenient and involved extracting 250 mg of oven-dried,
milled biomass in 3 mL of solvent, thus differing only in the solvent to mass ratio (12:1
as opposed to 6:1 for fresh). As the solvent ratio was shown to be an influential variable
in the extraction of fresh biomass, this increase in solvent ratio for the extraction of
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dried biomass was determined to be appropriate at the time. Whilst a variation in yield
was expected, it was not anticipated that this optimized extraction method for fresh
would result in such dramatic reduction in yield for dried biomass (from 56 mg.g-1 dry
weight equivalent to 3 mg.g-1 dry weight) (Figure 23). Therefore, further investigations
were carried out to see if this loss in yield could be recovered. It was found that the
optimised method for the extraction of fatty acids from dried biomass was the 3-Day13
extraction protocol that involved 2 over-night incubations and a solvent to mass ratio of
24:1 (250 mg in 6 mL extraction solvent) (Figure 23)

Fresh (non-homogenised)
Oven-dried (milled)
mg.g-1 d.w or equiv.

60

*
40

20

0

3-Day

1-Day

Figure 23 Comparison of the 3-Day extraction protocol for fresh (non-homogenised) and dried (milled)
biomass which involved either 2 g fresh or 250 mg dried biomass in 3 x 6 mL extraction solvent with 2
overnight incubations versus the 1-Day extraction protocol involving either 500 mg fresh or 250 mg dried
biomass in 3 x 3 ml consecutive extractions.
13

3-Day Protocol - Lipids extracted based on a standard method of Folch et al. 1957 [1] with
modifications based on Kumari et al. 2011 [2] In brief, either two grams of non-homogenized fresh
sample or 250 mg of dried biomass was extracted with 3 x 6 mL of chloroform/methanol (2/1, v/v) with
0.001% butylated hydroxytoluene (BHT) by vortexing (~1 min) and centrifugation (3000 rpm, rt, 15
mins), with two extractions left overnight. The extract was evaporated to a consistent weight (dryness) in
pre-weighed 9 mL Teflon lined screw top glass tubes under a stream of nitrogen. Crude lipid extracts
were transesterified according to the method of Lepage and Roy 1986 [3] with added BHT (0.01% w/v).
1-Day Protocol Involved either 500 mg of non-homogenized fresh sample or 250 mg of dried biomass
was extracted with 3 x 3 mL consecutive extractions of chloroform/methanol (2/1, v/v) with 0.001%
butylated hydroxytoluene (BHT) by vortexing (~1 min) and centrifugation (3000 rpm, rt, 15 mins).
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Whilst the there were no significant effects of the two extraction protocols on the total
fatty acid content recovery of fresh biomass, a significant increase and complete
recovery of total fatty acid yields is observed with the 3-Day extraction protocol (P <
0.0001) for dried biomass. This indicates that the extraction of dried milled powder
benefits positively from longer extraction times. It is possible that the solvent requires
more time to penetrate the matrix of dried biomass and dissolve the lipids compared to
fresh biomass. Future investigations of dried biomass should consider the addition of a
magnetic stirring bar during the extraction process and/or further increase the solvent
ratio to try and reduce the extraction time and thus increasing sample through-put.
Non-toxic Solvent Extraction
The results presented in Chapters 4 and 5 propose the idea that cultivated Ulva has the
potential to be formulated as an algal-derived oil supplement to complement human and
animal nutrition. However, the traditionally utilised lipid extraction protocol, which
uses a fixed ratio of chloroform to methanol is toxic and unsuitable for up-scaling at any
significant level beyond the laboratory due to its toxicity and lack of food grade
compatibility. Thus whilst it is an effective solvent extraction for initial characterisation,
safer non-toxic extraction techniques need to be considered and different solvents have
been found to effect both yield and composition of lipid extracts [4]. Therefore,
additional fresh samples cultured under optimal conditions for fatty acid output
(provided by Venus Shell Systems14) were analysed on a separate occasion to determine

14

Venus Shell Systems, Narrawallee, NSW, 2539, Australia
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if extraction with 100% ethanol can achieve comparable fatty acid yields and
composition as previously demonstrated in Chapter 4 and 5 (Figure 24).

Ethanol

mg.g-1 d.w. equiv.

50
40

*

Chloroform: Methanol

30

*

20
10
0

TFA

SFA

MUFA

PUFA

Figure 24 The total fatty acid yields (TFA), saturated fatty acids (SFA), monounsaturated fatty acids
(MUFA) and polyunsaturated fatty acids (PUFA) (mg.g-1 d.w. equivalent) for fresh Ulva biomass, which
was conditioned under optimal conditions (high nutrients) for desired fatty acid output and extracted with
two different solvents (ethanol and chloroform: methanol 2/1 v/v) as per the optimised protocol outlined
in Chapter 4 (P < 0.0001).

In terms of yields, ethanol compared very favourable to the tradition chloroform and
methanol extraction. Performing the lipid extraction with 100% ethanol yielded
significantly higher total fatty acids and total polyunsaturated fatty acids when
compared to the traditional chloroform and methanol solvent mixture. Furthermore
there was no significant effect of solvent on the fatty acid composition (% extract) F
(1,100) = 3.898, P = 0.0511. This result is in contrast to the findings reported by Schmid
et al. 2016 [4] in which ethanol was found to be the second most efficient solvent after
chloroform and methanol. However their analyses were conducted on freeze-dried
powders of Laminaria digitata (Phaeophyta) and Palmaria palmata (Rhodophyta)
differing in our analysis of fresh filamentous Ulva (Chlorophyta). However, in support
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of our finding Schmid et al. 2016 [4] did find that ethanol delivered the highest levels of
PUFA.

Thus ethanol is deemed as a suitable alternative to the traditional chloroform and
methanol solvent system for the extraction of lipids from fresh filamentous Ulva with
total fatty acids representing 4.1 % dry weight (d.w.). This is one of the higher yields
reported in the literature. For example Kumar et al. 2011 [5] reported total lipid contents
of 1.83, 2.03 and 2.00 % d.w. for wild collections of Ulva fasciata, U. reticulata and U.
rigida respectively. Recently, Trivedi et al. 2016 [6] further reported up to 2.7 % d.w.
for wild collections of Ulva fasciata using a sequential extraction process of multiple
algal components. With regards to cultivated Ulva, Mata et al. 2016 [7] reported a total
fatty acid yield of 2.0 % d.w. for cultivated U. ohnoi whilst Carl et al. 2016 [8] reported
a lipid yield of 3 % d.w. for cultivated U. tepida.
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FOREWORD TO CHAPTER 6

After the biological screening of a number of Australian macroalgal taxa (Chapter 3),
attention was directed towards the cultivation candidate Ulva. Due to the strong antiinflammatory activity identified in Ulva extracts in Chapter 3, it was hypothesised that
two major metabolite classes may be responsible for this activity. These two metabolite
classes were fatty acids and phytochemicals (pigments and phenolics). Thus Chapter 4
was dedicated to exploring the fatty acid profiles of Ulva. It offered a comprehensive
review of the literature and presented the fatty acid profiles for cultivated Ulva from
five different treatments conditions, along with method optimisation. Chapter 5 then
explored the distribution of these fatty acids across the neutral and phospholipids, along
with further highlighting considerations for the extraction method. As a result of the
work presented in Chapters 4 and 5, the nutritionally value of the proposed algalderived oil from cultivated Ulva from Venus Shell Systems15 was clearly defined. The
four samples, from four different treatment regimes, that were analysed in Chapter 5
were a dried commercially milled powder, provided by Venus Shell Systems. The
following Chapter 6 now presents the phytochemical analysis of these same four
samples to offer characterisation and quantification of pigments, phenolics and
flavonoid content and correlation of this content to anti-oxidant and anti-inflammatory
activity. It is presented as a prepared full research manuscript for submission.16.

15

Venus Shell Systems, Narrawallee, NSW, 2539, Australia
McCauley, J.I., et al., Anti-oxidant activity and anti-inflammatory activities of pigment extracts of
cultivated Ulva, Prepared Full Research Manuscript for Submission
16
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Abstract
Macroalgae are rich in photosynthetic pigments and phenolics. The biomass from
cultivated Ulva sp. (Chlorophyta) is a potentially sustainable and alternative source of
these nutritionally important metabolites. Algae can readily adjust their metabolism and
thus the production of these pigments and anti-oxidant molecules as a response to their
environment. Therefore, cultivation conditions can be engineered to optimise these
metabolite yields. However, in contrast to microalgal research, this has not been
explored as extensively for cultivated macroalgae. Thus, herein we determine the effect
of both cultivation and extraction processes on the yield and bioactivity, including both
anti-inflammatory and anti-oxidant functionalities, of pigments, phenolics and
flavonoids of a cultivated Ulva sp. It was found that ethanol (95%) extracts of high
nutrient cultures with natural sunlight were optimal to maximise levels of total
chlorophyll (1.48 mg.g-1 dry weight (d.w)), phenolics (1.58 mg.g-1 d.w.) and
corresponding anti-oxidant activity (18.8 % inhibition 1,1-diphenyl-2-picryl-hydrazyl
(DPPH) free radical). In contrast, acetone extracts of high nutrient cultures under
natural sunlight showed the highest carotenoid content (0.1 mg.g-1 d.w.) and antiinflammatory activity (97% inhibition of nitric oxide (NO) in lipopolysaccharide (LPS)
stimulated macrophages). Low nutrient conditions under natural sunlight however was
found to substantially increase flavonoid content (1.27 mg.g-1 d.w). No cell toxicity
(100 µg.mL-1) was observed in any extracts. In contrast, results indicate that ethanol
(95%) extracts, which contain the highest level of pigments and phenolics, promoted
cell proliferation at twice the rate when compared to controls. These results establish a
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foundation upon which to further optimise macroalgal culture for the production of
desired metabolites, such as pigments and phenolics, for functional food products.
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Introduction
Phytochemicals from plants have been increasingly highlighted as metabolites of
importance with a range of health benefits [1], These phytochemicals are abundant
within fruits and vegetables and include polyphenol compounds such as phenolic acids
and flavonoids, terpenoid derived compounds such as carotenoids, lutein, lycopene and
β-carotene, and substituted tetrapyrrole chlorophylls [2, 3]. Specific phytochemicals
have strong anti-oxidant and anti-inflammatory activities that have the ability to confer
protection and reduce the risk or aid the healing of disease [4, 5].
For example, the phenolic oleuropein has been shown to reduce damaging lipid
peroxidation caused by free radicals as well as suppress nitric oxide (NO) production
via inducible nitric oxide synthase (iNOS) [6]. Whilst NO is an important immune
modulator, high and persistent levels can lead to cellular and DNA mutagenesis and
damage [7, 8]. The ability of phytochemicals to confer health benefits is evident in
studies that correlate diets rich in fruit and vegetables with a lower risk of hypertension,
coronary heart disease, stroke [9] and reduced risk for cancer [10, 11]. The therapeutic
potential of phytochemicals has also been highlighted in the treatment of chronic
inflammatory disorders such as inflammatory bowel disease [12] and protection of the
liver due to their hepatoprotective effects [13]. These phytochemical classes are also
abundant in algae, and cultivated macroalgae has been highlighted as a potential source
for these high value anti-oxidant and anti-inflammatory phenolics and pigments [14-18].
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Due to the high natural chemical variability of wild seaweeds, controlled cultivation is
essential to deliver consistent biomass [19, 20]. Therefore the cultivation conditions that
optimise the desired bioactive profile must be defined. It is known that microalgae can
shift the type and contents of pigments and or phenolic compounds in culture [21], and
this process has been commercialised for the production of pigments such as β-carotene
and astaxanthin production by stressing cultures of Dunaliella salina or Haematococcus
pluvialis, respectively [22]. In contrast, other studies have shown that optimal growth
conditions of high light and high nutrients favour pigment profiles [23]. Whilst the
effect of cultivation on pigment profiles has not been explored as comprehensively for
macroalgae, such as Ulva spp. [24, 25], there are early findings consistent with
improved pigment profiles with optimal nutrient and growth conditions. For example,
improved pigment and anti-oxidant profiles for Ulva spp. has been shown for high light
and high nutrient cultivation [26]. Specific responses to different culture media with
subsequent shifts in pigments were also correlated to changes in anti-oxidant activities
for an Ulva lactuca sample [27].
Ulva spp. are a source of both oxidant-scavenging phenolics (Table 21) and chlorophyll
and carotenoid pigments [27, 28]. Evidence also shows that these profiles can be shifted
in culture. For example regarding chlorophyll content, Ulva lactuca cultured in artificial
seawater and low nutrients showed a loss of pigments, however the pigment
concentration can be recovered with complete nutrient provision by nitrate and
phosphate supplementation [29]. Similarly, Gómez Pinchetti et al. 1998 [30] found
maximum chlorophyll content in nitrogen enriched cultivation conditions for Ulva spp.
Variation in pigments have also been shown across species from different habitats. For
168

Chapter 6 Ulva Pigments & Phenolics

example a subtidal Ulva rotundata sample showed a three-fold increase in pigments
(chlorophyll a, chlorophyll b and carotenoids) when compared to an intertidal Ulva
olivascens sample [31]. Figueroa et al. 2003 [31] further showed that these two species
had different phytochemical adaptive responses to ultraviolet light treatments.
Whilst a number of studies have reported on the total phenolic content of Ulva (Table
21),

the effect of cultivation on total phenolics has been less investigated. Cabello-Pasini

et al. 2011 [32] however did show a 60% increase in phenolics for Ulva rigida when
cultured with high nitrate levels. Studied with other species of macroalgae have also
shown that low-stocking densities of land-based cultivated Derbesia tenuissima (class
Ulvophyceae) can boost anti-oxidant capacity by up to 88% with 22% higher phenolic
content when compared to high-stocking densities [33]. This indicates a potential effect
of internal fluctuating light intensities resulting from the different stocking densities
[33].
Other important considerations in the determination of total pigments and phenolics are
effects of the extraction process. Thus, it is important to select solvents and maintain
consistent condition of the biomass prior to extraction (Table 21) as both variables have
been shown to influence phenolic yields and anti-oxidant capacities [1]. In particular,
freeze-dried biomass has been shown to better preserve phenolic content as opposed to
oven-drying, and may explain the higher overall phenolic content observed for freezedried Ulva lactuca as opposed to the air-dried Ulva rigida as evident in Table 21 [34].
Thus it is hard to compare across research findings when the methods of extraction are
inconsistent. With regards to solvents, aqueous methanol, ethanol and acetone solutions
169

Chapter 6 Ulva Pigments & Phenolics

are commonly employed (Table 21). However, when compared to methanol, both
acetone and ethanol have been shown to yield higher amounts of phenolics and
flavonoids, with aqueous ethanol extracts showing the highest anti-oxidant activity [35].
Therefore, herein we have investigated the effects of cultivation and extraction solvents
on the yields of broad pigment categories (chlorophyll a; chlorophyll b; carotenoids;
phenolics and flavonoids) in one Australian species of Ulva. Two extraction solvents
(acetone and 95% ethanol) were used on algal biomass from four cultivation conditions.
The extracts were then tested across three basic assays for anti-oxidant, antiinflammatory and cell toxicity.

These results have the potential to aid in the

implementation of future protocol systems of cultivation and production. This will help
to deliver improved consistency in the functional aspects of algal-derived novel foods.
This is the first screening study to explore the effect of cultivation conditions and the
effect of extraction solvent on the pigments profiles and anti-oxidant and antiinflammatory bioactivities of a cultivated Ulva sp.
.
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Adriatic sea
Commercial
Sitka Alaska
Sitka Alaska
Sitka Alaska
Sitka Alaska

Tunisia
Tunisia
Tunisia
Tunisia
Marmara sea
Marmara sea

Location

Air-Dried
Air-Dried

Dried
Dried
Freeze-dried
Freeze-dried
Freeze-dried
Freeze-dried

Air-Dried
Air-Dried
Air-Dried
Air-Dried
Frozen
Air-Dried

Biomass

80% Methanol

80% Methanol
80% Methanol

Acetone
Ethanol
Hexane
Ethyl acetate
Butanol
Water

Chloroform
Ethyl acetate
Butanol
Water
Methanol
80% Methanol

Extract

13 ±1.1a17
19 ± 0.8a
6 ± 0.3a
5 ± 0.6a

mg PHGE.g−1

2 ± 0.3g

5 ± 0.7g

1 ± 0.1g
2 ± 0.3g

mg GAE g-1

Persian Gulf
Persian Gulf
Air-Dried

80% Methanol

6.0 ± 0.01e

0.73 ± 0.1b*
2 ± 0.3c#

Persian Gulf

Air-Dried

68.2f
113.4f
56.8f
81.7f

Persian Gulf

58 ± 1.1d

µg PE g-1

Table 21 Reported phenolic contents of various species of Ulva macroalgae (Chlorophyta) expressed as mg phloroglucinol (PHGE), mg gallic acid (GAE) or µg pyrocatechol
(PE) equivalents per gram of extract unless otherwise specified.
Species
Ulva rigida

Ulva lactuca

Ulva intestinalis

Ulva clathrata
Ulva linza
Ulva flexuosa
Persian Gulf Air-Dried
80% Methanol
3 ± 0.2g
*mg gallic acid equivalents per 100-gram fresh tissue; #mg gallic acid equivalent per gram dry weight powder

17

a
Trigui et al. 2013 [36]; b Yildiz et al. 2012 [37]; c Yildiz et al. 2014 [38]; d Kosanić et al. 2015 [39]; e Boisvert et al. 2015 [40]; f Kellogg and Lila 2013 [41]; g Farasat et al.
2014 [42]
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Materials and Methods
Algal Samples and Cultivation
The Ulva samples were provided as a dried commercially milled powder from Venus
Shell Systems Pty. Ltd., Mundamia, New South Wales, 2540, Australia. Samples were
from controlled scaled, cultivated stock and conditioned either in the presence of high
nutrients (natural sunlight with ammonia enriched media, control regime), low nutrients
(natural sunlight with reduced nutrients), low light (reduced natural sunlight with
ammonia enriched media) or added acetic acid (natural sunlight with ammonia enriched
media and added acetic acid supplementation).
Extraction
All samples (250 mg) were extracted in triplicate in 95% ethanol or 100% acetone (3 x
3 ml; total volume 9 ml) with brief vortexing followed by centrifugation (3000 rpm, 10
mins, rt). The extracts were immediately analysed for pigments and a portion of the
extract set aside for determination of phenolic and flavonoid contents and testing of
anti-oxidant activity.
Total Phenolic Content
Total phenolic content was determined as per the 96-plate method described by Herald
et al. 2012 [43]. Extracts or standards were diluted 1:4 with Milli-Q (75 µl Milli-Q; 25
µl) and mixed thoroughly with 25 µL of diluted Folin-Ciocalteu (1:1 with Milli-Q)
reagent using a multi-channel pipette. After 6 minutes, 100 µL of Na2CO3 was added to
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each well and the plate incubated for 90 minutes in the dark, after which absorbance
was read at 765 nm (SpectraMax). The values were determined from a calibration curve
prepared with gallic acid (0 - 500 µg.mL-1) and results expressed µg gallic equivalents
per mL extract (µg quercetin.mL-1) and µg gallic equivalents per g dry weight (µg
quercetin.g-1 d.w.). Each extracted sample was analysed in triplicate with each set of
cultivation data having a sample number (n) of 9.
Total Flavonoid Content
Total flavonoid content was determined as described by Santas et al. 2008 [44]. In brief,
100 µL of extract was diluted (1:1) with Milli-Q water and 200 µL of a 2% AlCl3 in
methanol solution was added (5% acetic acid in methanol). The plate was left to
incubate for 10 mins at room temperature before absorbance was read at 430 nm
(SpectraMax). The values were determined from a calibration curve prepared with
quercetin (0 - 500 µg.mL-1) and results expressed as µg quercetin equivalents per mL
extract (µg quercetin.mL-1) and µg quercetin equivalents per g dry weight (µg
quercetin.g-1 d.w.). Each extracted sample analysed 6 individual times with each set of
cultivation data having a sample number (n) of 18.
Total Chlorophyll and Carotenoid Content
Total chlorophyll and carotenoid content were determined by ultraviolet–visible
spectroscopy as per Foo et al. 2015 [45] and Kumar et al. 2010 [46] utilising the
equations described by Lichtenthaler 1987 [47]. If necessary the samples were diluted to
fall within the absorbance range of 0.3 and 0.85 [48]. Total content of chlorophyll a,
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chlorophyll b and carotenoids (xanthophylls and carotenes) determined for both ethanol
95% (v/v) and acetone 100% (v/v) using the following equations and then results
expressed as µg.g-1 dry weight (d.w.).

Equations for determination of pigments in 95% ethanol:
µg.mL-1 Chlorophyll a = 13.36A664.2 - 5.19A648.6
µg.mL-1 Chlorophyll b = 27.43A648.6 - 8.12A664.2.
µg.mL-1 Total chlorophylls = 5.24A664.2 + 22.24A648.6
µg.mL-1 Total carotenoids = 1000A470 - 2.13Ca - 97.64Cb/209.

Equation for the determination of pigments in 100% acetone:
µg.mL-1 Chlorophyll a = 11.24A661.6 - 2.04A644.8
µg.mL-1 Chlorophyll b = 20.13A644.8 - 4.19A661.1
µg.mL-1 Total chlorophylls = 7.05A661.6 + 18.09A644.8
µg.mL-1 Total carotenoids = 1000A470 - 1.90Ca - 63.14Cb/214.

Assessment of Antioxidant Activity via 1,1-Diphenyl-2-picryl-hydrazyl (DPPH) Assay
After extraction, the extracts were directly assessed for their free radical scavenging
activity for correlation against phenolic and flavonoid content. The anti-oxidant activity
was assessed by the 96-plate DPPH method as described by Herald et al. 2012 [43] with
some modifications [49]. In brief, 200 µl of 150 µM DPPH solution in ethanol is added
to 25 µL of extract or blank. The blank is left to incubate in the dark for up to 6 hours
and absorbance read at 517 nm (SpectraMax). The percentage (%) of DPPH scavenged
is calculated as the following equation:
Absorbance of the Control - Absorbance Sample / Absorbance Control x 100
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Each extracted sample was analysed in triplicate with each set of cultivation data having
a sample number (n) of 9.
Assessment of Cytotoxicity
After phytochemical analysis the triplicate extractions for each sample were combined
and dried under nitrogen and 10 mg.g-1 stocks in 100% dimethyl sulfoxide were
prepared for biological evaluation. The extracts were assessed for cytotoxity (100
µg.mL−1) on Abelson murine leukaemia virus-induced tumour macrophage (RAW
264.7) cell lines as described previously [50, 51]. The cytotoxicity of the extracts was
calculated as the % inhibition of cell proliferation against controls (24 hour incubation)
using 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2Htetrazolium inner salt (MTS) reagent (Promega). Data was normalised against a control
for analysis.
Assessment of Anti-inflammatory Activity
The anti-inflammatory activity was assessed as the percent (%) reduction of nitrite
(NO2-) in the cell supernatants determined spectrophometrically using Griess reagent (1
% sulphanilamide and 1 % N-(1-naphthyl)ethylenediamine dihydrochloride solution) as
previously described [51]. In brief, RAW 264.7 macrophage cells were co-incubated
with 1 µg.mL−1 lipopolysaccharides (LPS) and algal extract (100 µg mL−1) for 24 h (37
°C, 5 % CO2), including controls in 24-well plates. After incubation an equal volume of
Griess reagent was added to 50 µL of cell supernatant or standard (0 - 1000 µg.mL-1
sodium nitrite) and mixed thoroughly. After 10 minutes the absorbance was measured at
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550 nm with a baseline correction at 650 nm [52] and the amount of nitrite determined
using a standard curve (0 - 100 µM sodium nitrite). Data expressed as a % reduction of
nitrite compared to controls.
Statistical and Data Analysis
Two-way ANOVA and Tukey’s multiple comparisons were used to determine
significantly different means using GraphPad Prism version 6.00.
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Results and Discussion
Pigments
The pigments of chlorophyta species consist mainly of chlorophyll a and b, β-carotenes,
lutein and several xanthophylls [53]. A significant effect of the Ulva cultivation
treatment was observed on the pigment profiles when extracted with acetone (F (3, 32)
= 2486, P < 0.0001) (Figure 25). Low nutrient conditions (-N) showed the lowest total
chlorophyll content (17.1 µg.g-1 d.w.) and total carotenoids (2.6 µg.g-1 d.w.) in both
extraction solvents, which is consistent with reported environmental stress effects such
as nitrogen limitation [54-56]. In contrast, the high nutrient regime (+N) showed a
dramatic 57-fold increase in total chlorophyll content (990.9 µg.g-1 d.w.) and 37-fold
increase in total carotenoid content (102.8 µg.g-1 d.w.) (Figure 25).
Cultivation with high nutrients under shaded conditions (-L) significantly reduced the
level of total chlorophyll by 49% and carotenoid content by 73% when compared to the
high nutrients with natural sunlight. Acetic acid (+AA) cultivation reduced the acetone
yields for total chlorophyll and carotenoids by 66% and 78% to 336.7 µg.g-1 and 22.3
µg.g-1 d.w., respectively. Whilst supplementation with an organic carbon source was
investigated herein, supplementation with an inorganic carbon source (elevated carbon
dioxide (CO2) has also been shown to decrease total chlorophyll and carotenoid content
in cultures of Ulva rigida relative to a normal CO2 control [55]. Ethanol extracts (95%
v/v), showed similar trends as for the acetone extracts across the different cultures with
significant differences across culture treatments (F (3, 32) = 1101, P < 0.0001) (Figure
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25).

For both acetone and 95% ethanol extracts, high nutrients delivered the highest

combined yield for pigments (2085 µg.g-1 d.w. acetone; 3045 µg.g-1 d.w. 95% ethanol).
Significantly higher yields of total chlorophylls (1480.5 µg.g-1 d.w.) across all cultures
were obtained with ethanol extracts while the highest yields of carotenoids across all
cultures were obtained for the acetone extracts (chlorophyll a F (1, 16) = 150.7, p <
0.0001; chlorophyll b F (1, 16) = 226.8, p < 0.0001; total chlorophyll F (1, 16) = 211.0,
p < 0.0001 and; total carotenoids F (1, 16) = 12.33, p = 0.0029). This is likely due to
major carotenoids such as β-carotene and lutein having a higher solubility in acetone
compared to ethanol [57].
The increase in carotenoid levels for the high nutrients with natural sunlight may be an
acclimation response for high sun exposure as carotenoids prevent chlorophyll
photoxidation [54, 58]. The resulting higher a/b ratio is also indicative of the higher
chlorophyll a content responsible for light processing, in contrast to the accessory
chlorophyll b pigment responsible for light harvesting. Continual low light conditions
did not accumulate a pigment concentration beyond that achieved with full sunlight
with natural fluctuations. Accumulation of light harvesting pigments is one adaption of
low light plants in an attempt to maintain a high efficiency of light absorbance [59] and
Ulva has been shown to exhibit adaptive responses to ultraviolet light treatments [31].
However, limited studies have compared the effect of natural sunlight versus continual
shaded (low light) conditions for large-scale open pool cultivations of Ulva.
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Figure 25 Total chlorophyll, carotenoid content (µg.g-1 d.w.) and chlorophyll a/chlorophyll b ratios for 100% acetone and 95% ethanol extracts of Ulva from four different
cultivation treatments: + N: high nutrients with natural sunlight; - N: low nutrients with natural sunlight; - L: high nutrients under shaded sunlight; + AA: high nutrients with
natural sunlight and acetic acid supplementation.
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Light quality on the other hand, has been investigated for Ulva lactuca, but with no
significant effects on pigment concentration [56] while high nutrients significantly
increased levels of pigments [56]. Exposed wet thalli of Ulva fasciata, U. lactuca and
U. reticulata have shown a decrease in total pigments in response to ultraviolet B
radiation exposure over time [60]. However, this is not representative of true cultivation
conditions where algal cells can divide and acclimate and is likely the result of pigment
photoxidation. Sand-Jensen 1988 [59] suggested that Ulva found naturally in high light,
intertidal zones utilises other light adaptive mechanisms than a shade adaptive
mechanism of increased pigments in low light; a selective advantage to natural
fluctuating light conditions. Similarly, increasing chlorophyll content with increasing
light intensity has been shown in microalgae [61, 62]. Results herein, along with the
reported literature suggest that nutrients are the strongest determinant of pigment
concentration in natural light conditions.

Phenolics and Antioxidant Activity
Acetone extracts
For acetone extracts there was a significant effect of increased flavonoid content and
DPPH activity for low nutrient cultures (F (3, 132) = 100.5, P < 0.0001) (Figure 26),
while there were no significant differences in acetone-extracted phenolics across the
different cultivation regimes (6.15 - 9.08 µg.mL-1 GAE). Low nutrients showed a 5-fold
increased in flavonoid concentration (35.89 µg.mL-1 QE) when compared to the other
treatment groups (3.95 - 6.96 µg.mL-1 QE). Low light (6.95 µg.mL-1 QE) and samples
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supplemented with acetic acid (6.76 µg.mL-1 QE) also showed slightly elevated
flavonoid content compared to natural sunlight (3.95 µg.mL-1 QE) but an interaction of
this effect with nutrients was not tested and the scale was much smaller than that of
nutrient depletion.
As expected, acetone-extracted flavonoid content did not exceed phenolic content for
the high nutrient regimes (+ N, - L and + AA) as the phenolic assay measures all
compounds capable of reducing the Folin-Ciocalteu reagent, including flavonoids
(Figure 26). However the flavonoid content of the nutrient-starved regimes was
unusually higher than the phenolic content and requires further investigation. It may be
possible that the low nutrient cultures increase the synthesis of flavonoids, including
flavonols as a defence mechanism in response to environmental stress [63, 64]. The
flavonoids may also be highly substituted thus limiting their ability to react with the
Folin-Ciocalteu reagent. However the higher flavonoid content of the low nutrient
conditioned biomass did not equate to higher anti-oxidant activity (7.2 % inhibition)
compared to the high nutrients with natural sunlight (12.4 %) (P < 0.001).
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Figure 26 (a) The phenolic (µg.mL-1 gallic acid equivalent), (b) flavonoid content (µg.mL-1 quercetin
equivalents) and (c) relative DPPH free radical scavenging activity (% inhibition of DPPH free radical) of
acetone and ethanol (95% v/v) extracts for Ulva biomass conditioned using four different cultivations
treatments; nutrient-rich (+ N); nutrient-starved (- N), nutrient-rich; low-light (- L) and; nutrient-rich with
added acetic acid supplementation (+ AA).
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Ethanol Extracts

A significant effect of cultivation on the phenolic content, flavonoid content and DPPH
activity was observed for extracts from 95% ethanol compared to acetone extracts (F (3,
132) = 36.23, P < 0.0001). Furthermore, when extracted with 95% ethanol there is also
a significant effect of both solvent (F (1, 64) = 98.23, P < 0.0001) and cultivation (F (3,
64) = 23.11, P < 0.0001) on phenolic yields, which was not observed for acetone (Figure
26).

Extraction with 95% ethanol for the high nutrient culture with natural sunlight

resulted in a 4-fold increase in total phenolics when compared to acetone extracts (44.58
c.f. 9.08 µg.mL-1 GAE respectively). Apart from phenolics, all other trends observed for
the acetone extracts were maintained with the 95% ethanol extraction with the low
nutrient regime showing a marked increase in flavonoid content (34.26 µg.mL-1 QE)
when compared to the other regimes (6.23 - 9.66 µg.mL-1 QE) (Figure 26). Anti-oxidant
activity was again highest in the high nutrient culture with natural sunlight and with
ethanol extract (18.8% inhibition), which is potentially due to the significantly higher
levels of phenolics (44.58 µg.mL-1 GAE).

Comparison of the yields and activity of Ulva phenolics found here with reported
literature is difficult due to the different standards (phenolic equivalents) used and
different methods of reporting yields (Table 21). Table 22 shows the dry weight
equivalents (mg.g-1 d.w.) for phenolic and flavonoid contents across the four cultivation
regimes when extracted with either acetone or 95% ethanol. Yildiz et al. 2014 [38]
reported a value of 1.7 ± 0.3 mg GAE per g of dry weight for a dried Ulva rigida
sample extracted with 80% methanol, supporting our reported value herein of 1.58 ±
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0.21 mg GAE per g of dry weight for the high nutrient culture with natural sunlight.
However other studies with freeze dried material showed much higher levels of PHGE
equivalents and these equivalents and pre-processing effects were not explored here.

Herein our results indicate that high nutrients with natural sunlight is optimal for
phenolics and antioxidant activity, relative to the other treatment regimes, however for
more definitive, absolute amounts regarding total content, further investigations should
be carried out to optimise the extraction for algal samples. It is possible that higher
yields may be obtained by extraction of fresh or freeze-dried material as opposed to
oven-dried, as investigated herein [34, 65].
Table 22 The phenolic total content (gallic acid equivalents, GAE) and flavonoid (quercetin equivalents,
QE) content per gram of dried Ulva powder for acetone and 95% ethanol extracts from four different
cultivations treatments (nutrient-rich, nutrient-starved, nutrient-rich low-light and nutrient-rich with
added acetic acid supplementation).
Phenolics (mg.g-1 d.w. GAE)

Flavonoids (mg.g-1 d.w. QE equiv)

Nutrient-starved (- N)

0.25 ± 0.01

1.27 ± 0.02

Nutrient-rich (+ N)

0.32 ± 0.01

0.14 ± 0.02

Low light (- L)

0.28 ± 0.01

0.25 ± 0.03

+ Acetic Acid (+ AA)

0.22 ± 0.01

0.24 ± 0.02

Nutrient-starved (- N)

1.04 ± 0.10

1.21 ± 0.07

Nutrient-rich (+ N)

1.58 ± 0.21

0.22 ± 0.03

Low light (- L)

0.39 ± 0.03

0.34 ± 0.02

+ Acetic Acid (+ AA)

0.47 ± 0.07

0.33 ± 0.02

Acetone

Ethanol (95% v/v)

The chemical nature of the algal phenolics themselves will also direct the choice of
solvent-system so further solvents/solvent combinations should be investigated [1, 66].
For example Vijayavel and Martinez 2010 [67] reported appreciable NO, hydroxyl and
superoxide radical scavenging dose responses for Ulva fasciata in 100% ethanol
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extracts with corresponding total phenolic content of 0.21 mg GAE per g algal weight,
an 87% decrease compared to the total content reported herein. Aqueous organic
solvents, such 80% methanol or 95% ethanol have also been shown to extract higher
quantities of phenolic compounds than pure organic solvents [68] suggesting that the
acetone extraction herein may benefit by addition of a proportion of water.
Anti-inflammatory and Cytotoxicity
With regards to the inhibition of LPS-induced NO, no significant effects of cultivation
were observed for either the acetone or 95% ethanol extracts (F (3, 24) = 0.3892, P =
0.7618). All samples exhibited strong anti-inflammatory activity ≥ 76 % with no
evidence of cell cytotoxicity (% inhibition on cell proliferation) (Figure 27). However,
the extraction solvent did have a significant effect on the inhibition of NO (F (1, 24) =
16.49, P = 0.0005) with acetone extracts exhibiting significantly higher inhibition of
NO (94 - 97 %) than the 95% ethanol extracts (76 - 91 %) (Figure 27). It is unclear
which phytochemical is responsible for the increased NO activity as there are no
obvious differences in the profiles of the solvents that might explain this, other than that
carotenoids were generally higher in the acetone extracts but mostly in the nutrient rich
conditions (above).
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Figure 27 The increase in cell proliferation (normalised to control) and corresponding % inhibition of
nitric oxide (NO) for acetone and 95% ethanol extracts of Ulva from four different cultivations treatments
(nutrient-rich, nutrient-starved, nutrient-rich low-light and nutrient-rich with added acetic acid
supplementation).

Kellogg and Lila 2013 [41] reported similar levels of NO inhibition, up to 92 % for
hexane, ethyl acetate and water extracts from an Ulva lactuca. We have also previously
reported strong NO inhibition (>76 %) for Ulva dichloromethane and ethyl acetate
extracts [51]. This high NO inhibition across a variety of extracts with differing
polarities suggests that the anti-inflammatory functionality of Ulva is likely due to a
number of different structurally classed molecules such as fatty acids, phenolics,
terpenoids with possible synergistic effects. This however would need to be defined
through further purification and a bioassay guided fractionation approach.
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With regards to cell toxicities of both extracts, there was no observed inhibition of cell
proliferation. In contrast, cells incubated with Ulva acetone and 95% ethanol extracts
(100 µg.mL-1) showed enhanced cell growth. When normalised against a control, both
extracts indicated enhanced proliferation up to 1-fold. When normalised, significant
differences between 95% ethanol and acetone extracts were observed (F (1, 56) = 395.9,
P < 0.0001) (Figure 27). Ulva extracted with 95% ethanol showed a higher rate of cell
proliferation. This may correlate with the increased phenolic and total chlorophyll
content observed. Furthermore the increased NO inhibition observed for the acetone
extracts may be indicative that there was less LPS induced cells producing NO. Future
investigations should correct NO findings against a cell number or mg of cell protein
[52]. With regards to cultivation, no significant differences were observed across the
treatments for either the acetone or 95% ethanol extracts (F (3, 56) = 1.981, P =
0.1272). It is possible that the extracts are conferring a significant protective effect that
increases cell viability. Indeed Ulva rigida ethanol extracts have been reported to
protect human carcinoma cells from death induced by oxidative stress due to H2O2
exposure [69].
Conclusion
In summary, across all samples investigated here, acetone extracts of high nutrient
natural sunlight biomass showed the highest level of carotenoids and inhibition of NO
(Table 23). Important carotenoids present in Ulva include β-carotene, lutein [70] and
have been shown to influence important inflammatory mediators [71]. In contrast, the
low pigment, low nutrient samples when extracted with acetone showed a higher
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concentration of flavonoids. Flavonoids are also anti-oxidants, but they also exhibit a
vast range of pharmacological activities including anti-inflammatory, anti-diabetic,
hepato- and gastro-protective [72]. It has also been implied that the larger molecular
weight flavonoids exert their beneficial effects through their interactions with gut
microbiota [73]. However these biological activities were not measured or evident here.
The high flavonoid content of low nutrient culture is highlighted as a key area to
investigate using a bioassay guided fractionation approach to identify the metabolite
that is being enhanced through nutrient-starved culture conditions and for considering
further biological assays. However, the optimal cultivation condition of high nutrients
and ethanol extractions provided for the highest chlorophyll and phenolic content with
associated high anti-oxidant activity (Table 23). It will be important to build on these
findings by increasing the identification of phytochemicals present in the diverse
extracts and expanding the types of biological assays along with establishing
concentrations at 50% inhibition (IC50) for purified fractions.
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Table 23 Summary of the highest detected concentrations of chlorophyll, carotenoids, flavonoids, along with the highest detected anti-inflammatory, anti-oxidant and cell
proliferative activity for four different cultivations of Ulva macroalgae, extracted with two different solvents.
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Increasingly consumers are being exposed to information regarding the link between
diet and health. However, a proportion of the population will find it challenging to meet
the simple dietary intake requirements for fresh fruit and vegetables [1]. Specifically,
diets that are high in omega-6 and trans-unsaturated fatty acids have led to an increasing
prevalence of non-transmissible diseases [2]. For example, allergies, asthma and
inflammatory bowel, cardiovascular, metabolic and neurological diseases, all of which
are characterised by a persistent underlying low-grade inflammation [3-5]. However,
diets that are rich in plant phytochemicals and anti-inflammatory omega-3 fatty acids
confer protective benefits against these inflammatory diseases [6-11]. These metabolite
classes are abundant in algae and cultivated macroalgal crops have been highlighted as a
potential source for these high value anti-oxidant and anti-inflammatory compounds
[12-16].
A review of bioactive compounds in seaweed by Holdt and Kraan 2011 [17]
demonstrates that, collectively, seaweeds are a valuable source of nutrition including
essential dietary vitamins, minerals, fatty acids and amino acids. In addition, the
functionality of seaweeds also extends beyond that of simply providing nutrition, as
they are also a source of other functional compounds (Chapter 1). Northern hemisphere
seaweeds dominate this field of research, and yet Australia has a unique flora of
macroalgae in which the chemistry and biological activity is still poorly understood.
Therefore a number of Australian seaweeds were investigated herein to establish their
potential for cultivation for food and health markets (Chapter 3). These taxa included
Hormosira banksii, Phyllospora comosa, Ecklonia radiata, Myriogloea sciurus,
Solieria robusta and the green macroalgae Ulva spp. In particular, the study focused on
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dominant seaweed traits of interest, such as metabolites that function as antiinflammatories that could confer protection against underlying low-grade inflammation
that characterises many lifestyle diseases.
One anti-inflammatory class of molecules are polyunsaturated fatty acids (PUFA), in
particular omega-6 (n-6) fatty acids, which are substrates for pro-inflammatory
mediators and omega-3 (n-3) fatty acids, which are substrates for anti-inflammatory
mediators [18]. This is why a reduced ratio of dietary inflammatory n-6 fatty acids to
anti-inflammatory n-3 fatty acids (n-6/n-3) is considered important to suppress chronic
inflammatory disease [9, 19]. Therefore characteristics of the fatty acid profiles for
these Australian taxa were investigated. All six taxa had significantly different omega-6
to omega-3 ratios, although the environmental conditions had a big influence on this
too. However it was the green seaweed Ulva that was most nutritionally desirable,
exhibiting a low n-6/n-3 ratio of 0.4 and the only species to contain the important
omega-3 docosahexaenoic acid (DHA), albeit at low concentrations. The consumption
of n-6 to n-3 in a typical Western diet is approximately 15:1, while ratios of between
2.5-5 to 1 are desirable to reduce the risk of disease [9]. Furthermore, the non-polar
(lipid rich) extracts of all six algal species strongly inhibited production of the
inflammatory-mediator nitric oxide (Chapter 3). Investigations into cell toxicity also
revealed that extracts of both the Ulva sp. and H. banksii showed selective cytotoxicity
towards a human pancreatic cancer cell line, an interesting finding requiring further
exploration in the future.
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As a result, Ulva sp. and H. banksii and their extracts and fractions were identified as
key candidates for further investigation. There is also a potential opportunity to pursue
characterisation of the active component(s) as a new future research project emerging
from the work described herein. Identification of a novel bioactive may further direct
future anti-inflammatory drug design through a synthetic chemistry approach. However,
the attribution of a biological activity to an extract is an important first step in
characterising the functionalities of the biomass as a whole food matrix. Such
information contributes to more immediately attainable goals in which seaweeds, as
either a whole food, concentrated extracted or isolated class of metabolites have the
potential to contribute to human and animal nutrition as dietary functional foods and/or
ingredients with anti-inflammatory functionalities.
Collaborations with industry partner Venus Shell Systems Pty. Ltd. 18 enabled the
analysis of biomass from large-scale cultivation experiments to further explore the fatty
acid profiles and anti-inflammatory activity of the identified key candidate taxon Ulva
sp. There have been a number of reports quite recently of promising results regarding
large-scale cultivation of Ulva [20-23] and similar chlorophyta species such as Derbesia
tenuissima [24, 25]. These studies contribute important knowledge of various aspects of
cultivation (stocking density, seasonal productivities, harvesting and post-processing)
for chlorophyta species to maximize biomass yields and quality. With regard to quality,
they have focused on key compounds for biorefinery and commercial utilisation, such
fatty acids and lipids [24], carbohydrates, amino acids [22], protein [23], mineral salt

18

Venus Shell Systems, Narrawallee, NSW, 2539, Australia
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[20] and even phenolics and antioxidant activity [25]. On the basis of the results
presented in Chapter 3, it was hypothesised that the presence of two metabolites
classes are likely candidates for the strong anti-inflammatory activity of the extracts.
These include lipids rich in polyunsaturated fatty acids and pigments (including
phenolics).
Ulva can readily adjust its metabolism under specific environmental conditions, wherein
the lipids and fatty acids play an important role in this adaptation [26]. As such, the
profiles of reported FA for Ulva can show a wide degree of natural variation
(comprehensive review presented Chapter 4). Therefore, in complement to the reported
cultivation studies of Ulva described above, Chapter 4 demonstrates that growth
conditions are also an important consideration for biomass yield and quality. It was
demonstrated that high nutrient growth conditions deliver the most desirable fatty acid
profile for health with PUFA constituting 54% of the lipid extract. The n-6/n-3 was a
very favourable low 0.2, and important omega-3 PUFAs comprised up to 9%, 2% and
1% of stearidonic acid (SDA; C18:4n-3), eicosapentaenoic acid (EPA; C20:5n-3) and
docosahexaenoic acid (DHA; C22:5n-6), respectively. A number of studies have shown
potential for the rare stearidonic acid (C18:4 n-3) to boost tissues levels of the antiinflammatory eicosapentaenoic acid (EPA, C20:5 n-3) [27-29]. Furthermore, via a
thorough a comparison of lipid extraction procedures and subsequent development of an
optimised protocol for the extraction of fresh filamentous Ulva, a yield of 56 mg.g-1 dry
weight equivalent could be achieved.
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Chapter 5 explored the effect of environment on the distribution of these important
polyunsaturated fatty acids across the phospholipid and neutral lipid fractions. These
fractions perform important physiological roles in different cellular structures. In
particularly the fatty acid composition of Ulva phospholipids, which constitute between
10-50% of cell membranes and chloroplasts [30, 31] has been poorly explored [32],
compared with the typically more abundant glycolipids [33-35]
It is important to consider in which lipids the important omega-3 fatty acids are bound
as this may have implications regarding bioavailability of the algal-derived oil. Fish
derived PUFA from fish oil are commonly bound within triacylglycerides, however it
has been postulated that they may not be as efficient as other lipids classes, such as
triacylglycerides [14]. For example, Krill oil is unique in that as it has a substantial
proportion of EPA and DHA in abundant phospholipids and this has been used in
marketing to differentiate itself from the other typical fish oils. Whilst there is evidence
to suggest that polar lipids have a higher bioavailability than nonpolar triacylglycerides
further studies are required [15]. Nethertherless, for a marketable algal-derived oil this
is an important consideration. Secondly, such information can direct future extraction
protocols as different lipids have differing solubilities.
If was found herein that phospholipid fractions were characterised by the presence of
five major fatty acids including 16:0, 16:1n-7, 18:1n-7, 18:2n-6 and 18:3n-3 and that the
majority of important omega-3’s reside in the remaining neutral fractions
(triacylglycerides and glycolipids).
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Thus the neutral lipid fraction was highlighted as the richest fraction and target for a
nutritionally potent PUFA extract and could direct the future choice of extraction
protocol. For example, two feasible options for scaling the oil extraction include either a
non-toxic solvent approach such as ethanol [36] or super-critical carbon dioxide, which
offers a number of benefits over traditional solvent extractions including:19

•

Non-flammable, non-corrosive and inexpensive with no chemical residue;

•

Low critical temperature and decreased degradation of food components;

•

Higher diffusion coefficients and lower viscosity allowing for rapid matrix
penetration and enhanced extraction efficiencies; and

•

Selective for compounds of interest and can be recycled.

Phospholipids have a limited solubility in super-critical carbon dioxide thus requiring a
co-solvent such as ethanol [38]. For example, a one-step neat super-critical carbon
dioxide extraction without ethanol supplementation could optimise a sequential
biorefinery process that concentrates the neutral lipids fractions, such as glycolipids, to
deliver a nutritionally valuable high-end product with phospholipid by-product rich in
alpha linolenic acid (18:3n-3) and linoleic acid 18:2n-6 [38]. It was further found herein
that nitrogen-starvation could increase the yield for this neutral lipid compared to the
high nutrient conditions, however this was at a detriment to the overall quality of the
oil. Thus for products aimed at food and health markets it may be more important to
optimise the high quality rather than the quantity of fatty acids through the optimised
cultivation of Ulva. This understanding of the fatty acid distribution across different
19

Rozzi, N.L. and Singh, R., K., Supercritical fluids and the food industry. Comprehensive reviews in
food science and food safety, 2002. 1: p. 33-44 [37]
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lipids can define future selective biorefinery processes. Future investigations of Ulva
derived oils should further consider the fatty acid distributed across the different neutral
lipid classes such as glycolipids and triacylglycerols. In particular, more chemistryoriented approaches should be employed to identify and quantify lipids, for example
identification of phospholipid composition by electrospray mass spectrometry.
The results presented across both Chapters 4 and 5 present the idea that an algalderived oil from Ulva spp. could offset a proportion of the demand for fish derived oils.
Encapsulated omega-3 fish oils are highly promoted as part of a balanced diet, and
rightly so due to their health benefits associated with foetal development, cardiovascular
function, and Alzheimer’s disease [39]. Fish oil is also a valuable additive in feed for
aquaculture to boost tissues levels of omega-3 and replacement oils have been sought
due to declining wild fish stocks [40]. There is also particular promise for oils high in
stearidonic acid (C18:4 n-3) [41], such as is the case with an Ulva derived oil. High
levels of stearidonic fatty acids are found in seed based oils from Echium species,
however these oils are deficient in other important omega-3 such as EPA and DHA
[42]. Whether the omega-3 PUFA are delivered via the whole food matrix or as an
extracted oil supplement, there is additional evidence to suggest the benefits of
incorporating algae in aquaculture feeds. For example, the flavour of farmed
barramundi was shown to be enhanced, with other organoleptic attributes with an algal
diet (Ulva ohnoi) [43]. Macroalgal diets have also achieved high levels of important
omega-3 fatty acids in abalone [44], along with higher growth rates and overall
improved condition of the abalone [45]. Indeed, the latest report from the Food and
Agriculture Organisation of the United Nations [46] identified a surging demand in fish
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and fish products that can only be met by aquaculture, indicating a pressing need for
sustainable sources of beneficial omega-3 PUFA.
One particular limitation to our proposed algal-derived omega-3 oil from Ulva is the
level of docosahexaenoic fatty acid (DHA), which is only present in trace amounts. In
contrast to EPA, tissue levels of DHA can only be boosted with direct supplementation
[47]. An interesting future project could consider options to boost the DHA content of
the proposed algal-oil. Herein biomass was analysed from cultivations that differed in
two growth variables (light and nutrients). Future considerations could consider
exploring effects of salinity, pH, and temperature, however natural seasonal fluctuations
of these variables were found not to significantly effect total lipids and fatty acid
contents of a number of wild species including Ulva linza [48]. A more interesting and
challenging project might be to explore co-culturing techniques with other algal species
or even symbiotic bacteria [49]. A more simple option however may be to consider
supplementation of the Ulva derived oil with cultured microalgal oils rich in EPA and
DHA such as Synechocystis [50] and Isochrysis galbana [51], respectively. Regardless
of the approach, if the both the EPA and DHA content can be successfully boosted
beyond levels that are presented herein, or if supplementation to animal feeds becomes
a more standard practice to boost tropic bioaccumulation, there is real possibility that an
algal oil could offset a proportion of this demand for fish-derived oils in the future.
With regards to human nutrition, the human consumption of seaweed, and thus its
beneficial omega-3’s and other bioactive phytochemicals faces a bigger challenge for
acceptance, than it does for simple supplementing fish feed. In Western cultures
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seaweed as a recognisable whole food has struggled to expand significantly beyond
Asian Markets [52]. In cultures that have a more limited tradition in the utilisation of
seaweed, the consumption of algal-derived functional food ingredients and/or
supplements might be a more feasible option to pursue for consumer acceptance and
commercial success [14] (Figure 28).
As mentioned earlier, a proportion of society’s population will struggle to meet dietary
requirements for fresh fruit and vegetables. Fruit and vegetables are rich in
phytochemicals [53] and include polyphenol compounds such as phenolic acids and
flavonoids and terpenoid derived compounds such as carotenoids, lutein, lycopene and
β-carotene [54]. Seaweeds are also a source of these beneficial and abundant bioactive
phytochemicals [12, 13] and it was hypothesised based on the results of Chapter 3 that
the presence of pigments and phenolics may have attributed to the high antiinflammatory activity observed. Therefore, upon completion of the cultivation
investigation (Chapter 4 and 5), the harvested biomass was dried and milled and
subsequently analysed for phenolics and pigments as a potential class of metabolites for
biorefinery and utilisation.
Whilst phenolics have been reported for Ulva within the literature (Chapter 6) little has
been done to explore the effect of cultivation on the phytochemicals of Ulva. High
nutrient conditions were again deemed optimal to deliver the highest yields of phenolic
content, as well as anti-oxidant activity. Furthermore, a 4-fold increase in phenolic yield
is obtained with ethanol extraction as opposed to using acetone as the extraction
solvent. In contrast, acetone extracts of high nutrient cultures exhibited the highest
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carotenoid content and anti-inflammatory activity. Low nutrients cultures were also
correlated to substantially increased flavonoid content. These results again have
important implications that can direct future extraction protocols. Furthermore, whilst
this thesis presents the characterisation of the anti-inflammatory and anti-oxidant
functionalities at the level of extract there are further avenues to pursue and build upon
these results through further purification via a bioassay guided fractionation approach
combining both molecular and chemistry techniques.
Although a direct cause and effect relationship was not pursued to the level of
molecular fractions herein, the clear indications of in vitro anti-oxidative and antiinflammatory activities of phenolic/pigment rich macroalgae is an adequate position
from which to consider applying these seaweeds in nutritional studies. However, how
these activities should be applied in a nutritional sense to reduce the deficiencies in the
western diet still needs to be considered thoroughly. If direct consumption of these
seaweeds or their extracts is required, then the effects of any processing needs to be
considered. Here the optimisation of protocols for quantifying bioactive metabolites
will be of great use in pursuing this direction of research to quantify effects, as was
done in Chapter 5 (further investigations) based on the drying process.
In addition, any toxicity testing (Chapter 2) of the processed products will be of
importance as commercially processed and whole biomass effects were not undertaken
here. This area should be expanded upon to consider the content of trace elements and
metals, which were not investigated here. A full investigation of these attributes should
be used to characterise the seaweed biomass from a nutritional sense as well as for
208

Chapter 7 Discussion & Future Directions

safety. Following this, clinical testing of these seaweeds and their extracts as
supplements or food needs to be undertaken to confer that the metabolite attributes and
in vitro assays can be translated directly into benefits for humans and fortification of
inflammatory western diets.
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Figure 28 The development of robust analysis methods to determine the quantity and quality of cultivated seaweed biomass is an important first step for the successful
commercialisation of algal derived products to contribute to human and animal nutrition. This could be via consumption as either a whole food, an algal-derived oil or
pigment rich supplement.
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Conclusion
In conclusion, this thesis presents, in journal article style, a combination of published
and prepared manuscripts that screens the metabolite profiles and anti-inflammatory
activities of a number of South Eastern Australian, macroalgal species. These included
endemic and native species of Phaeophyta, Rhodophyta and Chlorophyta. All species
screened here exhibited anti-inflammatory activity associated with at least one extract
fraction, although there were clear characteristics in the anti-inflammatory activity and
FA profiles across the level of phyla, as well as species. In terms of FA profiles,
Hormosira banksii (Phaeophyta) is a promising candidate with high levels of PUFA,
however Ulva sp. exhibited more favourable Omega-3 ratios, which is important for
anti-inflammatory health applications. In addition, Ulva sp. exhibited selective cell
toxicity against pancreatic cancer cells in vitro and was investigated further for pigment
traits that can also explain anti-inflammatory activity. Therefore a range of cultivation
conditions and analytical methods were optimised to test the variability and actual
content of metabolites with anti-inflammatory potential (Figure 29).
An important requisite in the screening of new natural products is the toxicity for safety
concerns. In addition, targeted toxicity assays towards cancerous cell lines is of interest
and these aspects were explored in Chapter 2, published as “Bioassays for Anticancer
Activities” in the book Metabolomics Tools for Natural Product Discovery Methods and
Protocols. Using this screen for toxicity, as well as the FA profiles and antiinflammatory activities, Chapter 3, published in the Journal of Applied Phycology
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(impact factor 2.372), identified the important candidates of anti-inflammatory
compounds for further investigation aimed towards food and health markets.

Scoping Australian Macroalgae
• Proﬁling
• Cul5va5on
• Health Applica5ons

CH 6: Ulva Pigments
• Prepared Manuscript

CH 5: Ulva Lipids
• Prepared Manuscript

CH 2: Bioassay Methods
(Screen for Toxici5es)
• Book Chapter (2013)
CH 3: Species Proﬁling
• Journal of Applied Phycology
(2015)

CH 4: Ulva FaKy Acid Methods
• Food Chemistry (2016)

Figure 29 Graphical summary of the chapters and corresponding publications presented in this thesis.

A challenge to the adoption of natural products is the establishment of qualitycontrolled procedures that can provide a comprehensive comparative assessment of the
FA of cultivated Ulva sp. via a consistent methodological approach. This was developed
in Chapter 4, also presented as a published manuscript, which appeared in the journal
Food Chemistry (impact factor 3.391). A thorough review of FA from the genus Ulva
identified that there were inconsistencies in the published literature, and a focus on
method optimisation targeting these inconsistencies delivered a validated and
comprehensive approach to the analysis of FA in Ulva sp., taking into account the
effects of biomass preparation and extraction protocols. This was essential for the
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rigorous comparative work of Ulva biomass, which was cultivated in different
conditions to determine the effects on FA profiles presented in Chapter 5.
As a result of the findings presented in Chapters 4 & 5, a food safe solvent extraction
for FA was explored and it was found that Ulva sp. cultivated under optimal growth
conditions (high nutrients) can yield 4.1% dry weight (d.w.) of total FA. This is an
important finding and represents a doubling of the average reported lipid yield for Ulva
spp. in the literature (~2% d.w.). Due to this finding and the fact that ethanol as a
solvent extracts are also rich in pigments and phenolics, the characterisation of these
metabolite classes were explored. This investigation of the phenolics and pigments of
cultivated Ulva sp., along with associated anti-oxidant and anti-inflammatory activities,
is presented as a prepared full research manuscript in Chapter 6. The results presented
in Chapter 6 establish that Ulva sp., when cultivated under optimal conditions, delivers
a high yield of Omega-3 rich FA, pigments and phenolics, with associated antiinflammatory and anti-oxidant activity.
Thus, as Aristotle once said “in all things of nature there is something of the
marvelous” and indeed Australia’s unexplored bounty of endemic macroalgae has a
promising future of marvellous discovery.
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Appendix B
Protocols for Abelson murine leukaemia virus-induced tumor macrophage (RAW 267.4
cells)20
Protocol for Thawing Raw 264.7 cells
1. Cells are stored in media with 20% DMSO (which helps with freezing down).
Therefore there is a need to work quickly. Prepare your biological safety cabinet
(BSC) and equipment.
2. Prepare tissue culture media RPMI-1640 with 10% fetal calf serum and 1%
GlutaMAX with penicillin (100 U/mL) and streptomycin sulphate (100 µg/mL).
a. Note: Have found that High Glucose DMEM media with 10% FBS
(without added Glutamax) works just as well or even better I also found
that you so do not need antibiotics
3. Pre-warm media and thaw cryovial of cells in water bath (37 °C)
4. Add 40 ml of culture media to a 50 mL falcon tube. Add whole contents of
cryovial (1 mL) to the 40 ml of culture media to dilute DMSO (syringe works
well). Spin at 1500 rpm for 5 mins. Pour off supernatant. Using a syringe,
resuspend in 2 mL of culture media

20

Modifications of methods and feedback originally provided by Associate Professor Ronald Sluyter,
School of Biological Sciences, Faculty of Science, Medicine and Health, University of Wollongong,
Wollongong, NSW, 2522, Australia
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5. Add approximately 23 mL media to 75 cm2 tissue culture flask (total volume 25
mL) than add the 2 mL of resuspended cells.
6. Place in incubator with 5% CO2 at 37 °C.
Protocol for Passaging Raw 264.7 cells
1. Prepare BSC and equipment.
2. Pour off supernatant in tissue culture flask and add ~10 mL fresh media.
3. Scape cells off bottom of flask with tissue culture scraper.
a. Note: Contamination can easily occur with this step. Clean scraper
packet with ethanol thoroughly before putting in BSC. Be careful when
opening to ensure aseptic technique as plastic packet rips off-centre very
easily and tears).
4. Swirl flask to make homogenous.
5. Add 2ml of scraped cells suspension to new 75 cm2 flask with ~ 23 ml fresh
media.
Protocol for Freezing down Raw 264.7 cells
1. The day before put a cryovial container in the -80 °C freezer to cool.
2. Prepare 10 ml of a 20% DMSO solution in culture media in a 50 ml falcon tube
(2 ml 100% DMSO in 8 ml culture media). Put on ice.
3. Harvest flasks (5 x 75 cm2 flasks by first pouring off supernatant. Add fresh
culture media (~8 ml), scrape and pool into a 50 ml falcon tube. Spin for 5 mins
at 1500 rpm.
4. Pour off supernatant, resuspend in 10 ml culture media. Put on ice.
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5. Label 10 cryovials (2 cryovials per 75 cm2 flask) and removed the cryovial
container from the -80 °C freezer.
6. Add the cells slowly (drop wise), whilst continually stirring, to the 20% DMSO
solution in CM. This will now be a cell suspension in 10% DMSO in culture
media.
7. Aliquot ~1.8 ml of cell suspension in 10 % DMSO in culture media to each
cryovial (do not completely fill to the 2 ml mark) to
8. Put into the cryovial container and place container back in --80 °C freezer for 24
hours before storing in liquid nitrogen.
Preparation Phosphate Buffered Saline21
Table 24 Preparation for 1X and 10X phosphate buffered saline stock solutions.
Reagent

Amount to add
(for 1X solution)

Final concentration
(1X)

Amount to add
(for 10X stock)

Final concentration
(10X)

NaCl

8g

137 mM

80 g

1.37 M

KCl

0.2 g

2.7 mM

2g

27 mM

Na2HPO4

1.44 g

10 mM

14.4 g

100 mM

KH2PO4

0.24 g

1.8 mM

2.4 g

18 mM

If necessary, PBS may be supplemented with the following:
CaCl2•2H2O

0.133 g

1 mM

1.33 g

10 mM

MgCl2•6H2O

0.10 g

0.5 mM

1.0 g

5 mM

1. Dissolve the reagents listed above in 800 mL of H2O. Adjust the pH to 7.4 with
HCl, and then add H2O to 1 L.
2. Put the lid on the bottle loosely with autoclave tape and then autoclave it.
Lipopolysaccharide (LPS) Preparation
21

Provided courtesy of Nathanial Harris, PhD Candidate, Supervisor: Prof. Marie Ranson, School of
Biological Sciences, Faculty of Science, Medicine and Health, University of Wollongong, Wollongong,
NSW, 2522, Australia
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1. Sample supplied as 1 mg lyophilised powder. Resuspend in 1 ml phosphate
buffered saline or tissue culture media (1 mg.mL-1 stock solution).
a. Note: a significant amount of LPS may be on the underside of the rubber
lid so add 1 ml of PBS, recap and invert to mix. LPS dissolves rapidly.
2. Prepare 25 diluted aliquots in eppendorf tubes by taking 40 µL of stock solution
and make up to 1 mL (0.04 mg.mL-1). Store in -20 freezer. Avoid thaw and
freeze cycles.
3. For testing, one 1mL eppendorf is thawed and 25 µL is then added to each well
on a 24 well plate for a total volume of 1 mL. Volume required per plate 25 µL.
This gives a testing concentration of 1 µg.mL-1.
a. Note: if using a 96 well plate add 3 mL of sterile PBS to the 1 mL aliquot
and add 10 µL of diluted LPS solution per well to give a final testing
concentration of 1 µg.mL-1
b. Notes 2: I have found that for the determination of nitric oxide in LPS
stimulated RAW264.7 cells that 24 well plate method give much more
consistent results across replicate plates and replicate trials
1. Prepare 10 mg.mL-1 stocks of your test compound in 100% DMSO.
a. Note: Weigh your pre-labelled vial (with lid), add portion of extract and
evaporate down. Re-weigh you vial (with lid) and prepare your 10
mg.mL-1 using this extract weight and avoid trying to prepare a set mg
amount of extract.
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b. Note 2: Sample vials will be sprayed with ethanol before going into the
BSC so use proper labelling and not just marker for labelling your vials.
Also make up your stock solutions in the BSC.
c. Notes 3:I have found that using brand new vials and preparing stock
solution in 100% DMSO in the BSC suffice for sterility. Water soluble
samples will need further preparation to ensure they are sterile (sterile
filtering or autoclave (solution)
2. Prepare a dilution plate using a standard 96 well plate. Pipette 10 µL sample into
90 µL media (1/10 dilution to give a 1 mg.mL-1 solution in 10% DMSO).
3. This 100 µL of 1 mg.mL-1 solution in 10% DMSO will then further be diluted
1/10 when added to the cells to give a final testing concentration of 100 µg.mL-1
in 1% DMSO. This achieved by added 100 µL of 1 mg.mL-1 solution to 875 µL
cells (1.5 x 105 cell.mL-1) and 25 µL of LPS (24 well plate method, adjust
accordingly if needed for 96 well plate assay)
4. Test each sample in duplicate (minimum) which allow for four text samples per
24 well plate (Figure 30)
a. Note: With microplate (96-well plate) preparation it is standard practice
to avoid use of the outside well due to the “edge effect”. Therefore
avoiding the outside perimeter wells should be considered when
modifying this example set up for a 96 well plate assays.
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S1 + LPS
S2 + LPS
S3 + LPS
S4 + LPS

S1 + LPS
S2 + LPS
S3 + LPS
S4 + LPS

S1 + PBS
S2 + PBS
S3 + PBS
S4 + PBS

S1 + PBS
S2 + PBS
S3 + PBS
S4 + PBS

1% DMSO + LPS
1% DMSO + LPS
1% DMSO + PBS
1% DMSO + PBS

Figure 30 Example preparation for a 24 well plate for the testing of four samples at one concentration.
n S1-S4 Test sample with LPS; n S1-S4 Test sample with PBS (Blank); n Positive control (100%
LPS-stimulated nitric oxide production) n Negative control (Blank, 100% normal nitric oxide
production in non LPS-stimulated cells.
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Abstract Increasingly, macroalgae are being recognised as a
growth opportunity for functional foods and nutritional security in the future. Dominating traits of interest are metabolites
that function as anti-inflammatories and are antiproliferative.
However, seaweeds from the northern hemisphere dominate
this field of research. Australia has a unique flora of
macroalgae, and it is poorly understood which species should
be targeted for cultivation towards food and health markets.
Here, six Australian marine macroalgae were selected for
screening of one anti-inflammatory group; n-3 polyunsaturated fatty acids (PUFA). PUFA profiles were determined using
gas chromatography-mass spectrometry and multivariate
analysis. Thirty-one fatty acids (FA) were identified across
the six macroalgal species with C16:0 the dominant FA in all
samples, variations across taxa in the saturated FA C10:0,
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C14:0, C16:0, C18:0 and C20:0 and variations in monounsaturated FA attributed to C16:1 n-7 and C18:1 n-9. For PUFA
profiles, all six species had significantly different n-6/n-3
ratios, while the green seaweed Ulva species possessed the
lowest n-6/n-3 ratio of 0.4, along with a 2-fold higher C18:3 n3 to C18:2 n-6 content. Ulva sp. was the only species that
contained docosahexaenoic acid. Extracts of both the Ulva sp.
and Hormosira banksii showed selective cytotoxicity towards
a human pancreatic cancer cell line, while the nonpolar extracts of all six algae species strongly inhibited production of
the inflammatory-mediator nitric oxide.
Keywords Seaweeds . Fatty acid profiles . PUFA .
Omega-3 . Inflammation . Functional foods

Introduction
Macroalgae are a large and growing multibillion dollar food
and biotechnology industry (FAO 2012; Bixler and Porse
2011; Mazarrasa et al. 2013). Increasingly, they are being
recognised as a rich source of biologically active metabolites
for utilisation in functional foods, nutritional supplements
and/or pharmaceuticals (Stengel et al. 2011). This is due to
important functional roles of these metabolites in a range of
biological processes including cell mediation and immune
responses (Warude and Joshi 2006; Rubio-Rodríguez et al.
2010; Calder and Yaqoob 2009; Kumari et al. 2010;
Mohamed et al. 2012; Smit 2004). Research in medical and
health applications of seaweed metabolites now dominate the
publication of phycology-related scientific literature (Winberg
et al. 2014). There is particular promise for chronic inflammatory diseases and cancers of the digestive system (Vo et al.
2012; O’Sullivan et al. 2010) (Fig. 1). Metabolites that contribute to anti-inflammatory function include essential polyunsaturated fatty acids (PUFA) such as alpha-linolenic acid

230

231

Appendices

Appendix D
Supplementary Methods
Thin Layer Chromatography (TLC)
For the preliminary assessment of extracts and to determine the solvent system for
purification by flash chromatography, thin layer chromatography was used. TLC plates
(3.5 cm × 9.0 cm) were cut from commercially available aluminum backed sheets of
Silica Gel 60 F254 plates. The crude extracts (approx. 25 mg/ml) were transferred onto
the plates by capillary action and the plates were eluted in a closed chamber with
various mobile phases. After drying, the retention factors (rf) for any visible or UV
active components were recorded. The plates were then further stained using iodine
vapor, Hanessian’s stain (comprising 90 mL water, 5 g ammonium molybdate, 1 g
cerium sulfate and 10 mL concentrated sulfuric acid) and an anti-oxidant stain
(comprising of 0.2% w/v 2,2-diphenyl-2-picrylhydrazyl (DPPH) in methanol).
Flash Column Chromatography
Flash column chromatography using silica gel was used to purify extracts. Solvent
system chosen based on TLC (Table 25). Column fractions combined on the basis of
TLC and dried on the rotatory evaporator (Table 26). Weight recorded for each dried
fraction to determine mass recovery (Table 27). Combined dried fractions were tested for
biological activity and only the high yielding fractions with strong activity where
analysed by reverse-phase high-pressure liquid chromatography (RP-HPLC).
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Table 25 Solvent system chosen for flash column chromatography for Hormosira banksii ethyl acetate
extract based on thin layer chromatography (TLC)
Species

Extract

Solvent System

Hormosira banksii

Ethyl Acetate

Chloroform (100 %): Methanol (50 %):
Chloroform/Methanol/Water (6/4/1): Methanol (100 %)

Table 26 Summary of combined fractions after flash column chromatography of Hormosira banksii ethyl
acetate extract. Fractions combined based on TLC.
Species

Extract

Fraction #

Eluent

# Spot TLC

Mass (mg)

1

Combined
Column
Fraction
#1-10

Hormosira
banksii

Ethyl
Acetate

95% CHCl3

2

37.2

2

#11-27

2

27.6

3

#28-40

1

36.3

4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36

#41-51
#52-54
#55-60
#61
#62-64
#65
#66-67
#68
#69-71
#72
#73
#74-75
#76-77
#78-79
#80-81
#82-83
#84-86
#87-88
#89
#90
#91-93
#94
#95-97
#98
#99
#100-134
#135-147
#148
#149
#150
#151-159
#160-161
MeOH wash

92.5%
CHCl3
90%
CHCl3:
80% CHCl3
70% CHCl3
50% CHCl3
Magic
Magic
Magic
Magic
Magic
Magic
Magic
Magic
Magic
Magic
Magic
Magic
Magic
Magic
Magic
Magic
Magic
Magic
Magic
Magic
Magic
Magic
Magic
Magic
Magic
Magic
Magic
Magic
Magic
0% MeOH

1
2
1
1
1
2
2
4
3
1
2
3
1
1
1
1
1
2
1
1
1
1
1
1
2

22.2
15.4
16.8
1.8
37.5
23.4
36.9
7.2
70.6
12.3
14.3
31.3
26.3
5.9
3.8
4.7
2.7
5.8
7.8
3.5
3.8
1.7
1.8
1.4
0.8
9.7
3.1
25.9
12.6
2.4

1
1
1
1
1
1
1

233

Appendices

Table 27 The mass recovery for Hormosira banksii ethyl acetate extract for the combined 36 fractions
after flash column chromatography on silica gel.
Species

Extract

Initial Weight
(mg)

# Combined
Fractions

Mass Combined
Fraction (mg)

% Recovery

Hormosira
banksii

Ethyl
Acetate

610 mg

36

577.7

95

Reverse-Phase - High Pressure Liquid Chromatography (RP-HPLC)
Analytical RP-HPLC was performed on a Shimadzu system with either a dual UV
detector or PDA detector and Phenomenex Luna C18 column (4.6 mm x 250 mm).
Preparative RP-HPLC was performed on a Waters system with dual UV detector using
a Waters C18 column (19 x 150 mm). Mobile phase for both analytical and preparative
RP-HPLC outlined in Table 28.
Table 28 Solvent system used for both preparative and analytical -HPLC
Species

Extract

Solvent System

Hormosira banksii

Ethyl Acetate

Water (100%): Methanol (100%) (Increasing gradient over
40 mins run time)

234

235

Appendices

Appendix E
Supplementary results

HPLC # 10

Preparative Reverse-Phase High-Pressure Liquid Chromatography
Date: 5/12/13
Species: Hormosira banksii
Fraction: Ethyl Acetate Extract Fraction #10
Peak 1

Peak 8

Peak 3

Peak 9
Peak 11
Peak 5

Peak 2

Peak 6

Peak 10

Peak 12

Peak 4

1

Figure 31 Analytical RP-HPLC trace for Hormosira banksii ethyl acetate extract, fraction # 10

Preparative
Reverse-Phase High-Pressure Liquid Chromatography
2: 254 nm, 8 nm
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Figure 32 Analytical RP-HPLC trace for Hormosira banksii ethyl acetate extract, isolated peak 8 (via
preparative RP-HPLC) from fraction # 1
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a b s t r a c t
The fatty acids (FA) of Ulva have potential to contribute to nutrition. However the large variability of FA
profiles of Ulva species; thus the quality and quantity of FA in relation to nutrition is poorly defined.
Herein we investigate the FA profile of 74 cultured Ulva samples crossing five culture regimes, six extraction regimes and four post-harvesting processes. This is compared alongside a comprehensive review of
FA profiles of Ulva spp. With regard to the literature, Ulva is characterised by C16:0 (30.5 ± 11.5%), C18:3
n-3 (14.5 ± 6.3%), C18:4 n-3 (12.5 ± 5.4%), C16:4 n-3 (8.9 ± 4.8%) and C18:1 n-7 (10.1 ± 4.0%). The investigated Ulva fell within the reported range of specific FA. High nutrient conditions showed the most desirable FA profile for health, along with the highest total FA content (56 mg g!1 dry weight equivalent) when
extracted with an optimised protocol.
! 2016 Elsevier Ltd. All rights reserved.

1. Introduction
The marine macroalgal genus Ulva (Chlorophyta) is a source of
valuable long-chain polyunsaturated fatty acid (LC-PUFA) profiles,
in particular the biologically important eicosapentaenoic acid
(C20:5 n-3, EPA) (Holdt & Kraan, 2011). Ulva spp. also show the
presence of trace amounts of docosahexaenoic acid (C22:6 n-3,
DHA), however more abundant LC-PUFA include the DHA precursor, docosapentaenoic acid (C22:5 n-3, DPA), along with the more
unique C18:4 n-3 and C16:4 n-3 PUFA (Holdt & Kraan, 2011). Ulva
grows abundantly in waters enriched by nutrients and is frequently involved in green tides in eutrophicated coastal areas producing a high quantity of biomass (Leliaert et al., 2009). This
characteristic of Ulva means that it is well suited for cultivation.
Therefore as whole biomass or as part of a sequential biorefinery
system of production, cultivated Ulva biomass has the potential
to offer a sustainable source of essential FA for human and animal
consumption and nutrition.
The feasibility of cultivating marine macroalgae, as a sustainable
source of high value products is largely dependent on the costeffectiveness and scalability of cultivation to deliver high yields of
⇑ Corresponding author.
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quality controlled biomass. Ulva is a cosmopolitan genus (Fig. 1)
and can readily adjust its metabolism under specific environmental
conditions, wherein the lipids and FA play an important role in this
adaptation (Nesterov, Rozentsvet, & Bogdanova, 2013). As such, the
profiles of reported FA for Ulva show a wide degree of natural variation. For example Ulva intestinalis has demonstrated an increase in
unsaturation with increasing mineralisation in a study of a number
of abiotic factors (Nesterov et al., 2013). Seasonal comparison of
Ulva lactuca samples collected in Western Ireland showed a notable
decrease in the n-6/n-3 ratio when collected in November (cf. June)
(Schmid, Guihéneuf, & Stengel, 2014). Furthermore, the range of
reported n-6/n-3 values were also more favourable when compared
to an U. lactuca specimen collected from Northern Chile (Ortiz et al.,
2006). However, one of the appeals of Ulva in particular as a target
genus, is its ability to be grown effectively and rapidly in culture,
while tailoring PUFA profiles through nutrient replete conditions,
which have been demonstrated on the laboratory scale (Ak,
Öztas!kent, Özüğru, & Göksan, 2015). It has also been shown that culture conditions including temperature (An et al., 2013), pH (Spilling,
Brynjólfsdóttir, Enss, Rischer, & Svavarsson, 2013) and nutrient
availability along with the presence of organic carbon (Ak et al.,
2015), will also influence the lipid profile of many algae including
Ulva spp. Despite this, there are species-specific patterns within that
variability that can be determined with experimental means and
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